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ABSTRACT

THE EMERGING INVOLVEMENT OF GLIA IN SLEEP: INSIGHTS FROM
DROSOPHILA MELANOGASTER
Gregory S. Artiushin
Amita Sehgal

Sleep is a pervasive, but enigmatic behavioral state, and the search for its cellular and
molecular correlates and purpose has encompassed the entire brain. Glia are important
constituents of the nervous system, intricately tied to neuronal activity, and serving many
functions which coincide with the predominant hypotheses of sleeps functions. Nevertheless, the
contributions of these populations to sleep have so far been understudied. In Chapter 1, the
basics of sleep as a phenomenon are introduced, and are followed by a discussion of the
potential functions this state fulfills. Sleep is regulated by distinct neuronal populations, which are
described, with particular emphasis on Drosophila melanogaster circuitry. This serves as context
for reviewing the nascent literature on glial roles in sleep function and regulation. The work of this
thesis investigates new contributions to this interaction, using the fly as a model system. Chapter
2 presents findings which implicate endocytic trafficking in the barrier glia, the fly equivalent of a
blood-brain barrier, as both an influence on sleep amount, and a functional correlate of the state.
An additional mechanism to astrocytic regulation of sleep is introduced in Chapter 3, by
describing a monoamine catabolizing enzyme which is expressed in astrocytes, and is involved in
homeostatic sleep control in the fly. Chapter 4 returns to the barrier glia, and provides preliminary
findings from metabolomic profiling and a behavioral screen seeking to understand which barrierenriched genes may be consequential for sleep. Together these results expand the scope of glial
involvement in sleep and Chapter 5 concludes with a discussion of the broader implications of
barrier functions in sleep.
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Chapter 1: Introduction to Sleep Regulation and Functions in
Neurons and Glia
Introduction to Sleep
Of all fundamental behaviors common to animals, perhaps none is as universal,
recognizable, and yet simultaneously paradoxical and inexplicable as the state of sleep. For
humans, sleep commands an inordinately large portion of our time. Sleeps associations with
health are profound, and although the means of its influence are as of yet poorly defined, the
consequences of sleep loss are readily felt. Sleep is at the intersection of economic and societal
tension, as modern life creates and demands a world increasingly detached from the confines of
environmental rhythms. It is the host of dreams, a reoccurring spiritual and philosophical muse
throughout history, and as the only quotidian separation in an otherwise seamless flow of sensory
experience, even today may have something to teach us of the nature of consciousness.
Therefore, understanding what sleep entails – from the behavioral to the cellular, molecular and
genetic level – how it is regulated and what purposes it holds , represents not only a great
curiosity for our understanding of the brain and our daily cycles, but also a fundamental biological
puzzle, still recognized as among the most beguiling questions in the realm of scientific inquiry.

Sleep Definition
The first application of electrophysiological techniques in the form of rudimentary surface
electrodes place along the scalp provided early and spurring evidence to suggest that
phenomena of sleep are more complex than would have previously appeared. These
electroencephalograms (EEGs) demonstrated that rather than a quiescent or diminished state,
reflecting the visible behavior of the animal, the gross electrical patterns of a sleeping brain were
active and markedly distinct from those seen during wake. The development and combined use
of techniques including electroencephalography (EEG), electromyography (EMG), and
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electroocculagraphy (EOG) led to the description of two basic states of sleep, rapid eye
movement sleep (REM) and non-rapid eye movement sleep (NREM) (Aserinsky and Kleitman,
1953, Jouvet, 1967). Apart from the namesake movements of the eyes seen in certain
vertebrates, the two forms of sleep are distinguishable from wake by their EEG/EMG
characteristics. In REM, which is the relatively rarer state in adult terrestrial mammals, cortical
activity is desynchronized and dominated by faster frequencies similar to wake, while muscular
activity is essentially absent, reflecting the paralyzing effect of brainstem circuits (Brown et al.,
2012). NREM, or slow-wave sleep, is defined by synchronous, high amplitude frequencies known
as delta (0 – 4 Hz), with the power of this band serving as a proxy for sleep pressure or need,
which dissipates over the course of the resting period (Dijk et al., 1990). This NREM EEG pattern
is a product of synchronous depolarized and hyperpolarized states in cortical neurons (Contreras
and Steriade, 1995), resulting from rhythmic loops with thalamus. Importantly, these
electrophysiological definitions of sleep states, with some variation, hold for humans and other
mammals, as well as for birds, which initially suggested that NREM and REM emerged through
convergent evolution (Rattenborg, 2006).
While polysomnography is often used to score sleep in humans, mammals, and birds, the
presence of electrophysiological signatures of sleep appears to largely depend on a developed
neocortex or hyperpallium (in birds). The brains of reptiles and amphibians have been generally
impervious to the detection of EEG patterns of sleep (Siegel, 2008), despite behavioral
observations suggesting that sleep is abundant, particularly in reptiles. With some liberties, recent
reports have also argued for the existence of slow-waves and REM in the bearded dragon
(Shein-Idelson et al., 2016, Libourel et al., 2018), which would instead define a common ancestor
for the states in mammals and birds. Crayfish, which are a part of the protostome branch, an
early split away from vertebrates, appear to have more synchronous activity in the sleep state,
although not within the same frequencies as NREM (Ramón et al., 2004). Likewise, more recent
branches of insects such as Drosophila show some alterations in broadband field potentials with
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state changes (Van Alphen et al., 2013, Yap et al., 2017), but these are not as recognizable or
reliable as mammalian and bird signals, and overt comparisons to slow-waves are arguable.
Therefore, as a matter of principle as well as of practicality in smaller and less complex
organisms, there exist simpler and more broadly applicable criteria for sleep, which are based in
behavior. The behavioral definition of sleep includes several key attributes. Sleep is marked by
increased threshold for behavioral response to diverse sensory stimuli (auditory, etc.), but is also
a rapidly reversible state, which differentiates it from other states such as hibernation, general
anesthesia, and coma. Sleep occurs in species-dependent specific patterns across the 24-hour
circadian cycle. This timing is thought to be influenced by the circadian clock, whose phase is set
by environmental factors (Merrow et al., 2005). Functionally, these daily patterns of unperturbed
sleep are referred to as ‘baseline’ sleep, as to distinguish it from homeostatic sleep, which will be
described shortly. An influential conceptualization of sleep regulation has been the two-process
model (Borbély, 1982), which predicts propensity to sleep as an interaction of two independent
influences of circadian time, as well as homeostatic sleep pressure, which rises with time awake.
Nevertheless, emerging evidence suggests that these processes are not fully independent, but
have mutual influence on each other (Borbély et al., 2016), although the circuit-level mechanisms
are not well established.
The final, and crucial behavioral characteristic of sleep, is that it follows homeostatic
regulation. When sleep occurring at the appropriate circadian time is foregone, or forcibly
deprived, there is a compensatory rebound, which manifests as increased time or depth of sleep
(Deboer, 2013), often occurring at the next available opportunity which, if homeostatic pressure is
great enough, may occur at inappropriate circadian times. While baseline sleep is often
considered to be under homeostatic influence, as propensity for sleep increases with time awake,
there is evidence to suggest that the neuronal and genetic factors of homeostatic and baseline
sleep are separable (Dubowy and Sehgal, 2017).
By these behavioral criteria, several non-mammalian model organisms have become
popular in sleep neuroscience within the past two decades, including the fruit fly, Drosophila
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melanogaster. The roundworm, C. elegans, also fulfills the behavioral criteria of sleep through
lethargus, which occurs during larval development (Raizen et al., 2008), as well as stress-induced
sleep state in adults (Hill et al., 2014). Recent reports argue that sleep can be demonstrated in
increasingly ancestral organisms, such as jellyfish (Nath et al., 2017), while others have
suggested that patterns of excitability even in isolated cells may be a prototypical form of sleep
(Hinard et al., 2012). For the purposes of the current work in Drosophila, we adopt the behavioral
definition, of which flies fulfill every criterion (Hendricks et al., 2000, Shaw et al., 2000) and share
considerable overlap with other organisms in the genetic, molecular (Sehgal and Mignot, 2011),
and cellular (Bushey et al., 2011) correlates of sleep states.

Sleep Functions
Within phylogeny, sleep is both deeply and broadly present, suggesting that the profound
conservation and/or perpetual convergent emergence of the state in different lineages points to a
core, inescapable value or function. An evolutionarily ancient or unifying function would not
exclude additional roles for sleep which would arise or be co-opted as necessary in particular
lineages. Nevertheless, a testament to the controversial nature of the purpose of sleep is the
very existence of a ‘null’ hypothesis for sleep (Cirelli and Tononi, 2008), a proposal which would
seem unthinkable by comparison if one were to ask the function of equally basic behaviors such
as eating or respiration. This argument posits that sleep serves no function or is at most a
mechanism to deter animals from activity at energetically or environmentally unfavorable times
(Siegel, 2008).
But even if sleep was nothing more than a passive state, it could be argued to hold an
energetic or metabolic advantage. Of the major hypotheses of sleeps function, the
energetic/metabolic homeostasis hypothesis is more likely to be a fundamental, rather than
ancillary adaptation of sleep, because several other putative sleep functions such as plasticity or
macromolecular biosynthesis may in fact be driven by energetic demands. Furthermore, cycles of
metabolic activity and energy availability are almost universally relevant, even to the function of
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unicellular organisms. In mammals, the brain uses a disproportionately large amount of the
body’s energy to sustain daily function. While superficially, glucose imaging studies support that
metabolic rate is diminished in NREM sleep as compared to wake (Heiss et al., 1985, Ramm and
Frost, 1986), this decline is moderate, and is complicated by the fact that there are regional
discrepancies and REM may even be more metabolically demanding (Buchsbaum et al., 2001).
To understand the interplay between states and metabolism requires a finer view of neuronal and
glial populations and their energy supply. There is disagreement as to what the dominant
energetic substrates in the brain are, with hypotheses focusing on either glucose/glycogen
(Benington and Heller, 1995) or lactate trafficking (Pellerin and Magistretti, 1994). In both cases,
neuronal firing during wake would tax glial energy stores, and be manifest as accruing some
homeostatic signal, such as adenosine or glutamate levels. Sleep has been proposed to serve as
a time to replenish glycogen, which is found in astrocytes (Benington and Heller, 1995). The
evidence that glycogen is altered as a function of state is inconsistent, with studies in multiple
animal models showing conflicting changes, with only examples of decrements occurring after
sleep deprivation (Franken et al., 2003, Zimmerman et al., 2004). While glucose is clearly used
by neurons, lactate may also contribute, as it has found to be used by specific sleep-wake
circuitry (Clasadonte et al., 2017), and astrocyte-specific changes transcript changes show some
support for state-dependent lactate use (Petit et al., 2013).
Transcriptional work has also formed the basis of the macromolecular biosynthesis
hypothesis of sleep (Mackiewicz et al., 2007). Studies of global gene expression, performed
primarily with microarrays, (Mackiewicz et al., 2007, Jones et al., 2008, Cirelli et al., 2005, Cirelli
et al., 2004) have found consistent changes in classes of genes between sleep, wake and sleep
deprived states, even among different animals including flies, rodents, and birds. These changes
suggest that genes elevated during sleep are involved in processes that contribute to
membranes, vesicular and intracellular traffic, as well as synthesis of protein, cholesterol and lipid
trafficking, among others (Cirelli, 2009, Mackiewicz et al., 2007). Whether or not these changes at
the level of transcripts, are reflected in protein (Wang et al., 2018) and actual function needs to be
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determined, but this hypothesis is also supported by studies which have attempted to quantify
protein synthesis rates across state, and tend to find evidence for greater translation with NREM
sleep (Nakanishi et al., 1997, Ramm and Smith, 1990). On the other hand, sleep deprivation can
lead to accumulation of unfolded proteins and the mobilization of chaperones and signaling in this
pathway can itself influence sleep amount (Naidoo et al., 2007, Naidoo et al., 2005).The
macromolecular hypothesis has been considered as a component of a greater
metabolic/energetic hypothesis, wherein processes of cellular upkeep predominantly occur during
sleep as an energetic division of labor, as they may be less efficient or interrupt ongoing neuronal
function during wake (Schmidt, 2014).
As with other intuitive ideas for the purpose of sleep, the concept of sleep as a restorative
removal of deleterious products which arise from waking experience far outdates any conclusive
evidence for it. In recent years, a new mechanism by which cerebrospinal fluid exchanges with
the interstitial fluid of the brain has been described, known as the glymphatic system (Iliff et al.,
2012). From this follows the newest, albeit least examined hypothesis – the glymphatic
hypothesis of sleep. The volume of interstitial space in sleeping mice was found to be more than
60% greater than in awake mice, and clearance of injected CSF markers was substantially
elevated (Xie et al., 2013). Therefore, sleep may be a state which supports rejuvenation of the
brain through enhanced turnover and clearance of interstitial fluid.
In humans, the importance of sleep is most pressingly demonstrated by the cognitive
deficits which abound when one forgoes sleep. A rich literature spanning vertebrate and
invertebrate animal models exists showing a relationship between sleep and learning, memory,
and the underlying mechanisms of synaptic plasticity (Abel et al., 2013, Diekelmann and Born,
2010, Stickgold and Walker, 2005). Sleep loss in a critical time window following learning is
detrimental to memory consolidation (Graves et al., 2003, Vecsey et al., 2009), while attaining
sleep can improve subsequent memory performance (Donlea et al., 2011, Marshall et al., 2006).
Within this vein of sleep research, an organizing hypothesis is the synaptic homeostasis
hypothesis (Tononi and Cirelli, 2014). In short, this hypothesis proposes that neuronal activity
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throughout the day leads to a general potentiation, or strengthening of synaptic connections
evidenced by firing rates, structural changes in spines and greater AMPA receptor inclusion, and
that sleep serves a regulatory function by downscaling these effects, to the service of continued
plasticity and potential energetic savings. Importantly, there are many forms of synaptic plasticity,
whose expression is variable depending on stimuli and specific circuits in question (Malenka and
Bear, 2004). Evidence during development (Frank et al., 2001) and following motor-learning in
adult animals (Yang et al., 2014) finds that NREM and REM periods may in fact support synaptic
strengthening and spine formation, or at least prevent their elimination. Likewise, homeostatic
scaling in neuronal firing rate has been found to occur during wake, rather than sleep (Hengen et
al., 2016). Therefore, while plasticity and sleep have profound interactions, the full extent of
mechanisms still requires much study.
Finally, sleep and sleepiness may increase in individuals during sickness, and sleep
could aid in recovery (Prather et al., 2015). This interaction is bidirectional, in that sleep loss is
detrimental to immune function and may increase inflammation (Besedovsky et al., 2012), while
immune factors enhance sleep during infection as well as in daily, healthy states (Fang et al.,
1997, Fang et al., 1998). Cytokines such as interleukin-1 promote NREM sleep, and their levels
correlate with sleep need (Krueger, 2008, Krueger et al., 1984). TNFα is another example, which
is also a prominent regulator of synaptic plasticity (Rockstrom et al., 2018). Many other cytokines
are secondary effectors of the state, potentially acting through IL-1 and various targets (Krueger,
2008, Opp, 2005). Sickness and immune factors also regulate states in invertebrates (Williams et
al., 2007), with sleep promoting survival after infection in the fly (Kuo and Williams, 2014), and
cellular stress being among the only ways to induce sleep in adult C. elegans (Trojanowski et al.,
2015). It has also been found that antimicrobial peptides in the fly promote sleep (Dissel et al.,
2015b, Toda et al., 2019), further supporting that substances involved in infection response and
immunity serve a dual role by affecting sleep.
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Sleep Control
Independently of the potential physiological or cellular functions, a preponderance of
research has focused on discovering circuits and their respective neuronal populations which
may modulate sleep upon silencing, activation or ablation.
In mammals, a conceptual principle for NREM regulation has emerged known as the flipflop switch circuitry (Saper et al., 2010), which posits that NREM transitions are a result of
mutually inhibitory sleep and wake-promoting circuits (reviewed extensively (Brown et al., 2012,
Saper et al., 2010, Scammell et al., 2017, Weber and Dan, 2016)). The wake circuits are
composed of the ascending arousal network – including the noradrenergic locus coeruleus,
serotoninergic dorsal/median raphe nucleus, histaminergic tuberomamillary nucleus, and
dopaminergic ventral periaqueductal gray and ventral tegmental area. Overall, cortical
concentrations of these excitatory neuromodulators are increased in wake and reduced in sleep.
The glutamatergic projections of the parabrachial nucleus also promote wake, and project widely
in the cortex as well as to the basal forebrain, which though diverse, is important for arousal
(Scammell et al., 2017). The orexinergic neurons of the hypothalamus are considered a
stabilizing force on wake circuits, as they innervate essentially all of the above circuits to promote
wake.
The hypothalamus is highly diverse, but contains two populations which promote sleep
and show electrophysiological correlates of sleep need. These are the ventrolateral preoptic area
(VLPO) and median preoptic nucleus (MnPO) (Alam et al., 2014), which form the sleep-side of
the switch, by inhibiting the aforementioned ascending arousal circuitry. Additional sleep
promoting areas are in the brain stem parafacial zone, which promote NREM through inhibition of
the parabrachial nucleus (Anaclet et al., 2015) , and in the ventral zona incerta, where
GABAergic, LIM homeodomain factor-positive neurons receive abundant projections from much
of the aforementioned circuitry and promote sleep by inhibiting orexinergic neurons (Lui et al.,
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2017). There are also sleep-promoting nNos cortical and basal forebrain neurons, although it is
unclear how these populations relate to the remaining sleep circuitry (Scammell et al., 2017).
REM sleep, while occurring interspersed between NREM sleep bouts, is regulated by overlapping
inputs, but also distinct circuitry located primarily in the pons and medulla (Scammell et al., 2017).
The sublateral dorsal nucleus (SLD) of the pons contains REM-active neurons (Lu et al., 2006),
which along with neurons of the ventromedial medulla, project to the spinal cord to produce the
muscle atonia of REM. Populations in the ventrolateral periaqueductal gray area inhibit REM by
acting on SLD (Weber and Dan, 2016), as do some of the arousing monoaminergic populations
such as the noradrenergic locus coeruleus, and the serotonergic dorsal raphe, thereby providing
overlap with NREM inhibition. Likewise, there are also REM promoting neurons in the
hypothalamus, adjacent to VLPO (Lu et al., 2002), as well as the REM-inhibiting orexinergic cells
(Scammell et al., 2017).
The aforementioned circuitry is generally informative to sleep-wake control in mammals,
but neuronal circuitry, even if it shares molecular signatures, is poorly conserved in more distant
phylogenetic relatives, and is hence largely not translatable to universal conclusions about sleep.
Therefore, the specifics of circuit-based sleep regulation beyond basic principles such as mutually
inhibitory sleep and wake populations must, at present, be regarded in reference to the particular
model organism of interest. Since the work of this thesis employs Drosophila melanogaster as a
model to study new cellular influences on sleep, the following section will specifically review the
fly neuronal populations and circuits currently known to affect sleep in both unperturbed and
homeostatic response conditions. This will establish the foundation from which to investigate how
glial cells, the often overlooked but major component of brain tissue, integrate within this circuitry
to influence sleep and wake.
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Abstract:
Sleep is a deeply conserved, yet fundamentally mysterious behavioral state. Knowledge of the
circuitry of sleep-wake regulation is an essential step in understanding the physiology of the
sleeping brain. Recent efforts in Drosophila have revealed new populations which impact sleep,
as well as provided unprecedented mechanistic and electrophysiological detail of established
sleep-regulating neurons. Multiple, distributed centers of sleep-wake circuitry exist in the fly,
including the mushroom bodies, central complex and the circadian clock cells. Intriguingly, certain
populations have been implicated in specific roles in homeostatic rebound sleep, occurring after
sleep loss. In short, our knowledge of fly sleep circuitry advances towards a greater view of brainwide connectivity and integration of the signals and correlates of the state of sleep.
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Introduction:
The use of Drosophila as a model for sleep research has grown for more than 15 years
(Hendricks et al., 2000, Shaw et al., 2000) to become a vital component of our efforts to
understand the molecular and cellular mechanisms and functions of this enigmatic behavioral
state. The ease and power of genetic manipulation in this model has enabled targeted
examination of neurotransmitter/neuromodulator systems (Crocker and Sehgal, 2010, Nall and
Sehgal, 2014, Griffith, 2013) and neuropeptides (Sehgal and Mignot, 2011) for a role in sleepwake states, and led the way in forward-genetic screens to identify novel genes that regulate
sleep (Koh et al., 2008, Shi et al., 2014, Stavropoulos and Young, 2011).
The focus of this review will be on the circuitry of sleep-wake states, which has also been
comprehensively studied in Drosophila. Advances in our understanding of fly brain anatomy,
coupled with technology to manipulate activity of specific neurons, have facilitated the
identification of neural populations required for daily baseline sleep and arousal as well as those
that function in sleep homeostasis. The latter is typically assayed by depriving flies of sleep and
monitoring the increased sleep (rebound) that follows. Interestingly, as discussed below,
baseline and homeostatic sleep may be controlled by distinct neurons.

Sleep and Wake-Promoting Circuits in the Mushroom Bodies:
Located in the protocerebrum of the Drosophila brain, the mushroom body (MB) is a
structure which has classically been established as an essential associative center for olfactory
learning and memory, although more recently, this network has begun to be appreciated for much
broader roles in behavior (Aso et al., 2014a, Aso et al., 2014b). The mushroom bodies are
comprised of Kenyon cells (KCs) whose axons project together to form the three MB lobes –
α/β, α’/β’, and γ – which can be further divided into 2-3 types, depending on projection pattern
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within each lobe. KCs synapse with the mushroom body output neurons (MBONs), whose
dendrites cover the lobes as distinct “compartments” (Aso et al., 2014a).
Early circuitry studies identified both sleep and wake-promoting populations in the mushroom
body (Joiner et al., 2006, Pitman et al., 2006). Manipulation of signaling or neural activity by the
Gal4-UAS system in multiple MB lobes revealed that sleep effects arise, at least in part, from α/β
populations. Examination of cellular mechanisms implicates Go signaling as important for sleep
regulation through the MBs (Guo et al., 2011, Yi et al., 2013). Limiting expression of a
constitutively active Go to adulthood with a specific MB driver decreased total sleep, while
blocking Go signaling via pertussis toxin led to increased day sleep and nighttime fragmentation,
attributable to a cholinergic population(Yi et al., 2013). Interestingly, pertussis toxin produced loss
of sleep with other MB drivers, supporting varied effects of multiple sleep-regulating MB neurons
(Yi et al., 2013).
In these, as in other circuit examinations, promiscuity of driver expression pattern is a
constant caveat. As example, the 201y-Gal4 driver exhibits broad MB expression and promotes
sleep when driving PKA(Joiner et al., 2006). In addition, conditional depolarization of 201Y
neurons by activation of the heat-sensitive TrpA1 channel(Hamada et al., 2008) increases total
sleep, while silencing with Shibire, a temperature-sensitive dominant negative dynamin (Kitamoto,
2001), decreases sleep(Cavanaugh et al., 2015). Nevertheless, Gal80 (an inhibitor of Gal4)
experiments show that these effects come from populations external to the mushroom
body(Cavanaugh et al., 2015).
More recent studies of the MB have taken advantage of improved tools for the dissection
of Drosophila circuitry, namely the “split-Gal4” system (Luan et al., 2006), which considerably
refines expression by segregating Gal4 domains to two enhancers whose expression must
overlap. Using such drivers to target the KCs, TrpA1 activation revealed 5 split-Gal4
combinations localized to α’/β’ KCs to be wake-promoting(Sitaraman et al., 2015a). The γmain KCs
were also wake-promoting, while γdorsal KCs promoted sleep. Interestingly, no effects were shown
with α/β lobe split-Gal4s. While comparative strength of classic and split-Gal4 drivers may be
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questioned, previous works implicating α/β (Joiner et al., 2006, Pitman et al., 2006, Yi et al.,
2013) concluded so based on overlapping driver expression, which often also contained γ lobe
expression.

Output from the Mushroom Bodies:
Regarding the postsynaptic targets of KCs, the GABAergic MBONs which synapse with
y3 and B'1 KCs (MBON-y3B'1 and MBON-y3) were found to promote sleep upon TrpA1-mediated
activation, as did the cholinergic MBON-calyx and MBON-y2a'1. Wake-promoting MBONs
(y4>y1y2, B'2mp, y5B'2a, B'2mp_bilateral) were also discovered, with all being glutamatergic(Aso
et al., 2014b, Sitaraman et al., 2015a). Curiously, although MBONs are convergent outputs of KC
signaling, neither the wake-promoting MBON-γ5β'2α/β'2mp/β'2mp_bilateral nor the sleeppromoting MBON-γ2α'1 produced significant baseline sleep alteration when conditionally silenced
with Shibire(Sitaraman et al., 2015a), suggesting that they, or at least sleep-promoting MBONs,
have a greater role in homeostatic sleep (see below).
Since sleep-promoting (MBON-γ2α'1) and wake-promoting (MBONγ5β'2α/β'2mp/β'2mp_bilateral) output neurons receive input from both sleep and wake-promoting
KCs, the question of how these signals are integrated arises (Aso et al., 2014a, Sitaraman et al.,
2015a). The sleep-loss produced by α’/β’ KC activation could be abrogated by simultaneously
silencing MBON-γ5β'2α/β'2mp/β'2mp_bilateral, but not MBON-γ2α'1. This behavior correlated
with a stronger Ca

2+

response to local excitation of α’/β’ KCs in MBON-

γ5β'2α/β'2mp/β'2mp_bilateral than in MBON-γ2α'1 (Sitaraman et al., 2015a). On the other hand,
using a genetically encoded voltage indicator, greater spontaneous activity was seen in certain
sleep-promoting populations (MBON-γ2α'1 and γdorsal KCs) following sleep-deprivation, with
diminished activity in wake-promoting populations (α’/β’ KCs and MBONγ5β'2α/β'2mp/β'2mp_bilateral). Silencing sleep-promoting MBON-γ2α'1 with Shibire following
sleep deprivation, also limited the resultant rebound sleep (Sitaraman et al., 2015a). Together
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these findings indicate that sleep and wake signals can be traced through KCs to MBONs, and
certain MBONs are important for rebound.

Inputs to the Mushroom Bodies:
The MB lobes are known to receive numerous modulatory inputs, such as from dorsal
paired medial neurons (DPM) and dopaminergic neurons (DANs). DANs innervate distinct
sections which largely cover the MB lobes, and co-localize with the separate MBON dendrites,
allowing the MB lobes to be portioned into “compartments” defined by MBON and DAN
arborization(Aso et al., 2014a, Aso et al., 2014b). TrpA1 activation revealed a number of DANs to
be wake-promoting, while none were sleep-promoting(Sitaraman et al., 2015b). DANs projecting
to the γ5, γ4 and β'2 compartments all increased wake, matching the arborization patterns of
wake-promoting MBONs. At the same time, stimulating certain MB lobe compartments through
DANs increased wake while activation of the respective MBONs did not(Sitaraman et al., 2015b).
Additionally, a sub-population of the dopaminergic PAM neurons, which project to the MBs, is
necessary for the wake-promoting effect of caffeine(Nall et al., 2016), likely through Dop1R1
receptors(Andretic et al., 2008).
A prominent input to the MB are the DPMs – which project to all lobes, and are important
for memory (Haynes et al., 2015, Liu et al., 2008). Lui et al. (Liu et al., 2008) demonstrated that
inhibiting synaptic release from DPMs with tetanus toxin (TNT) leads to shorter, more numerous
sleep bouts. This phenotype was similar to that of mutants lacking the peptide amnesiac,
although DPMs are not the sole source of amnesiac, and also package other
neurotransmitters(Haynes et al., 2015). Consistent with a sleep-regulating function of DPMs,
TrpA1 activation increased total sleep, and conditional Kir2.1 inhibition lead to a decrease in
sleep at night (Haynes et al., 2015). DPM input is inhibitory to the MB and RNAi knockdown of
either the vesicular GABA transporter (VGAT) or tryptophan hydroxylase (serotonin synthesis)
caused a loss of nighttime sleep – suggesting GABA and serotonin signaling. The relevant
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serotonin receptor is likely d5-HT1a, previously implicated in sleep consolidation through its
action in the MBs(Yuan et al., 2006).
In short, the mushroom body has a complex role in sleep-wake regulation (Figure 1).
Kenyon cells of all three major lobes have been implicated, although initial use of broader drivers
may necessitate validation of α/β involvement, with more recent findings focusing on the α’/β’ and
γ divisions. MBONs integrate diverse KC innervations to drive either sleep or wake. Modulatory
inputs from DANs appear to solely be wake-promoting, while inhibitory DPM input is sleeppromoting.

Components of the Central Complex Drive Sleep:
Fan-Shaped Body:
The central complex in Drosophila refers to a group of central brain neuropils, including
the fan-shaped and ellipsoid body which, collectively, are implicated in processes such as
sensory integration and locomotion, memory, and most recently, sleep (Wolff et al., 2015).
Neuronal activation revealed ExFl2 cells of the dorsal fan-shaped body (dFSB) to be profoundly
sleep-promoting (Donlea et al., 2011). Acute activation by TrpA1 demonstrated that sleep could
be driven in defined windows (Donlea et al., 2011, Ueno et al., 2012), with flies showing
increased arousal threshold over the course of activation (Donlea et al., 2011), while
constitutively silencing this population resulted in sleep loss(Liu et al., 2012)
Numerous studies have implicated dopamine in the promotion of wake and arousal in
Drosophila (Andretic et al., 2008, Donlea et al., 2014, Liu et al., 2012, Ueno et al., 2012). DANs
promote wake through the MBs, but dopaminergic input to the dFSB has also been established
anatomically(Liu et al., 2012, Ueno et al., 2012) as well as functionally through cAMP imaging
and electrophysiology (Pimentel et al., 2016, Ueno et al., 2012). Using spatially-restricted DANGal4s to drive TrpA1, Liu et al (Liu et al., 2012) reported that dFSB-projecting DANs of the PPL1
cluster are wake-promoting. Further, silencing through conditional Kir2.1 expression produced an
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opposing increase in sleep (Liu et al., 2012), and multiple DANs exhibited greater vesicular
release during the day (vs night) and following sleep deprivation. Alternatively, employing
stochastic targeting through MARCM(Lee and Luo, 2001), Ueno et al (Ueno et al., 2012)
expressed TrpA1 in individual DANs to show that dFSB-projecting PPM3 cluster neurons promote
wake. Regulation of the DAN-FSB circuit also accounts for heightened sleep of newly eclosed
flies (Kayser et al., 2014, Shaw et al., 2000), which display diminished DAN activity and
concurrently elevated dFSB activty (Kayser et al., 2014).
Consistently, these groups identified Dop1R1 (also referred to as DA1 or DopR) as
mediating the effects of dopamine in the dFSB (Liu et al., 2012, Ueno et al., 2012). Dop1R1
expression restricted to the dFSB supports the low-sleep phenotype of a fumin (dopamine
transporter) mutant (Ueno et al., 2012), as well as increased wake in response to L-dopa feeding
(Liu et al., 2012). However, others found that dFSB knockdown of Dop1R2, but not Dop1R1 or
other dopamine receptors, led to an increase in total sleep (Pimentel et al., 2016). Ueno et al.
(Ueno et al., 2012) also did not see an effect of dFSB Dop1R1 knockdown in otherwise wild-type
background flies. It is possible that both receptors function in the dFSB, with Dop1R1 being
sufficient but not necessary.
In agreement with dopamine operating through a Gs-coupled D1-like receptor,
expression of a constitutively active Gαs in the dFSB produces a decrease in sleep (Ueno et al.,
2012). Further, the dFSB responds directly to dopamine application by increasing cAMP, which is
eliminated with concurrent Dop1R1 knockdown (Ueno et al., 2012). Driving constitutively active
PKA also results in a loss of sleep (Liu et al., 2012), suggesting that dopamine-dependent
inhibition of the dFSB operates through cAMP-dependent signaling. In contrast, while Pimentel et
al (Pimentel et al., 2016) show that dopamine application indeed hyperpolarizes dFSB neurons
through potassium conductance, this effect could be eliminated by pertussis toxin, arguing for a
Gi/o-coupled mechanism downstream of Dop1R2 (Pimentel et al., 2016). As noted above, both
mechanisms are possible.
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Regardless of the relevant receptor(s), sustained dopaminergic tone, as would be
expected during times of wake, is thought to switch dFSB neurons from an excitable, sleeppromoting “ON” state to an electrically quiet “OFF” state (Pimentel et al., 2016). In the ON state,
potassium conductance is dominated by A-type current from Shaker and Shab channels, while
the OFF state is marked by a non-A type current based in Sandman. Appropriately, knockdown of
Shaker or Shab in the dFSB produces a loss of sleep, while decreasing Sandman leads to
greater sleep amount. Impressively, the membrane properties of dFSB neurons correlate with
homeostatic sleep pressure, as the excitability of these neurons was heightened in sleepdeprived flies and normalized with recovery sleep (Donlea et al., 2014). This sensitivity depends
on the Rho-GTPase-activating protein crossveinless-c, and dFSB knockdown of crossveinless-c
impairs the rebound sleep following deprivation.
In sum, the dorsal fan-shaped body and its dopaminergic inputs (Figure 2), represent
one of the best-characterized centers of Drosophila sleep-wake circuitry. Although the exact
identity of the cells providing dopaminergic input as well as the receptor(s) through which
dopamine acts on this population may still be debatable, it is clear that dopamine promotes wake
in the fly, in part, through inhibition of the dFSB.

Ellipsoid Body:
While the ellipsoid body (EB) was not originally found to impact baseline sleep(Donlea
et al., 2011), subsequent work identified R2 EB neurons as mediators of homeostatic sleep
pressure(Liu et al., 2016). R2 activation produces lasting sleep increases, while TNT silencing
during sleep deprivation significantly abrogates rebound sleep. As in the dFSB, excitability of R2
neurons builds across the day, and is further heightened by sleep deprivation. Even further, sleep
need correlates with heightened Ca

2+

levels in R2 neurons, and surprisingly, greater synaptic

density as measured by the active zone protein, Brp. This plasticity is likely dependent on NMDAreceptors, as dNR1 or NR2 knockdown in R2 neurons reduced rebound sleep following
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deprivation. Silencing dFSB neurons prevents the sleep increase produced by R2 activation,
although the circuit is likely not monosynaptic(Liu et al., 2016).

Circadian Clock Cells
The clock neurons, which possess the molecular components of the circadian clock, are
a diffuse network of groups, comprised of the PDF-positive small and large ventral lateral neurons
(sLNVs and lLNVs), the dorsal neurons (DN1s, DN2s, and DN3s) and the dorsal lateral neurons
(LNds) (for detailed review see(Allada and Chung, 2010, Kumar and Sehgal, 2015)).
Constitutive hyperpolarization of PDF-positive cells increases total sleep, while activating the
same population results in sleep loss(Parisky et al., 2008, Sheeba et al., 2008). A much subtler
loss of sleep, limited to the early night, was seen when excitation of the LNvs was limited to
adulthood by TrpA1 (Parisky et al., 2008). In support, mutants lacking PDF(Parisky et al., 2008),
the PDF receptor, or PDF neurons altogether(Chung et al., 2009), exhibit greater sleep.
Since both lLNVs and sLNVs express PDF, multiple groups have attempted to
differentiate the effects of each population on sleep (Parisky et al., 2008, Shang et al., 2008,
Sheeba et al., 2008). These studies have been limited by a lack of drivers for lNVs alone,
necessitating different strategies, which may account for differences in results. Multiple groups
have employed the c929-Gal4 driver, which targets a large span of peptidergic neurons, including
the lLNVs but not the sLNVs (Parisky et al., 2008, Shang et al., 2008, Sheeba et al., 2008).
Consistently, activating c929-Gal4 produced decreases in nighttime sleep (Parisky et al., 2008,
Shang et al., 2008), although non-clock cells also contribute to the phenotype. A separate
strategy ablated Pdf-G4-expressing sLNvs with poly-Q Huntingtin protein while activating the
lLNvs with NachBac, and found that lLNv hyperexcitability is sufficient to decrease nighttime
sleep (Sheeba et al., 2008). Knocking down PDFR in the PDF-Gal4 population is argued to
mainly impact sLNVs, as the lLNVs are not as responsive to the neuropeptide, and doing so
produces an increase in day and night sleep (Parisky et al., 2008), but another group used an
sLNV-specific driver (R6-Gal4) and found no effect on sleep with NaChBac activation (Shang et
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al., 2008). The very widely expressed, sleep-promoting short neuropeptide F (sNPF) may have a
weak role in sleep-promotion through sLNVs(Shang et al., 2013). In short, multiple findings
demonstrate that lLNvs are wake-promoting cells, while the role of sLNvs is not well defined.
GABAergic input to the LNvs is important for sleep as knock down of the GABAA receptor,
Resistant to dieldrin (Rdl) by PDF-Gal4 decreased total sleep (Parisky et al., 2008). Given that
Rdl expression was largely detected in lLNvs, these findings suggest that GABA may promote
sleep by inhibiting lLNvs, which otherwise promote wake, at least in part, though PDF signaling
(Figure 3) (Chung et al., 2009). Interestingly, WIDE AWAKE acts in lLNVs to control Rdl levels
as a function of the circadian clock, thereby dampening arousal-promoting effects of these cells at
dusk (Liu et al., 2014).
More recently, the DN1 neurons, which connect anatomically (Guo et al., 2016, Kunst et
al., 2014) and functionally (Guo et al., 2016) to sLNVs and LNds, were shown to modulate sleepwake patterns. Kunst et al (Kunst et al., 2014) showed that the fly ortholog of calcitonin generelated peptide, DH31, acts in a small sub-set of DN1s to promote wakefulness. Expressing
DH31 in this population in a DH31 mutant background produced a modest increase in wake in the
hours before dawn, a phenotype mimicked by tethered-PDF expression. However, this DN1 subpopulation is not the sole mediator of PDF influence on sleep. Using the same tethered-PDF
construct, others have found that the PLP sub-type of allatostatin-A (AstA) positive cells
increases sleep in response to PDF, as well as TrpA1 activation (Chen et al., 2016). Consistently,
AstA dendrites are found in close association to PDF-positive terminals and exhibit a cAMP
response to PDF. While TrpA1 activation of DN1s produced an even greater sleep loss than
DH31 expression(Kunst et al., 2014), another group used the same DN1 driver for optogenetic
manipulation and instead found an increase in daytime sleep with excitation, and a loss of
nighttime sleep with inhibition(Guo et al., 2016). This discrepancy may come from time-of-dayspecific effects of DN1s, in particular reflecting their interaction with light (Guo et al., 2016,
Parisky et al., 2016). DN1s inhibit multiple clock populations through glutamate, suggesting a
mechanism for the behavioral effects (Guo et al., 2016). Together, these results show a DN1
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contribution to wake, through DH31 signaling, and sleep by inhibition of the clock neuron network
(Figure 3).

The Pars Intercerebralis and Other Sleep-wake Regulating Populations
One other region of well-described sleep-wake circuitry lies in the pars intercerebralis (PI), a
diverse, neuropeptidergic population which has been compared to the mammalian hypothalamus
(Foltenyi et al., 2007).
The insulin-producing cells (IPCs) in the PI are wake-promoting (Crocker et al., 2010).
This population is depolarized by octopamine, a wake-promoting neuromodulator, which
produces an increase in cAMP, and affects the Slowpoke potassium current. Thereby, the model
posits that octopamine-mediated excitation of the IPCs reduces sleep and this is likely mediated
by the OAMB receptor, as OAMB rescue by IPC-G4 in a receptor null background restored sleep
loss due to octopamine feeding. The ASM subset of octopaminergic neurons is sufficient to
promote wake and is located close to the PI (Crocker et al., 2010) (Figure 4).
Additionally, the PI may impact sleep through epidermal growth factor (EGF)(Foltenyi et al., 2007)
and SIFamide signaling(Park et al., 2014). Using several drivers which overlap in the PI, Foltenyi
et al (Foltenyi et al., 2007) demonstrated that conditional expression of the secreted EGFR
ligand, s-Spitz, increased total sleep, while knockdown of its processing enzyme, Rho, reduced
day and night sleep. SIFamide is expressed in four PI cells(Cavanaugh et al., 2014)and its
knockdown resulted in a loss of sleep (Park et al., 2014). In sum, the PI contains wake-promoting
IPCs and sleep-promoting neuropeptidergic cells (Figure 4).
Still other sleep-wake regulating populations have been identified that, to date, lack
placement in a particular circuit (Figure 4). A split-Gal4 population common to ppk-Gal4 and
24C10-Gal4 projects to the thoracic and gnathal ganglia, promotes wake and elicits a
homeostatic sleep increase following its activation. However, these neurons do not produce loss
of sleep when silenced and are not involved in baseline sleep (Seidner et al., 2015). Interestingly,
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the ppk-Gal4 population has also been found to be involved in temperature-induced alterations of
daytime sleep, potentially through signaling to DN1s, to which some anatomically connectivity has
been demonstrated(Lamaze A, 2017). Elsewhere, CycA, Cdk1 and the novel gene TARANIS
interact to affect sleep in a wake-promoting pars lateralis population(Afonso et al., 2015).
A final, often underappreciated “circuit” member, are glial cells. Tools to selectively target glia
adjoining specific neurons have largely been lacking. Nevertheless, astrocytes of the MB have
been argued to affect homeostatic sleep, as Delta overexpression in MB neurons, or the
intracellular domain of its receptor Notch in astroctyes can impair rebound sleep(Seugnet et al.,
2011). Additionally, the short-sleeping sleepless mutants are known to exhibit lower GABA
levels, which is thought to result from upregulation of GABA transaminase in glia(Chen et al.,
2015).

Conclusion:
In conclusion, multiple circuits of sleep-wake regulating neurons are found throughout the
Drosophila brain. A clear, outstanding question is whether and how these disparate loci connect
to control states, particularly given that any number of populations can mediate profound sleepwake alteration. In fact, few studies(Cavanaugh et al., 2015) have attempted to link the currently
known centers of sleep-wake circuitry.
Another major interest regards the interplay between baseline and homeostatic sleep
regulation. A molecular or electrophysiological correlate of homeostatic sleep need has been
described in at least three of the major circuits (Donlea et al., 2014, Liu et al., 2016, Pimentel et
al., 2016, Sitaraman et al., 2015a), again prompting the question of connectivity. Further, several
populations appear to function in daily as well as rebound sleep(Donlea et al., 2014, Sitaraman et
al., 2015a, Donlea et al., 2011), while others have a dedicated homeostatic role (Liu et al., 2016,
Seidner et al., 2015).
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The Drosophila anatomy differs considerably from that of mammals (Saper et al., 2010),
but the fly provides ultimate value in identifying signals integrated in sleep circuits and circuit
principles that underlie regulation of the sleep state.
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Figure 1: The mushroom body exhibits complicated influence on sleep and wake
Mushroom body α’β’ and γm KCs are wake-promoting, while γd promote sleep. All of these KCs
synapse at MBONs within the MB lobes, and the signal is integrated by glutamatergic wakepromoting MBONs (γ5,β’2, γ4) or sleep-promoting GABAergic (γ3,β’1) or cholinergic (α’ γ2)
MBONS. DANs project to MBONs, and are wake-promoting through dopamine. DPMs are sleep
promoting, and signal through GABA and serotonin. DPMs project to all lobes and are thought to
be inhibitory. Blue fills indicate a sleep-promoting population. Red fills indicate a wake-promoting
population. DA = dopamine. 5HT = serotonin. GLUT = glutamate. ACH = acetylcholine.
Mushroom body and DAN depiction based on representations in Aso et al. [11] and Sitaraman et
al. [21].
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Figure 2: The central complex promotes sleep: dorsal Fan-shaped body and ellipsoid body
ExFl2 neurons of the dFSB and R2 neurons of the ellipsoid body are sleep-promoting. dFSB
neurons are inhibited by dopaminergic neurons of the PPL1 and PPM3 cluster. The sleeppromoting effect of R2 depends on dFSB activity; the connectivity is unknown, but not
monosynaptic. Blue fills indicate a sleep-promoting population. Red fills indicate a wakepromoting population. DA = dopamine
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Figure 3: The circadian clock network influences both sleep and wake
The LNVs have been found to promote wake, at least in part through release of wake-promoting
PDF. lLNvs are inhibited by GABA, although the source is unknown. DN1s are both wakepromoting through DH31+ neurons, as well as sleep-promoting through inhibition of sLNvs by
glutamate. Whether these populations are distinct is unknown. Blue fills indicate a sleeppromoting population. Red fills indicate a wake-promoting population. Purple fills indicate
populations which may promote sleep and wake. Diamonds are neuropeptides, with red fill
indicating wake-promotion. GLUT = glutamate.
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Figure 4: The PI is a diverse neurosecretory center which can promote sleep and wake
IPCs of the PI are wake-promoting and are depolarized by the wake-promoting neuromodulator,
octopamine. Other neurons within or adjacent to the PI are sleep promoting, through EGF and/or
SIFamide signaling. A PL population is wake promoting, although not linked to currently known
circuitry. Blue fills indicate a sleep-promoting population. Red fills indicate a wake-promoting
population. Diamonds are neurotransmitters/peptides. OA = octopamine.
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Glia and Sleep
Introduction:
While neurons and circuits are almost unequivocally (see dissent (Galambos, 1961))
considered to be the computational units and actuators of behavior, a complete understanding of
the nervous system must incorporate glial cells. Far beyond a copious but passive substrate, the
functions of neuronal physiology are inextricable from glial influence, whether during
developmental guidance and synaptic shaping, or through the trophic support, neurotransmitter
and ion homeostasis, cytokine signaling and immune function, and debris engulfment
contributions that this class provides throughout an organism’s life. With such essential functions,
among a growing literature of nuanced roles, it follows that glial physiology is consequential to
behavior in adult animals, with novel genetic tools allowing for the investigation of these
phenomena in living organisms.
A fundamental justification for the importance of glia is simply their abundance. The early
neuroanatomists recognized their ample presence but nevertheless foreshadowed the deference
to neuronal research for a century to come, inherent in the name ‘glia’, which stems from the
Latin for ‘glue’. Notably, the idea of a privileged glial role in sleep was also an early hypothesis of
the foundational neuroanatomists, as Ramon y Cajal (Frank, 2013) proposed that glia physically
impinge on synaptic transmission, and thereby control sleep and wake. Although recent studies
(Azevedo et al., 2009) have tempered the extent to which glial populations outnumber neurons,
even by conservative estimates within the human brain the ratio is close to 1:1, and is
considerably higher in certain areas of the brain. The glial:neuronal ratio is additionally variable
across the animal kingdom (Verkhratsky and Butt, 2018), but it is evident that glia form a
significant proportion of the nervous systems of complex animals. Even by this token alone, glia
should hold considerable interest to sleep research.
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While other behaviors have identifiable purposes and hence can be traced and grounded
in their respective circuitry, for sleep, this is not sufficient. Sleep is peculiar in that not only is its
purpose varied and uncertain, the totality of what comprises sleep within the brain (or even the
body) is also not circumscribed. Clearly, during sleep there are broad and profound
electrophysiological and chemical neuromodulatory changes across the brain, which are tethered
to underlying genetic and cellular differences. In turn, the predominant theories of sleep’s
function also favor explanations which would serve global benefits, or at least, universally
necessary neuronal functions, which are manifest in a use-dependent manner. These proposed
functions strain against the limited neuronal populations whose manipulation alters states, as it is
unclear how these populations homeostatically sense completion of sleeps functions. There are
few experimental or even theoretical models to reconcile that specific circuits control sleep, yet
the implications of the state are evident far beyond these populations, and the
electrophysiological (Huber et al., 2004, Vyazovskiy et al., 2000) and cellular markers (Diering et
al., 2017) of sleep need are patent across the brain. Therefore, for a behavior whose search for
purpose spans the entire central nervous system, it follows that investigating glia, a significant if
not prevailing cellular constituent of the brain, would yield promise. Furthermore, as glia are
expansive and interact with large swaths of neuronal tissue, these populations may be the key in
bridging the local and global characteristics of sleep (Frank, 2013).
For all of the major proposed functions of sleep, there are immediate, if not central,
implications for how glial cells would contribute. In metabolic or energetic hypotheses, glia would
be pivotal as intermediaries between circulation and neurons, containing the enzymatic
machinery necessary to provide energy substrates. The prevailing variants of this hypothesis,
whether it is glucose/glycogen or lactate shuttling that is proposed, astrocytes are the source
(Benington and Heller, 1995, Petit and Magistretti, 2016). For the glymphatic hypothesis, as
evident in the name, glia are the essential cell type for this function because the enhanced
interstitial fluid flow is thought to depend on aquaporin4 in astrocytes (Mestre et al., 2018, Xie et
al., 2013). In consideration of immune functions and sleep, glial cells are both the targets and
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sources of cytokine signals, as astrocytes release and respond to multiple cytokines (Sofroniew,
2014), and microglia, which are the CNS immune cell, release IL-1 and TNFa in vitro (Bianco et
al., 2005, Hide et al., 2000). Finally, in regards to the synaptic hypothesis of sleep, while TNFa
can itself regulate plasticity (Stellwagen and Malenka, 2006), astrocytes have the potential to
shape neuronal synaptic strength through gliotransmitters, and balancing of local
neurotransmitter environments (De Pitta et al., 2016). Glial manipulations which affect sleep, also
at once modulate memory (Halassa et al., 2009, Seugnet et al., 2011).
Given these potential commonalities, the studies which have investigated glial impact on
sleep and characteristics of glia across states have been remarkably few. In the current chapter
we discuss this nascent literature, beginning with a review of the basic forms of glia.

Glial classes in mammals and flies:
Glial cells are a diverse group comprised of both central and peripheral nervous system
constituents. As defined for vertebrates, the major classes of glia include astrocytes,
oligodendrocytes (and Schwann cells in the peripheral nervous system (PNS)), and microglia. In
continuation of an emphasis on Drosophila anatomy as the basis for the forthcoming research,
we will also review the fly glial classes as a representative of invertebrates.
Astrocytes are the most abundant and well characterized glial cell in the mammalian
brain, and are intimately tied to metabolic, circulatory, and neuromodulatory control of neurons.
Even still, the range of astrocyte morphological and functional specialization is only beginning to
be understood (Ben Haim and Rowitch, 2017). In general, astrocytes surround cell bodies,
dendrites and axons in a non-overlapping manner within the adult nervous system, with individual
cells capable of interacting with multiple neuronal soma, hundreds of dendrites, and thousands of
synapses (Bushong et al., 2002, Halassa et al., 2007). This is accomplished through the
branched processes of astrocytes, which are highly refined and interact closely with axonal
boutons and dendritic spines to the extent that they have been considered to be a third
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component of the synapse (Araque et al., 1999). Drosophila contain a neuropil class of glial cells
which are known as astrocyte-like glia (Awasaki et al., 2008). As in mammals, astrocyte-like glia
extend projections which interdigitate with synapses.
In Drosophila melanogaster, there are two glial classes that nominally lack a mammalian
analog, but based on morphology and function can be compared to astrocytes, and perhaps
viewed as specialized subtypes of the class (Freeman, 2015). The first of these are cortex glia,
which are expansive cells that surround the cell bodies of many neurons. In this manner, cortex
glia are similar to protoplasmic type of astrocyte (Freeman, 2015). The functions of cortex glia are
not well established, but since at their superficial boundary these cells contact the fly equivalent
of the blood-brain barrier (discussed below), a parallel can again be drawn to mammalian
astrocytes, which are at the interface of nutrient exchange between the vasculature and neurons,
and may have remote influence on barrier permeability and function (Abbott et al., 2006). The
second of these classes is the ensheathing glia, which will further be compared to another
mammalian glial class below. Ensheathing glia can also be seen as functionally similar to
astrocytes due to engulfing degenerating neurons (Hilu-Dadia et al., 2018, MacDonald et al.,
2006).
Oligodendrocytes are an essential contributor to neuronal function. Through repetitive
wrapping of their myelin-rich membranes around axons, oligodendrocytes provide the insulation
necessary for rapid and energy-efficient salutatory conduction. Additionally, emerging work
suggests that these cells independently provide metabolic support to neurons (Lee et al., 2012).
Mammals also have oligodendrocyte precursor cells (OPCs) or NG2 cells, which are a minor
progenitor population which continue to give rise to oligodendrocytes in the adult brain
(Richardson et al., 2011), but have interesting properties such as electrical communications with
neurons (Bergles et al., 2000). While there are isolated examples of myelination of axons in
invertebrates (shrimp and earthworms), the general principle of glia insulating projections is
evident. Drosophila ensheathing glia compartmentalize neuropil and surround fiber tracts, as well
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as individual projections. Similarly in the Drosophila PNS, wrapping glia insulate projections, as
do Schwann cells in the mammalian periphery.
Microglia are the dedicated immune and macrophage cells of the brain, which surveil the
central nervous system through elaborately branched and labile projections (Nimmerjahn et al.,
2005, Wake et al., 2009). Activated microglia scavenge the brain for apoptotic cells and other
injuries, but microglial phagocytosis is also important in pruning synapses during development
(Paolicelli et al., 2011). Drosophila contain immune cells within the body (hemocytes), but no
directly comparable cell exists for the central nervous system. As stated, engulfment of apoptotic
or cellular debris appears to be accomplished by ensheathing glia in flies (Hilu-Dadia et al., 2018,
MacDonald et al., 2006).
An important distinction between the blood (or hemolymph)-brain barriers of most
vertebrates and those of flies and other relevant invertebrates rests in whether the stringent
barrier-forming cell type is endothelial (for mammals) or glial (for invertebrates, as well as
elasmobranch fish (Bundgaard and Abbott, 2008). Therefore, flies also contain two prominent
populations of barrier-forming or surface glial cells, which do not have a mammalian glial
counterpart, but are analogous in function to endothelial blood-brain barrier cells, and the
supporting pericytes and astrocytic endfeet. The similarities and differences between blood and
hemolymph-barriers will be expanded in the Discussion section, but at present we will describe
the Drosophila surface glial populations.
The fly hemolymph-brain barrier is a continuous enveloping bilayer, up to several microns
in thickness, which is formed by the perineurial glia (PG) and the subperineurial glia (SPG). The
PG are the apical layer, representing a couple thousand cells which overlap to form a loose
physical barrier. The role of the PG layer is not well established, but it appears to have metabolic
significance, as the main sugar energy source, trehalose, is taken up and processed through
glycolysis by PG cells (Volkenhoff et al., 2015). Through sensing of nutrition status, this
populations also has a developmental signaling role to neural stem cells (Chell and Brand, 2010,
Speder and Brand, 2014). The basal SPG layer, are large, polyploid (Unhavaithaya and Orr-
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Weaver, 2012) cells numbering only in the hundreds (Kremer et al., 2017), and are bound
together by septate junctions, thereby forming the tight diffusion barrier (Stork et al., 2008). The
barrier populations are linked by gap junctions (Speder and Brand, 2014). The barrier populations
work in concert to control solute transport between the brain and periphery, whether ions,
nutrients, metabolites, signaling molecules, or xenobiotics (Hindle and Bainton, 2014). The two
layers are known to a certain extent to have non-overlapping transporter and receptor expression
(DeSalvo et al., 2014), although they are unlikely to be completely mutually exclusive, and the
degree to which functions are segregated between the populations is an open question.

Current evidence for glial involvement in sleep regulation and function:
Astrocytes
Astrocytes are among the best studied of glial sub-populations, and a confluence of the
preliminary studies into glial roles in sleep have demonstrated the importance of astrocytes in
both mammalian and invertebrate model organisms. Genetic manipulation of astrocytes has
shown these glia to contribute to homeostatic sleep response (Halassa et al., 2009, Seugnet et
al., 2011), but also to baseline sleep. These effects appear to be attributable to the astrocytic
functions of signaling and neurotransmitter recycling, with both potentially being a consequence
of metabolic/energetic sensing. Still other phenomena regarding astrocytes have been observed
to have dependence on sleep state, and suggest novel functions of sleep (Bellesi et al., 2015, Xie
et al., 2013) even if at present it is unclear if the direct manipulation of this biology would alter
sleep amounts.
One of the earliest and most compelling studies to implicate astrocytes as regulators of
sleep focused on inhibiting exocytotic signaling from glia, a process known as gliotransmission,
through the conditional, adult-specific expression of a dominant negative domain of synaptobrevin
(dnSNARE) (Halassa et al., 2009). Mice with blocked gliotransmission had normal baseline sleep,
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apart from diminished light-phase slow wave activity, but did not display the typically elevated
sleep time and delta power which follows during recovery sleep after sleep deprivation. What is
more, sleep deprivation did not affect memory performance on a novel object recognition task in
the dnSNARE mice, suggesting that astrocytes release substance(s) which promote homeostatic
sleep responses and the resultant cognitive deficits. Optogenetic stimulation of hypothalamic
astrocytes also increased NREM and REM sleep time during the treatment, although by unknown
mechanisms (Pelluru et al., 2016) . Among other neurotransmitters, metabolites and cytokines,
astrocytes are known to release ATP, which is converted to adenosine within the synaptic cleft
(Blutstein and Haydon, 2013). Adenosine was proposed to be mediating astrocytic effects on
homeostatic sleep, since application of an A1 receptor antagonist would recapitulate the
phenotype of the dnSNARE mice (Halassa et al., 2009).
As a neurotransmitter, adenosine is supported by numerous studies to be a somnogen,
as concentrations rise with time awake and sleep deprivation (Porkka-Heiskanen et al., 2000,
Porkka-Heiskanen et al., 1997). Furthermore, caffeine, which is perhaps the most widely used
stimulant, is an antagonist to the adenosine receptors (Huang et al., 2005). Conditional astrocytic
knockdown of adenosine kinase, which breaks down adenosine to AMP and ADP, produced mice
which have greater SWA during baseline and recovery sleep, although sleep time was not
affected in either condition(Bjorness et al., 2016). This study proposes that astrocytic uptake and
processing of adenosine modulates sleep through its role in SWA, and that this is a consequence
of metabolic factors sensed by astrocytes (Bjorness et al., 2016).
Using the fly model, the first studies to assess sleep under glial manipulation, also found
astrocytes to be important for homeostatic sleep (Seugnet et al., 2011). By expressing the
intracellular domain of Notch in astrocytes, or its receptor Delta in the mushroom body neurons,
flies which were sleep deprived no longer showed homeostatic recovery sleep. Mirroring the
experiments of Halassa et al. (2009) in the mouse, expression of Notch also prevented memory
impairments following sleep deprivation as evaluated by the aversive phototaxic suppression task
(Seugnet et al., 2011). These findings substantiate that astrocytic signaling may be a conserved
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and hence vital contributor to sleep regulation, but interestingly advance that adenosine may not
be the sole mediator. While the effect of the classical neurotransmitters on sleep is remarkably
consistent between mammals and flies (Nall and Sehgal, 2014), knockout of the only known
adenosine receptor in the fly does not alter sleep (Wu et al., 2009).
Another body of evidence implicates sleep in immune function (Krueger et al., 2008), and
astrocytes are known to secrete cytokines and respond to immune signals (Sofroniew, 2014).
Astrocytic knockdown of the Drosophila homolog of mammalian tumor necrosis factor alpha
(TNFα), eiger, reduces baseline sleep (Vanderheyden et al., 2018a). Knockdown of the TNF
receptor homologue, wengen, in neurons did not reduce baseline sleep, but negated the
homeostatic recovery sleep after sleep deprivation. Injection of human recombinant TNFα
elevated sleep in the fly, but was abrogated by loss of wengen in neurons. In sum, these findings
establish yet another mechanism for an astrocyte-neuron axis of sleep regulation. Evidence from
a limited number of species suggests that exposure or enrichment by conspecifics can increase
sleep need (Ganguly-Fitzgerald et al., 2006). Interestingly, knockdown of eiger in astrocytes also
prevented social-enrichment effects on sleep (Vanderheyden et al., 2018), thus being the first
example of a glial contribution to this experience-dependent input into sleep-wake.
Ubiquitous overexpression of fabp7, a member of the fatty acid bind proteins which help
transport lipids, increases sleep in the fly (Gerstner et al., 2011), and astrocytic expression of a
human mutant form (T61M) has diminished daytime sleep with shorter and more numerous
bouts, when compared to astrocytic expression of a wildtype human fabp7 (Gerstner et al., 2017).
Fabp7 expression in mammals appears to be enriched in astrocytes, and impressively, both
fabp7 knock-out mice and humans with the fabp7.T61M mutation also display shorter and more
numerous sleep bouts (Gerstner et al., 2017)
While astrocytes may potentiate cytokine and adenosine signals through specialized
signaling, a different mode of astrocytic influence on sleep is through the well-recognized function
of recycling and buffering classical neurotransmitters, particularly glutamate and GABA
(Schousboe et al., 2013). Glial uptake and catabolism of GABA may be a significant contributor to
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sleep amount in the fly. The short-sleeping sleepless mutants have decreased GABA levels, and
increased expression of GABA transaminase (GABAT), an enzyme which breaks down GABA
(Chen et al., 2015). While sleepless is necessary in neurons, the mutant appears to disrupt
GABAT non-cell-autonomously, since a partial rescue of sleep is accomplished in sssP1;gabatF
double mutants by glial expression of GABAT (Chen et al., 2015).
In mammals, EAAT1 and especially EAAT2 (known as GLT-1) are recognized as
glutamate transporters and enriched in astrocytes (Rothstein et al., 1994). Knocking down the
glutamate transporter, Eaat1, in the cortex glia/astrocytes of flies decreases sleep (Luna et al.,
2017). Manipulation of the fly homolog of amyloid precursor protein, Appl, bi-directionally affects
sleep, and decreases glutamine synthase protein levels upon glial knockdown (Luna et al., 2017).
Knockdown of Eaat2 in ensheating glia increased daytime sleep amount in adult flies (Stahl et al.,
2018), potentially acting on transport of taurine. Feeding of taurine increased sleep in wildtype,
but not Eaat2 mutant flies, while expression of Eaat2 in ensheathing glia in the mutant
background rescues the taurine effect on sleep (Stahl et al., 2018). These studies define a
contribution of glial amino acid transporters to sleep, but it remains unclear if these effects are
through altered global levels, or they act specifically on sleep-wake circuitry. A noteworthy study
examined GLT-1 expression surrounding sleep and wake-promoting neurons in rats. After 6
hours of SD, as compared to undisturbed animals, the length of GLT-1 apposition surrounding
neuronal soma was affected in opposite ways, with a ~10% decrease at orexinergic neurons, and
an ~16% increase at melanin concentrating hormone (MCH) cells, which was reversible with
recovery sleep (Briggs et al., 2018). These changes were associated with divergent
electrophysiological effects in these populations.
Astrocytes can also signal between each other, through extensive gap junction networks,
which are thought to underlie the ability of these populations to sample metabolic conditions from
wide swaths of the nervous system. Global astrocytic knock-out of Cx43, an essential gap
junction component, produces mice with greater NREM and REM sleep during the active phase,
and marked by frequent transitions between states (Clasadonte et al., 2017). Orexinergic
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neurons, which promote wake and are thought to stabilize the switch sleep circuitry of mammals
(Saper et al., 2010), are lost in narcoleptics, who similarly display state instability. Viral knock-out
of gap junctions amid orexin cells in the lateral hypothalamus also produced mice with greater
transitions, and increased NREM during the active period. Orexinergic neurons from knock-out
animals showed decreased spontaneous and induced firing, which could be rescued by lactate
dialysis into astrocytes within the area, or extracellular lactate. Likewise, infusion of lactate to
virally treated animals also restored sleep characteristics (Clasadonte et al., 2017). Presumably
other components of sleep-wake circuitry would also be sensitive to changing energy demands,
so it remains a question as to whether astrocytic lactate availability in other parts of the brain
would also influence state transitions.
Astrocytes phagocytize neuronal material and prune synaptic connections during
development (Chung et al., 2015). Furthermore, astrocytic projections are quite dynamic in
developed animals, being capable of protracting and retracting in response to synaptic activity
(Bernardinelli et al., 2014, Hirrlinger et al., 2004). Recently, the use of serial-block face electron
microscopy across the brains of mice in sleep, wake, and sleep-deprived conditions has led to
several insights concerning cellular changes with state (Bellesi et al., 2017, Bellesi et al., 2015,
de Vivo et al., 2017). Astrocytic projections were found to be in the process of phagocyting axonal
and dendritic components to a greater extent in acutely sleep-deprived or chronically (multi-day)
sleep restricted conditions as compared to naturally sleeping or awake timepoints (Bellesi et al.,
2017). There was no difference between sleep and wake conditions, which might suggest that
sleep loss, as from enforced wake which exceeds daily amounts, is an additional pathological
burden potentially due to enhanced oxidative stress and resultant Mer tyrosine kinase (MERTK)
expression in enforced wake conditions (Bellesi et al., 2017).
The venerated neuroanatomist, Santiago Ramon y Cajal seemingly recognized the
plasticity of astrocytic projections even by static histological techniques, as he presciently offered
glia the commanding role in state control, suggesting that sleep is produced when astrocytes
physical abrogate synaptic connections by intrusion of their projections (Frank, 2013, Tso and
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Herzog, 2015). This question was also examined by EM, and the amount of astrocytic apposition
of neuronal spines in layer II of the prefrontal cortex was significantly higher in mice which had
undergone a 4 day chronic sleep restriction (CSR) than those who had been sleeping or sleep
deprived for at least 6 hours (Bellesi et al., 2015). The degree to which the synaptic cleft was
apposed by astrocytic perimeter was also increased in CSR condition mice over sleep and SD,
while mice taken from wake had greater synaptic coverage than ones which had been sleeping
(Bellesi et al., 2015). This singular evidence suggests that there is a state dependence to
astrocytic proximity, if not as dramatic as Ramon y Cajal’s prediction. Interestingly, a specific
demonstration of the necessity of glial regulation of a sleep circuit was discovered recently in C.
elegans. Ablation of the CEPsh glia, which surround the sleep-promoting ALA neuron’s synapse
with the AVE neuron, produces worms which show longer sleep, and other movement differences
(Katz et al., 2018).
Finally, the newly emerged glymphatic hypothesis states that the movement of CSF
along periarterial space to eventually mix and result in exchange with interstitial fluid in the brain
is dependent on aquaporin-4 expression in the vascular endfeet of astrocytes (Iliff et al., 2014).
Sleeping mice were found to have substantially greater volumes of interstitial space than during
wake, which allowed for greater clearance of injected Aβ during the state (Xie et al., 2013), while
conversely sleep deprivation inhibited the spread of injected apoE3 beyond the arteries
(Achariyar et al., 2016). The importance of astrocytic aquaporin channels was specifically
challenged on the grounds that knock-out animals did not have a detectable difference in tracer
movement in the extracellular space (Smith et al., 2017), but a subsequent rebuttal substantiated
aquaporin-4 dependence in multiple knock-out lines, including the one used in the dissenting
study (Mestre et al., 2018). Nevertheless, whether or not interstitial space or rates of convective
flow are altered by sleep and sleep loss has yet to be disputed or confirmed.
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Microglia
Several studies have examined a link between sleep loss and microglial activation.
Protracted sleep restriction by the disc-over-water method has suggested that there is greater
microglial activation in the hippocampus of rats after 5 days of restriction (Hsu et al., 2003), but
this was measured by OX-42 staining, which is not entirely specific to microglia (Jeong et al.,
2013). In another work comparing sleep, SD and chronic sleep restriction (CSR) conditions,
microglial number was not different and either was the number of processes, although the length
of these processes was diminished only in the CSR condition (Bellesi et al., 2017). This group
also examined microglial phagocytosis of neuronal material across these conditions by
counterstaining for VGLUT-1 positive terminals to find that the number and volume of phagocyted
puncta are higher in CSR than in sleep (Bellesi et al., 2017). Under these conditions TNFα was
highest in sleep, although generally sleep deprivation is considered to raise TNFα levels
(Rockstrom et al., 2008). A converse strategy was to prevent microglial activation by the drug
minocycline (Yrjanheikki et al., 1998), and examine the effect on subsequent sleep (Wisor et al.,
2011). NREM sleep amount was not altered, but animals on the drug had diminished delta power
during NREM, a marker of sleep depth. In contrast, this study used quite moderate sleep
deprivation, which yielded lowered expression of microglial Cd11b, which could promote cytokine
signaling from these cells (Wisor et al., 2011). Together these studies find that overt microglial
activation may only be a consequence of pathological extended periods of sleep loss, but these
are far from exhaustive, as microglia also have considerable signaling ability, which remains to be
investigated in the context of sleep.

Oligodendrocytes
To date, oligodendrocytes have not been intensively studied in relationship to sleep. To
assess the status of oligodendrocyte progenitor cells (OPCs) across states, one group injected
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BrdU to mark replicating cells in mice prior to 8 hour periods of sleep, wake, or forced wake
through sleep deprivation, and revealed a greater colocalization with an OPC marker during sleep
over both forms of wake, meaning that OPC proliferation rate is higher during the state (Bellesi et
al., 2013). Specifically, the amount of new OPCs was correlated with time in REM sleep. It is
unclear what the physiological significance of this enhanced proliferation would be, as OPC
numbers are thought to be stable in the brain (Psachoulia et al., 2009) and a commensurate
increase in differentiation of OPCs was not reported, save for a modest increase, inexplicably
during sleep deprivation (Bellesi et al., 2013).
If sleep/wake state is reflected in oligodendrocyte function, it would be important to
examine characteristics of mature oligodendrocytes to look for effects of sleep loss. By electron
microscopy, myelin thickness was diminished in mice that had been chronically sleep restricted
as compared to those who engaged in spontaneous sleep (Bellesi et al., 2018). Nevertheless,
there was no appreciable difference between unperturbed animals and those which had more
limited, acute periods of sleep deprivation, nor were other characteristics such as myelin density
or distance between nodes of Ranvier significantly altered between conditions.
Ultimately, this is only one study, so many more questions can be imagined. Of particular
interest could be the emerging metabolic roles of oligodendrocytes (Lee et al., 2012), which may
change as a function of sleep-wake state but not be evident in anatomy. It has been proposed
that myelin could impact sleep (Morelli et al., 2011) through delivery of ATP, although the idea
that myelin itself can generate ATP is debated (Harris and Attwell, 2013, Ravera et al., 2009).

Conclusion:
To summarize, these pioneering studies have demonstrated that glial manipulation can
affect adult behaviors including sleep, and cellular correlates of sleep and wake are evident in
glial populations. Astrocytes have thus far been the most strongly implicated glial population, with
parallels to sleep in many of the major functions of this class. Nevertheless, the investigation of
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any one of these mechanisms has been limited to only a few papers, demonstrating that our
understanding of sleeps relationship to astrocytes, and especially to other glial classes, is only
beginning.
In the following chapters (Chapter 2, 3, and 4), we explore new modes of glial
participation in sleep regulation and function. In Chapter 2, we describe a new glial locus of sleep
influence, which depends on endocytic trafficking in the fly hemolymph-brain barrier. We expand
on astrocytic roles in Chapter 3, by describing how glial monoamine metabolism is yet another
input to homeostatic sleep regulation. Finally, in Chapter 4 we return to barrier mechanisms of
sleep, and present preliminary results concerning what transporters and substrates at the fly
hemolymph-brain barrier may be significant for sleep.
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Abstract:
Glia are important modulators of neural activity, yet few studies link glia to sleep
regulation. We find that blocking activity of the endocytosis protein, dynamin, in adult Drosophila
glia increases sleep and enhances sleep need, manifest as resistance to sleep deprivation.
Surface glia comprising the fly equivalent of the blood-brain barrier (BBB) mediate the effect of
dynamin on sleep. Blocking dynamin in the surface glia causes ultrastructural changes, albeit
without compromising the integrity of the barrier. Supporting a role for endocytic trafficking in
sleep, a screen of Rab GTPases identifies sleep-modulating effects of the recycling endosome
Rab11 in surface glia. We also find that endocytosis is increased in BBB glia during sleep and
reflects sleep need. We propose that endocytic trafficking through the BBB represents a function
of sleep.
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Introduction:
Sleep is a conserved behavioral state of fundamental significance. Nevertheless, the
nature of its relevance to brain function is still a matter of active research and debate (Krueger et
al., 2016). Most studies of sleep function focus on consequences of sleep loss for performance,
in particular cognitive ability, or for overall physiology. Little is known about the impact of sleep
on basic cell physiology or the extent to which cellular perturbations affect sleep. Amid the
existing hypotheses for the purpose of sleep, multiple avenues exist for glial contribution to both
regulation and function (Frank, 2018), which have been minimally explored.
Glial function has been linked to sleep in some contexts (Bjorness et al., 2016, Chen et
al., 2015, Halassa et al., 2009, Luna et al., 2017, Seugnet et al., 2011). Sleep is well-associated
with improved learning and memory, and appears to support synaptic remodeling (Krueger et al.,
2016, Tononi and Cirelli, 2014), which may be accomplished in part by astrocyte and microglial
activation (Bellesi et al., 2017). Clearance of brain interstitial fluid has been shown to require the
glymphatic system that involves astrocytes and whose function is enhanced during sleep (Xie et
al., 2013). Glial signaling may also contribute to sleep need (Bjorness et al., 2016, Halassa et al.,
2009), potentially as a consequence of astrocytic sensing of metabolic or energetic conditions
(Clasadonte et al., 2017).
In Drosophila (Seugnet et al., 2011) and mice (Halassa et al., 2009), astrocytes
reportedly influence sleep amount or quality following sleep deprivation. Disruption of vesicular
trafficking in mouse astrocytes by dnSNARE expression prevented homeostatic rebound sleep
following deprivation, suggesting that glia release sleep-promoting factors (Halassa et al., 2009).
Likewise, Notch signaling acts in fly astrocytes to modulate sleep and learning in response to
sleep loss (Seugnet et al., 2011). Endocytic/exocytic trafficking is also important in fly glia for the
regulation of circadian behavior (Ng and Jackson, 2015, Ng et al., 2011), but effects on sleep
have not been explored. Given the genetic tools and accessibility of defined glial populations in
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Drosophila (Edwards and Meinertzhagen, 2010), the model is well positioned to discover new
aspects of glial influence on sleep.

Results:
Blocking vesicular trafficking in glia increases sleep:
To address the role of glia in homeostatic sleep in Drosophila, specifically rebound sleep
following deprivation, we blocked vesicular trafficking during sleep deprivation using Shibire

ts1

(or

1

Shi ), a temperature-sensitive dominant negative allele of dynamin, a GTPase involved in
membrane scission(van der Bliek and Meyerowrtz, 1991). Flies expressing Shibire

ts1

1

(UAS-Shi )

by a pan-glial driver (Repo-GAL4) were raised at permissive temperature (18°C) until adulthood
and subjected to mechanical sleep deprivation while being monitored for sleep/activity levels.
1

Concurrently with the start of mechanical deprivation at lights off (Zeitgeber Time (ZT) 12), Shi

was induced by raising the temperature to a restrictive 30°C. Mechanical deprivation was applied
for 12 hours, concluding at the beginning of the following day (ZT 0), when the temperature was
returned to permissive 18°C.
While mechanical sleep deprivation is not always total, and acclimation occurs over
1

longer timespans, Repo-GAL4>UAS-Shi flies exhibited a surprisingly large amount of sleep
above controls throughout the deprivation period, precluding any analysis of subsequent rebound.
Experimental flies slept over 300 minutes in the course of 12 hours of mechanical deprivation,
significantly greater than both parental controls (Figure 1A). This effect was present in both
males and females, and was confirmed with an additional line containing an independent single
1

1

Shi insertion (UAS-20xShi ) (Figure 1A).
1

In principle, Shi is an allele for a temperature-sensitive dynamin whose vesicle-forming
membrane scission function declines with heightened temperature to act as a dominant negative.
However, we found, quite surprisingly, that increased sleep evident during mechanical deprivation
1

was not dependent on a shift from permissive to restrictive temperature, as Repo->Shi flies

43

deprived at 18°C exhibited greater sleep as compared to controls, commensurate to experimental
flies at 30°C ( Figure 1B). As discussed later, the temperature benchmarks established for
dynamin inactivation may not be appropriate for all cell populations or phenotypes (Kilman et al.,
1

2009). Importantly, the locomotor activity during wake (activity index) of Repo>Shi flies at
permissive temperature does not significantly differ from that of controls (Figure 2), suggesting
that the effect is particular to sleep and not simply locomotor impairment which may otherwise be
1

observed with glial manipulation (Zhang et al., 2017). Additionally, to rule out that Repo>Shi flies
may be less sensitive to the mechanical deprivation stimulus, we stimulated flies between ZT11
and ZT12, a time when most flies are awake. We found that stimulation of awake flies increased
beam crossing, and that the average locomotor activity for experimental flies during this time did
not differ significantly from that of controls (Figure 1 – figure supplement 1). Therefore it is
1

unlikely that the increased sleep of Repo>Shi flies during mechanical deprivation is a result of
diminished sensitivity to the stimulus.
1

Based on the resistance to sleep deprivation displayed by Repo>Shi flies, which may
represent greater sleep pressure, we closely examined daily, unperturbed sleep. Flies expressing
1

Shi in all glia had significantly greater total sleep than controls (Figure 2A) at 18°C, which was
1

consistent across independent Shi lines (Figure 2B) in females as well as males (Figure 2 –
1

figure supplement 1A-B). Expression of Shi with Repo-GAL4 at permissive temperature
resulted in an equivalent number of sleep bouts across the day, but significantly longer average
bout lengths in almost all lines and sexes (see exception in Figure 2 – figure supplement 1A),
suggesting that sleep was also better consolidated (Figure 2 and Figure 2 – figure supplement
1A-B).
While we did not observe an appreciable difference in resistance to sleep deprivation
1

between 18° C and 30°C, adult Repo->Shi flies raised at 18°C were also shifted to 30°C for 2
days to examine if the baseline sleep phenotype could be exaggerated. The pattern of Drosophila
sleep across the day is known to alter at temperatures exceeding those preferred by flies
(~25°C)– with greater sleep occurring during the daytime at the expense of nighttime sleep
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(Parisky et al., 2016). Appropriately, when kept at 30°C, sleep loss occurred during the nighttime
1

in all flies, but a significantly greater amount of nighttime sleep was seen in Repo>Shi flies
(Figure 2 – figure supplement 2A). Total sleep at 30°C in experimental female flies was
equivalent to that at 18 degrees (Figure 2 – figure supplement 2B , and even diminished in
1

males Figure 2 – figure supplement 2C), suggesting that the effect of glial Shi on daily sleep is
substantial even at allegedly permissive temperature. A nighttime phenotype is not seen at 18°C
most likely due to ceiling amounts of sleep in controls, but is clearly present at 30°C, where the
temperature-dependent change in sleep pattern shifts control sleep to daytime hours. This
suggests that Shi1 expression can increase sleep throughout the day.
1

To determine whether increased sleep is the result of a partially dominant-negative Shi
1

at lower temperature or the overexpression of Shi , we compared the effects of WT dynamin
WT

(Shi

K44A

) with Shi

K44A

, a constitutive dominant negative allele of dynamin. While Shi

is also

1

deficient for GTP hydrolysis, it is a distinct mutation from Shi (G273D) (van der Bliek and
K44A

Meyerowrtz, 1991). Expression of Shi

in all glia resulted in significantly elevated sleep, in
WT

particular during the day, while expression of Shi

had no effect (Figure 2C, Figure 2 – figure

supplement 3 for total sleep). Given that a constitutively dominant negative dynamin
1

phenocopies the effect of Shi expression at 18°C, the sleep phenotype likely arises from
1

inhibition of dynamin by Shi even at the reportedly permissive temperature.

Glia of the blood brain barrier link sleep to vesicular trafficking:
As noted above, astrocytes have previously been implicated in sleep (Bjorness et al.,
2016, Halassa et al., 2009, Seugnet et al., 2011). In the fly, various glial classes have been
described with corresponding GAL4 drivers generated for these classes (Stork et al., 2012). Apart
from astrocytes (Doherty et al., 2009), Drosophila glia include the ensheathing/wrapping glia
(Doherty et al., 2009, Ito et al., 1995), cortex glia (Awasaki et al., 2008), and the two layers of the
surface or blood-brain barrier glia (Awasaki et al., 2008, Schwabe et al., 2005). To determine
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1

1

whether any specific glial class is sufficient for the Shi phenotype, we expressed Shi at the
permissive temperature using a panel of previously published GAL4 drivers targeting different
glial populations (Figure 3A), with preference given to drivers which would isolate individual glial
classes. Surprisingly, we did not observe a significant effect on sleep as compared to controls
1

when using drivers expressed in astrocyte-like glia. Instead, expression of Shi in the
subperineurial (SPG) glia of the blood brain barrier, by moody-GAL4, produced a significant
increase in total sleep time (Figure 3A). The same was true, although to a lesser extent, with the
NP6293-GAL4 driver, which expresses in the perineurial glia (PG), the second layer of the fly
BBB. The cumulative sleep increase produced by the two drivers is somewhat less than with
Repo-G4, which likely reflects discrepancy in driver strength, but could also suggest a role for
other populations – nevertheless only the surface glial drivers were sufficient in isolation. Surface
glia were also sufficient for the resistance to sleep deprivation phenotype, although only through
1

the PG population (Fig. S3.3). Together these data indicate an involvement of BBB glia in Shi mediated effects on fly sleep.

Inducing block of vesicular trafficking in adult blood brain barrier glia
increases sleep:
As an additional glial sub-type GAL4 driver, we observed that Rab9-GAL4 exhibits
prominent expression in the BBB glia. To identify the BBB glial population labeled by Rab9-G4 we
drove expression of a nuclear-localized GFP, which can differentiate the surface glial populations
based on nuclear morphology and abundance (DeSalvo et al., 2014). The nuclei of perineurial
glial are numerous and relatively small, while those of subperineurial glia are distinctively large
and limited in number, consistent with the size and distribution of this glial class. The pattern of
expression of nuclear GFP under the control of Rab9-G4 was typical of the subperineurial glia
(Figure 3 – figure supplement 2A), marking Rab9-G4 as an SPG driver. In addition, Rab9-G4
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also shows some, albeit sparse, neuronal expression in the brain (Figure 3 – figure supplement
2B for Repo-Gal80 images).
1

While constitutive expression of Shi , even at permissive temperature, with Rab9-G4 was
1

lethal, we observed prominently enhanced sleep when Shi was conditionally expressed in
adulthood using the TARGET system (McGuire et al., 2004) (Figure 3B). Further, conditional
1

expression of Shi with Rab9-G4 in the presence of Repo-GAL80, an inhibitor of GAL4 localized
to all glial cells, prevented the increase in sleep otherwise seen with this driver (Figure 3C),
concomitant with elimination of barrier expression (Figure 3 – figure supplement 2B). These
data exclude a contribution of neuronal expression of this driver and confirm the sufficiency of the
1

subperineurial glia for the Shi -mediated increase in sleep. We confirmed adult-specificity of Shi

1

1

effects by also using the TARGET system to induce Repo>Shi expression conditionally during
adulthood. A temperature-shift increases sleep in these flies, and upon return to restrictive
temperature, the sleep of experimental flies was no longer significantly different from that of
controls (Figure 3 – figure supplement 1B), demonstrating that the phenotype is not likely the
result of permanent detrimental effects. Together these data establish that sleep increase upon
Shi expression is inducible and reversible in adult animals, and is not solely a result of
developmental changes.

Shibire1 expression alters ultrastructure but not general integrity of the
barrier:
Behavioral, electrophysiological or morphological phenotypes have previously been
1

noted from Shi expression at permissive temperature (Gonzalez-Bellido et al., 2009, Kilman et
1

al., 2009). Most prominently, overexpression of Shi at 19°C within retinal cells produces a
modified ERG profile, accompanied by a decrement in endocytic vesicles and a striking
accumulation of microtubule bundles, amounting to gross morphological alteration at the
ultrastructural level (Gonzalez-Bellido et al., 2009). To determine whether the morphology of fly
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1

glia is affected by Shi expression, we performed transmission electron microscopy (TEM) on
1

Repo>Shi flies raised at permissive temperature. When viewed as a horizontal section through
the fly brain, the BBB glia form the two most superficial cell layers which continuously envelope
the entire circumference of the brain. The thicker and seemingly less electron-dense PG layer
faces the luminal side, and the underlying SPG, considered to be the tight barrier by virtue of
septate junctions, appear as a predominantly thinner layer with periodic expanded involutions and
protrusions. Examination of the superficial layers reveals a dense and distinct cytoplasmic make1

up in Repo>Shi brains. Most prominently, amassed and repeated ring-like structures, resembling
the microtubule bundles previously reported (Gonzalez-Bellido et al., 2009), appear in the
experimental animals, but are not seen in controls (Figure 4A). Additionally, the PG layer
appears relatively thinner as compared to controls. This finding shows that in glia, as in neurons,
1

Shi expression even at permissive temperature results in a morphological alteration.

The principle role of the hemolymph-brain barrier is to preserve a selective barrier
preventing free exchange of hemolymph and brain interstitial fluid. To assess whether expression
1

1

of Shi in glia compromises the general integrity of the barrier, we injected Repo>Shi flies with
10kD dextran conjugated to Alexa647, and dissected brains the next day for fixation and analysis
by confocal microscopy. In animals with intact barriers, 10kd dextran is restricted from the brain,
1

and forms a layer external to the surface glia (Pinsonneault et al., 2011). In both Repo>Shi flies
as well as parental controls, the fluorescent dextran was seen at the periphery of the brain
1

(Figure 4B) indicating that Shi expression does not create a leaky barrier. Taken together with
1

the electron micrographs, these images support the finding that with Shi expression, general
barrier integrity is intact, but intracellular morphology is altered, although the link of the altered
morphology to endocytosis is unclear.

Alterations in specific Rab proteins affect sleep:
To better define the relevant pathway, we sought a relatively unbiased method for
perturbing trafficking. The Rab proteins are a family of membrane-bound GTPases that
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demarcate trafficking compartments (e.g. early, recycling, late endosomes, etc) and are known to
regulate diverse vesicle movement within the cell, including exo- and endocytotic pathways. We
asked which trafficking pathways are important in glia for sleep regulation by screening an
existing collection of UAS-Rab lines (Zhang et al., 2007), which include both constitutively active
(CA) and dominant negative (DN) constructs for the currently described Drosophila Rabs. For
most Rabs in this collection, two separate insertions exist for each construct (DN and CA), and in
the initial screen all available lines were crossed to a pan-glial driver, with hits defined as Rabs
that showed opposing effects on sleep of all available CA as compared to all DN lines . In order to
avoid potential lethality from overexpression of dominant negative constructs, we used a newly
created hormone-inducible pan-glial driver, Repo-GeneSwitch (RepoGS). While lethality was not
seen for any Rab using this driver, with or without RU486 feeding, we observed that expression
was leaky (Figure 4 – figure supplement 1A), i.e. not totally dependent on RU486, which has
also been reported for other GeneSwitch lines (Scialo et al., 2016). Unfortunately, leakiness of
RepoGS seemed particularly prominent in the surface glia, and so we examined effects of DN
and CA lines on sleep in the presence and absence of RU486. When UAS-Rabs were expressed
by RepoGS in the absence of RU, significant differences in sleep between DN and CA lines were
found for Rab3, Rab9 and Rab11 (Figure 4C). In the presence of RU486, Rab1, Rab5, Rab27
and Rab30 were found significant (Figure 4– figure supplement 1B), albeit with only one line
available for each DN and CA construct in the case of Rab30.
As preliminary screening compared only experimental flies (RepoGS>UAS-Rab) with or
without RU, the Rabs of interest were confirmed with Repo-GAL4, including the full complement
of UAS and GAL4 controls. For Rab3, Rab5 and Rab9, we did not observe sleep increases by
this driver (Figure 4 – figure supplement 1C), and while some Rab27 and Rab30 constructs did
exhibit significant increases, we did not find consistent phenotypes when these lines were
expressed by surface-glial drivers (data not shown). Rab1 CA also increased sleep relative to
parental controls, but given that it affects ER/Golgi transport (Kiral et al., 2018), we considered it
1

is less likely to be mechanistically similar to Shi . In contrast, expression of recycling-endosome

49

associated Rab11 CA resulted in a robust sleep increase when driven in all glia (Figure 4D), and
was significant for both CA lines. Unlike with RepoGS, Rab11 DN driven by Repo-GAL4 yielded
lethality (Figure 4 – figure supplement 1C), with no adult flies detected, which may be indicative
of Repo-GAL4 as a stronger driver. Likewise, expression of Rab11 DN in either BBB population
resulted in lethality (data not shown) while expression of Rab11 CA in either surface glial
1

population was sufficient to produce increases in total sleep (Figure 4D). Unlike with Shi , we did
not see resistance to sleep deprivation with Rab11 driven in glia (Figure 4 – figure supplement
1

2B), which could indicate more widespread alteration in trafficking by Shi than by Rab11 alone.
Rab11 is associated with the recycling endosome, and through multiple effectors, is also
necessary for endocytic transport, particularly in polarized cells (Jing and Prekeris, 2009).
Together these results identify the importance of Rab11 in the surface glia, and support the role
of endocytic/endosomal trafficking in the sleep function of the surface glia.

Endocytosis occurs during sleep and is influenced by prior wakefulness
Considering that inhibition of endocytic trafficking in the fly hemolymph-brain barrier
increases sleep, could rates of endocytosis at the barrier depend on sleep-wake state? Recent
work in mice suggests that sleep serves to promote clearance of interstitial fluid, and
consequently harmful metabolites which may have accumulated as a result of sustained neuronal
activity during wake, through the glymphatic system (Xie et al., 2013). Whether such clearance
during sleep is a conserved feature in other organisms is currently unknown, but given that the
barrier glia divide brain and body hemolymph in the fly, they are a prime candidate for regulating
transport from brain interstitial fluid to the periphery as a function of sleep-wake state.
In order to evaluate effects of sleep-wake state on endocytosis, we collected flies from an
early night time point (ZT14 - two hours after lights off) and an early day time point (ZT2 - two
hours after lights on) (Figure 5A). At ZT14, sleep pressure is typically high following daytime
arousal (flies are diurnal) and a majority of flies experience consolidated sleep, while ZT2 is
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associated with high locomotor activity. To quantify the amount of endocytosis in the surface glia,
we labeled both surface glial layers with UAS-CD8::GFP using the 9-137-Gal4 driver and
dissociated the brains to allow access of fluorescence-conjugated 10 kD dextran to the
basolateral surface of the barrier (as even a smaller dextran did not penetrate the brain from the
apical surface of the BBB Figure 5 – figure supplement 3). Dissociated brain cells were
incubated for 30 minutes at room temperature, prior to analysis by flow cytometry (Methods)
(Figure 5 – figure supplement 1, for gating strategy). Barrier cells from flies at ZT14 contained
significantly higher dextran, suggesting that endocytosis is favored by high sleep or sleep need
(Figure 5A). To verify that incorporation of dextran into GFP+ surface glial cells reflects
endocytosis, samples were also pre-incubated with dynasore (Macia et al., 2006), an inhibitor of
GTP hydrolysis in dynamin family proteins. At all time points, the AF-dextran signal was
significantly diminished by the presence of dynasore (Figure 5A), indicating that a substantial
portion of the signal is due to endocytosis.
Given that a difference between ZT14 and ZT2 may be indicative of a circadian effect,
independent of sleep-wake state, we evaluated flies at an identical time-point (ZT2), but following
sleep deprivation (SD). Flies in the SD condition were mechanically sleep deprived for 12 hours
beginning at ZT12 and ending at ZT0, and allowed 2 hours to recover, before also being
dissected at ZT2. Hence, circadian time is equivalent between SD and non-SD animals, but flies
recovering from SD should have greater sleep pressure. We find that flies taken from a state of
recovery sleep following deprivation show substantially higher rates of endocytosed AF-dextran
than their un-deprived controls at ZT2 (Figure 5A) – a level of endocytosis commensurate to that
from flies at ZT14.
Brains collected at 6 hour intervals over the course of the 24 hour day showed a rhythmic
pattern, which was not significant as a circadian cycle by JTK, but indicated lowest and highest
levels of endocytosis at ZT2 and ZT14 respectively (Figure 5 –figure supplement 2B). To
determine when endocytosis declines after the peak at ZT14, we assessed rates over the course
of sleep to find that endocytosis is higher at ZT14, as compared to ZT18, ZT22 and ZT2, which
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are not statistically distinguishable (Figure 5B). This would suggest that endocytosis at the
barrier is maximal and largely accomplished within the first half of the night. Since enhanced
endocytosis at ZT2 following sleep deprivation could be a result of stress rather than enhanced
sleep, we fed the sleep-inducing drug, Gaboxadol (GBX) (otherwise known as THIP) (Berry et al.,
2015, Dissel et al., 2015a, Wafford and Ebert, 2006). While exposure to Gaboxadol during the
day did not alter the high endocytosis observed at ZT14 (Figure 5 –figure supplement 2A),
Gaboxadol-treated flies showed increased endocytosis at ZT2 (Figure 5C).
Together these findings demonstrate that endocytosis at the hemolymph-brain barrier
occurs preferentially during sleep and reflects sleep need. It is normally high during the early
night when sleep predominates, but can be increased in the early day if flies undergo recovery
sleep following deprivation the prior night or if they are induced to sleep by drug treatment.

Discussion:
Glial cells are an important constituent of blood or hemolymph-brain barriers, a
conserved feature of complex organisms that protects the central nervous system from
unregulated exchange with humoral fluids. In this study, we show that manipulations of
endocytosis and vesicular trafficking in the surface glia, particularly the subperineurial glia of the
fly BBB, are sufficient to elevate baseline sleep amounts, and that at the BBB, endocytosis itself
is influenced by sleep-wake state. Our findings expand the scope of glial involvement in sleep
and suggest that trafficking through hemolymph- or blood-brain barriers is an underexplored
determinant of sleep-wake behavior.
1

Expression of Shibire has been a popular method to probe circuit-level influence on
various fly behavior, with the prevailing interpretation being that exposure to non-permissive
temperature abrogates synaptic transmission via an eventual depletion of the synaptic vesicle
pool -- a consequence of inhibited endocytosis. Ultrastructural work in neurons has revealed,
1

however, that expression of Shibire at the lower limit of permissive temperature markedly alters
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electrophysiological properties and intracellular structures (Gonzalez-Bellido et al., 2009), which
we also now find in glia. The microtubule defects we report in glia support cellular effects of
1

Shibire at permissive temperatures, although they are not necessarily related to behavioral
1

phenotypes of Shibire expression in glia (this work) or neurons (Kilman et al., 2009) under these
conditions. Evidence for dynamin interaction with microtubules has primarily been from early in
vitro experiments (Ferguson and De Camilli, 2012), with in vivo work showing that only certain
dynamin mutations alter microtubules (Tanabe and Takei, 2009), underscoring a potentially
separable impact of dynamin on endocytosis and microtubules.
1

Shibire expression in Drosophila astrocytes was previously shown to disrupt circadian
rhythms (Ng et al., 2011), but those experiments were designed to prevent expression of Shibire

1

at permissive temperatures, leaving open the question of whether other glial phenotypes are
independent of temperature. Interestingly, this study showed a decrement in rhythmicity upon
1

expression of Shibire at non-permissive temperature in either of the surface glia, although the
total percentage of rhythmic animals was unaffected (Ng et al., 2011). While sleep was not
directly analyzed, a loss of robustness might be explained by increased sleep, present in the
context of otherwise intact daily activity patterns. In our experiments, conditional expression of
1

Shibire in the surface glia or all glia of adult flies was sufficient to increase sleep, demonstrating
that while a phenotype is evident at permissive temperature, it is likewise inducible in adulthood
and therefore cannot be accounted for by developmental effects.
Dynamin (Shibire) is known to be fundamental to endocytosis and vesicle formation.
Nevertheless, the stages of vesicular trafficking are intimately linked, making it difficult to
exclusively manipulate, even at the level of molecular machinery, the processes of endocytosis
and exocytosis (Wu et al., 2014). Indeed, SNARE family members such as synaptobrevin,
considered to be specific to exocytosis, have also been found to affect endocytosis (Xu et al.,
2013, Zhang et al., 2013). Therefore, we cannot exclude a contribution of exocytotic processes to
the influence of the barrier on sleep, although our data clearly implicate endocytosis in barrier
cells.
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Rab GTPase family members orchestrate vesicular and membrane traffic within cells
including glia (Dunst et al., 2015, Ng and Tang, 2008) and the BBB, although knowledge of their
roles in these populations has been limited. Knockdown of the microtubular motor protein, kinesin
heavy chain (Khc), results in locomotor deficits attributable to developmental alterations in
subperineurial glia (Schmidt et al., 2012), and also seen with pan-glial Rab21 knockdown. While
dynamin also could interact with microtubules, we did not observe locomotor deficits in flies
1

expressing Shibire . Through screening of available CA and DN Rab constructs we identified
Rab11 as important for sleep regulation in the barrier glia. We find that Rab11 CA expression, like
1

Shibire , produces increases in total sleep when driven in the barrier populations. Constitutive
expression of a dominant negative Rab11 is lethal when present in all glia or even just in surface
glia, underscoring the importance of this Rab in barrier cells. Rab11 is considered a marker of the
recycling endosome compartment, regulating recycling of plasma membrane constituent proteins,
although evidence also links Rab11 to more direct participation in early endocytosis. For
example, Rab11 functions in Drosophila astrocytes to regulate endocytosis of the GABA
transporter (GAT) (Zhang et al., 2017) and Rab11 knockdown has been shown to inhibit
endocytosis and transcytosis of LDL in human iPSC-derived neurons (Woodruff et al., 2016).
Considering that DN and CA mutations of Rab11 can alter trafficking in the same direction in
some conditions (Khvotchev et al., 2003), it is possible that Rab11CA inhibits endocytosis at the
1

BBB. Alternatively, Rab11CA could produce a similar phenotype to Shi by a different, but related
mechanism. For example, while Rab11 DN inhibits recycling of plasma membrane components
(Kiral et al., 2018), Rab11 CA could enhance recycling. If the mechanism underlying sleep
increase at the BBB involves trafficking a particular receptor then according to this model, both
inhibiting endocytosis and enhancing recycling would keep this receptor at the membrane.
While we demonstrate that interference with vesicle trafficking and endocytosis at the
BBB can alter sleep, and endocytosis in these populations is affected by sleep-wake state, the
nature of the sleep-relevant substrates or molecules remains to be determined. The hemolymph-
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brain barrier, like its mammalian counterpart, contains numerous transporters and receptors
(DeSalvo et al., 2014) serving to selectively move nutrients and metabolites in, and deleterious
compounds such as xenobiotics out. Mutants for the xenobiotic transporter, Mdr65, show greater
total sleep, but effects have not been directly mapped to the barrier (Hindle et al., 2017). We
demonstrated recently that efflux transporters in the Drosophila BBB are under circadian
regulation such that they preferentially pump out xenobiotics during the day. At night, a decrease
in transporter activity increases permeability of xenobiotics into the brain (Zhang et al., 2018).
Based on our current findings, we suggest that activities of the BBB are temporally
compartmentalized, such that efflux occurs during the day and endocytosis at night. However,
endocytosis is dependent on sleep and sleep history rather than the circadian clock as it will
occur during daytime recovery sleep following sleep deprivation at night.
Neurotransmitter/modulator levels are known to influence, and vary according to, sleep-wake
state (Sehgal and Mignot, 2011) and are regulated by glial populations, which could include the
BBB glia. To determine if this was the case, we assessed biogenic amine and amino acid content
1

in the brains of Repo>Shi flies, but found no consistent differences relative to controls (Figure 5
–figure supplement 4).
In mammals, a glymphatic system, involving aquaporin channels in astrocytes, promotes
flow of interstitial fluid along the brain vasculature and mixing with cerebrospinal fluid to allow
exchange of brain fluids and clearance of waste products (Iliff et al., 2014, Xie et al., 2013).
Interestingly, this flow is enhanced during the sleep state (Xie et al., 2013). Drosophila, as other
invertebrates, possess an open circulatory system and thereby lack vasculature within the brain.
Nevertheless, separation between the interstitial fluid of the brain and the hemolymph at large is
maintained by the hemolymph-brain barrier. Our finding of a role for barrier glia in fly sleep, and
the influence of sleep state on endocytosis at the barrier, supports the possibility that clearance or
interstitial exchange is a conserved function of sleep. As we find that peripherally-injected 10kd
dextran does not enter the brain, we speculate that sleep-dependent endocytosis in dissociated
BBB cells reflects trafficking from, rather than to, the brain. We suggest that BBB endocytosis
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occurs during sleep to resolve products of wakefulness and thereby restore metabolic/neural
homeostasis, which would account for the increased sleep need that results from a block in
endocytosis. In other words, endocytosis would be highest during sleep, and decrease during the
night as sleep pressure is resolved. Flies with inhibited endocytosis would be unable to perform
this function and resolve sleep pressure, and would in consequence exhibit constantly elevated
sleep. By this model, administration of Gaboxadol increases sleep pressure and so is associated
with high endocytosis at ZT2 and ZT14, regardless of the baseline levels of endocytosis at these
time points.
Sleep was previously linked to permeability of the BBB in rodents, where sleep loss, and
even just REM restriction, was shown to increase BBB permeability (Gomez-Gonzalez et al.,
2013, He et al., 2014, Hurtado-Alvarado et al., 2016). These effects were attributed to adenosine
(Hurtado-Alvarado et al., 2016), which is also considered a somnogenic molecule (PorkkaHeiskanen and Kalinchuk, 2011). In fact, adenosine may be relevant to the interaction between
astrocytes and sleep (Fujita et al., 2014, Halassa et al., 2009, Schmitt et al., 2012). Given that
astrocytes contribute to the mammalian BBB (Abbott, 2002), it is possible that sleep effects
produced by inhibiting astrocyte signaling (Halassa et al., 2009) involve secondary effects on the
BBB.
Drosophila sleep studies have focused on neuronal circuits controlling sleep-wake
(Artiushin and Sehgal, 2017, Dubowy and Sehgal, 2017), with comparatively few studies
investigating the contribution of glia to this circuitry. We identify the barrier glia as regulators of
sleep and propose that endocytic trafficking through the barrier is an important function of the
sleep state. The specific differences between mammalian and invertebrate barriers
notwithstanding, the identification of the glial/endothelial barrier as a population that can mediate
changes in daily sleep aligns with emerging ideas of BBB involvement in behavior (Hoxha et al.,
2013, Parkhurst et al., 2018) and sleep function (Pan and Kastin, 2017, Verheggen et al., 2018),
and provides a readily identifiable cellular target to interrogate in other model organisms.
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Materials and Methods
Fly lines
Stocks present in the lab collection include ;;Repo-GAL4/TM3,Sb and UAS-Shi.ts1;
1

UAS-Shi.ts1 (referred to as UAS-Shi in the text) and UAS-CD8::GFP and UAS-nGFP. For
control genotypes, GAL4 and UAS lines were crossed to iso31. ;;UAS-20xShi.ts1 (referred to as
1

UAS-20xShi ) was shared by Gerald Rubin. UAS-Shi.WT and UAS-Shi.K44A were shared by
Konrad Zinsmaier. NP2222-GAL4, NP6293-GAL4, Alrm-GAL4, MZ0709-GAL4, MZ0097-GAL4
were shared by Marc Freeman. Moody-GAL4 and 9-137-Gal4 was shared by Roland Bainton.
UAS-Rab CA and DN lines were acquired from the Bloomington Drosophila Stock Center. Rab9GAL4 (#51587) was also acquired from Bloomington.
To generate the ;;Repo-GeneSwitch 2301 line a 4.2 kb genomic fragment (between
coordinates 18231884 and 18236068, FlyBase release 6.19) was amplified by PCR and cloned
into a PUAST-AttB-Sfi-GeneSwitch vector. Transgenesis for this construct was performed by
BestGene at landing site AttP154 (97D2).

Behavior
Flies were raised in bottles on standard food at either room, or non-permissive
temperature (18-19°C) for Shibire and TARGET system (McGuire et al., 2004) experiments.
For sleep recording, flies were loaded into glass locomotor tubes containing 5% sucrose in 2%
agar, and additionally 0.5 mM RU-486 (mifepristone) in the case of GeneSwitch experiments.
Locomotor data was collected using the Drosophila Activity Monitoring (DAM) System (Trikinetics,
Waltham, MA) and processed using PySolo(Gilestro and Cirelli, 2009). Data are processed as 1
minute bins, with sleep defined as 5 minutes without activity. Activity index refers to the average
number of beam crossings within an active bout.
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Sleep deprivation was performed by mechanical disruption using a vortexer triggered to
shake randomly for 2 seconds out of every 20, for the span of 12 hours beginning at lights-OFF,
ZT12. Flies were kept in incubators under 12 hour light : 12 hour dark (LD12:12) cycles and
constant temperature (25°C or 18°C) except in the case of the initial temperature shift
1

experiments with Shibire , in which flies were kept at 18°C, and shifted to 30°C for the duration of
the night, before being returned to 18°C at lights-ON, ZT0. For behavioral experiments, adult flies
of at least 6 day post-eclosion were used, except in the case of tubGal80.ts experiments, where
younger flies were loaded to grant additional time to compensate for the loss of strength due to
incomplete de-repression of tubGal80.ts.

Confocal Imaging
Fly brains were fixed in 4% PFA in PBS with 0.1% TritonX-100 for 15 – 20 minutes, and
washed in PBST for 30 minutes at room temperature, before mounting in VectaShield H-1000
(Vector Laboratories). Confocal imaging was performed on a Leica TCS SP5.

Electron Microscopy
1

Heads from female Repo>UAS-20xShi flies approximately two weeks post-eclosion
were dissected in a cold room in PBS and fixed with osmium tetroxide. Flies were not strictly
circadian entrained or taken at an exact time of day, but dissections were performed together in
the afternoon. Reported images represent sections from single flies from each genotype,
although the experimental was compared to both parental controls. The described microtubule
structures were not seen in the controls. Embedding, staining and sectioning was performed by
the Electron Microscopy Resource Laboratory at Penn. Imaging of the samples was performed at
the core facility.
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Hemolymph-Brain Barrier Permeability
Integrity of the barrier was assessed as previously described(Pinsonneault et al., 2011).
Female flies were injected with Alexa fluor 647-conjugated 10 kd dextran (ThermoFisher D22914)
the day before dissection and kept in standard food vials. Heads were removed and fixed in 4%
PFA in PBS for 10 – 15 minutes before brains were further dissected out and cleaned. Brains
were additionally washed in PBS for 30 minutes before being mounted in VectaShield H-1000
(Vector Laboratories) and imaged by confocal microscopy.

HPLC / LC-MS
The brains of female flies ranging from 10 – 20 days post eclosion were dissected in cold
PBS, and collected to 20 brains per vial. Excess PBS was pipetted off after spinning the samples
down by micro-centrifuge. The samples were frozen on dry ice and submitted to the Children’s
Hospital of Pennsylvania Metabolomic Core for HPLC analysis.

Endocytosis Assay and Flow Cytometry
Flies expressing membrane bound GFP in the surface glia (9-137-GAL4;UAS-CD8::GFP)
were dissected in ice-cold AHL (108mM NaCl, 5mM KCl, 2mM CaCl2, 8.2mM MgCl2, 4mM
NaHCO3, 1mM NaH2PO4-H2O, 5mM trehalose, 10mM sucrose, 5mM HEPES; pH 7.5), and 20
brains were collected per condition. To each sample, 60 μL of Collagenase IV (25 mg/mL) and 10
μL of DNase I (1 mg/mL) were added. Following shaking at 37°C for 15 minutes, brains were
broken up by 3 rounds of gently pipetting. Using a 70 μm cell strainer, the brain samples were
then transferred to FACS tubes, to which 3 mL of AHL was added and spun down for 5 minutes
(2500 RPM). After removing the supernatant, the pellet was resuspended in AHL and brought to
a volume of 200 μL, at which point the sample was split into two new FACS tubes of 100 μL each.
One tube received an additional 50 μL of vehicle solution while 50 μL of dynasore hydrate
solution (10 μM final concentration) was added to the other. The samples were mixed well and
incubated at room temperature for 10 minutes. Following incubation, 50 μL of Alexa fluor 647-
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10kd dextran (50 μg/ml final concentration) was added to each tube, mixed, and incubated at
room temperature for 30 minutes. 4 mL of FACS buffer (0.5% BSA w/v + 0.1% w/v sodium azide
in PBS) were added to each tube, spun down and the supernatant removed. Samples were
immediately analyzed using a FACS Canto II (BD Biosciences).

Gaboxadol Feeding
Gaboxadol hydrochloride (Cayman Chemical Company) was added to standard 5%
sucrose in 2% agar food in locomotor tubes at 0.1 mg/mL. For the ZT14 timepoint, flies were
flipped to Gaboxadol food at lights ON (ZT0) while for the ZT2 timepoint they were flipped onto
drug just before lights OFF (ZT12). In both cases, they remained on this food for ~14 hours until
dissection.

Live Imaging
6-cm plates were coated with poly-L-lysine (0.01%) for greater than 10 mins, removed,
and let dry. Brains were dissected in AHL, placed on the coated plates, and incubated with 50 μl
droplet of 500 μl/ml 3kD FITC-conjugated dextran and either imaged continuously for 10 mins or
dye was washed off and brains were imaged in AHL for 5 mins. Confocol imaging was performed
with 20x submergible water objective (with the lens touching the dye droplet) at
excitation/emission wavelengths of 488/520. For a permeable dye, brains were dissected in AHL
and incubated with 50 μl droplet of 125 μl/ml Rhodamine B and imaged continuously for 10 mins.
Imaging was performed with 20x submergible water objective at excitation/emission wavelengths
of 543/555.

Statistical Analysis
Graphs and statistical tests were completed using Excel and GraphPad Prism. FACS
analysis was performed in FlowJo. For measures of sleep, Controls (GAL4 alone and UAS alone)
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were compared to Experimental (GAL4>UAS) animals by One-Way ANOVA with Holm-Sidak
post-hoc correction. For comparison of endocytosis between ZT2 and ZT14 or ZT2 and ZT2 SD
or between each time point control and inhibitor, Students’ T Test was performed. Additional
details regarding tests and significance values are provided in the figure legends.
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Figure 1: Inhibition of endocytosis in glia produces resistance to mechanical sleep
deprivation
(A) Resistance to mechanical sleep deprivation, manifest as elevated sleep during stimulation, for
Repo-GAL4>UAS-Shi.ts1;UAS-Shi.ts1 female flies (n=14-16, per genotype) and male (n = 16,
per genotype) at both 30°C and 18°C. Dashed box indicates the period of mechanical
deprivation, ZT12-24. Red shading indicates 30°C, otherwise the temperature is 18°C.
(B) Sleep during deprivation at permissive temperature (18°C ) was also present using an
1

additional Shi line, in Repo-GAL4>UAS-20xShi.ts1 females (n=16, per genotype) and males
(n=16, per genotype). One-way ANOVA with Holm-Sidak post-hoc test, * P < 0.05, ** P < 0.01,
*** P < 0.001. Error bars represent standard error of the mean (SEM).
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1

Figure 1 – figure supplement 1. Glial Shi expression does not affect responsiveness to
mechanical stimulus during wake
(A) Mean activity (beam breaks) of Repo-GAL4>UAS-20xShi.ts1 and control female flies at 18°C
between ZT11 and 12, during mechanical stimulation (dashed box) as used for sleep deprivation
(n = 16, each genotype). One-way ANOVA with Holm-Sidak post-hoc test, * P < 0.05, ** P < 0.01,
*** P < 0.001. Error bars represent standard error of the mean (SEM).
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Figure 2. Inhibition of endocytosis in glia increases baseline sleep
(A) Daily baseline sleep amount (3 day mean) and sleep/activity characteristics including mean
daytime sleep bout number, bout length, and activity index for Repo-GAL4>UAS-Shi.ts1;UASShi.ts1 female flies at 18°C (n=19-26), and (B) Repo-GAL4>UAS-20xShi.ts1 females (n=23-31).
(C) Daytime sleep for female flies at 18°C expressing either a constitutively dominant negative
Shi (UAS-Shi.K44A) (n=15-16) or a wild-type Shi (UAS-Shi.WT)(n =15-32) by Repo-GAL4. Oneway ANOVA with Holm-Sidak post-hoc test, * P < 0.05, ** P < 0.01, *** P < 0.001. Error bars
represent standard error of the mean (SEM).
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Figure 2 – figure supplement 1. Inhibition of endocytosis in glia increases baseline sleep
in males
(A) Daily baseline sleep amount (3 day mean) and sleep/activity characteristics including mean
daytime sleep bout number, bout length, and activity index for Repo-GAL4>UAS-Shi.ts1;UASShi.ts1 male flies at 18°C (n=24-26), and (B) Repo-GAL4>UAS-20xShi.ts1 males (n=28-31).

66

1

Figure 2 – figure supplement 2. Shi expression at 30°C in glia increases baseline sleep
similar to expression at 18°C
(A) Daily baseline sleep amount for Repo-GAL4>UAS-20xShi.ts1 female flies at 30°C (2 day
mean), n=23-31. One-way ANOVA with Holm-Sidak post-hoc test, * P < 0.05, ** P < 0.01, *** P <
0.001. Error bars represent standard error of the mean (SEM).
(B) Total sleep of Repo-GAL4>UAS-20xShi.ts1 females flies at 18°C (mean of 3 days) and 30°C
(mean of 2 days) (n=30). Unpaired t-test.
(C) Daily baseline sleep amount for Repo-GAL4>UAS-20xShi.ts1 male flies at 30°C (2 day
mean), n=28-31. One-way ANOVA with Holm-Sidak post-hoc test, * P < 0.05, ** P < 0.01, *** P <
0.001. Error bars represent standard error of the mean (SEM).
(D) Total sleep of Repo-GAL4>UAS-20xShi.ts1 males flies at 18°C (mean of 3 days) and 30°C
(mean of 2 days) (n=30). Unpaired t-test.
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Figure 2 – figure supplement 3. Inhibition of endocytosis in glia increases total baseline
sleep
(A) Total baseline sleep amount (3 day mean) and sleep/activity characteristics including mean
daytime sleep bout number, bout length, and activity index for Repo-GAL4>UAS-Shi.ts1;UASShi.ts1 female flies at 18°C (n=19-26), Repo-GAL4>UAS-20xShi.ts1 females (n=23-31), RepoGAL4>UAS-Shi.ts1;UAS-Shi.ts1 male flies at 18°C (n=24-26), and Repo-GAL4>UAS-20xShi.ts1
males at 18°C (n=28-31).
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(B) Total sleep time for female flies at 18°C expressing either a constitutively dominant negative
Shi (UAS-Shi.K44A) (n=15-16) or a wild-type Shi (UAS-Shi.WT)(n =15-32) by Repo-GAL4. Oneway ANOVA with Holm-Sidak post-hoc test, * P < 0.05, ** P < 0.01, *** P < 0.001. Error bars
represent standard error of the mean (SEM).
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Figure 3. Inhibition of endocytosis in surface glia is sufficient to increase sleep
(A) Total sleep at 18°C for female flies expressing Shibire (UAS-20xShi.ts1) by, from left to right,
Alrm-GAL4 (n= 16, each genotype), MZ0709-GAL4 (n=16-32), MZ0097-GAL4 (n= 16-32),
NP2222-GAL4 (n= 16-32), NP6293-GAL4 (n= 29-32), moody-GAL4 (n=16). MZ0709, MZ0097,
and NP2222 experiments were loaded simultaneously and therefore share the same UASControl, graphed repeatedly for each to aid comparison.

(B) Conditional expression of UAS-20xShi.ts1 using tubGal80.ts;Rab9-GAL4 at permissive (18°C)
and restrictive temperature (30°C, red shading) (n = 9-19 females, mean of 4 days).
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(C) Exclusion of glial expression by Repo-Gal80 from the conditional expression of UAS20xShi.ts1 by tubGal80.ts;Rab9-GAL4 at restrictive (18°C) and permissive temperature (30°C) (n
=15-16, mean of 4 days). One-way ANOVA with Holm-Sidak post-hoc test, * P < 0.05, ** P <
0.01, *** is P < 0.001. Error bars represent standard error of the mean (SEM).
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Figure 3 – figure supplement 1. Glial adult-specific Shibire induction increases sleep and
is reversible
(A) Day sleep at 18°C for female flies expressing Shibire (UAS-20xShi.ts1) by, from left to right,
Alrm-GAL4 (n= 16, each genotype), MZ0709-GAL4 (n=16-32), MZ0097-GAL4 (n= 16-32),
NP2222-GAL4 (n= 16-32), NP6293-GAL4 (n= 29-32), moody-GAL4 (n=16). MZ0709, MZ0097,
and NP2222 experiments were loaded simultaneously and therefore share the same UASControl, graphed repeatedly for each to aid comparison.

(B) Conditional expression of UAS-20xShi.ts1 using UAS-tubGal80.ts;Repo-GAL4 at restrictive
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(18°C), then permissive temperature (30°C, red shading), and back to restrictive (n = 14-16
females, mean of 3-4 days). One-way ANOVA with Holm-Sidak post-hoc test, * P < 0.05, ** P <
0.01, *** is P < 0.001. Error bars represent standard error of the mean (SEM).
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Figure 3 – figure supplement 2. Expression patterns of Rab9-G4 and the BBB drivers
(A) Superficial z-slices from confocal images of brains expressing UAS-nGFP driven by Rab9GAL4, moody-Gal4 (subperineurial glia), and NP6293-Gal4 (perineurial glia) reveals the
characteristically large and sparse nuclei of subperineurial glia.
(B) BBB driver expression of UAS-CD8::GFP without and with Repo-Gal80 (revealing neuronal
expression). Large images are single slices from the middle of the brain, insets are max
projections of the entire brain. Laser power settings were maintained for comparison except in
NP6293-Gal4>UAS-GFP + Repo-Gal80 images where they are higher to reveal weak expression
which is otherwise not visible at all.
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Figure 3 – figure supplement 3. Perineurial glia are sufficient for Shibire rebound
phenotype
(A) Sleep during deprivation for NP6293-Gal4 and moody-Gal4 driving UAS-20xShi.ts1 at 18°C
for female flies (n= 16-30). One-way ANOVA with Holm-Sidak post-hoc test, * P < 0.05, ** P <
0.01, *** is P < 0.001. Error bars represent standard error of the mean (SEM).
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Figure 4. Ultrastructural morphology and genetic analysis of Rab proteins support a sleeprelevant function of vesicle trafficking in surface glia
(A) Transmission electron micrographs of surface glia of individual Repo-GAL4>UAS-20xShi.ts1
and Control female fly brains. Perineurial glia are the most superficial layer with subperineurial
glia appearing as the generally thinner and darker layer immediately basal to the perineurial glia.
White arrows indicate presence of microtubule bundles.
(B) External aspect of hemolymph-brain barrier visualized by injection and fixation of Alexa64710kd dextran in Repo-GAL4>USA-20xShi.ts1 and Control brains, demonstrating an intact barrier
in both genotypes.
(C) Total sleep time of RepoGS>UAS-Rab CA or DN flies, in the absence of RU486. Red bars
represent UAS-Rab DN and green bars are UAS-Rab CA, with two insertions available in most
cases (n=7-16, for all genotypes). Significant Rabs are those in which all DN lines were
consistently and significantly different from all CA lines measured by One-way ANOVA with HolmSidak post-hoc test or unpaired t-test for Rab30, with * P < 0.05, **P < 0.01, *** P < 0.001.
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Displayed significance value represents the largest p-value of the 3-4 comparison. Error bars
represent standard error of the mean (SEM).
(D) Total sleep time of flies expressing Rab11 CA in all glia (Repo-Gal4), perineurial glia
(NP6293-GAL4), and subperineurial glia (Rab9-GAL4) as compared to GAL4 and UAS controls
(n =15-30), statistics as above.
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Figure 4 – figure supplement 1. Rab screen with pan-glial driver Repo-GS and Repo-GAL4
(A) Maximum projection z-stack confocal images of brains from Repo-GeneSwitch>CD8::GFP
flies in the presence and absence of RU486. Confocal imaging parameters are kept constant to
demonstrate difference in expression between conditions.

(B) Total sleep time of RepoGeneSwitch>UAS-Rab CA and DN flies, in the presence of RU486.
Red bars represent UAS-Rab DN and green bars are UAS-Rab CA lines, n =5-16, per each
genotype. Significant Rabs are those in which all available DN lines were consistently and
significantly different from all CA lines measured by One-way ANOVA with Holm-Sidak post-hoc
test or unpaired t-test for Rab30, * P < 0.05, ** P < 0.01, *** P < 0.001. Displayed significance
value represents the largest p-value of the 3-4 comparisons between all DN and CA lines. Error
bars represent standard error of the mean (SEM).

(C) Total sleep time of flies with Repo-Gal4 driving select UAS-Rab CA and DN lines, including
both parental controls. Lethality was seen for pan-glial expression of the DN constructs of Rab1,
5 and 11. One-way ANOVA with Holm-Sidak post-hoc test, * P < 0.05, ** is P < 0.01, *** is P <
0.001. Error bars represent standard error of the mean (SEM). The top star(s) represent
significance compared to Repo-GAL4 Control (n=92, average 5 experiments), while bottom
star(s) represent comparison to UAS Control. (n=15-16, for each UAS Control and Experimental
genotype)
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Figure 4 – figure supplement 2. Daytime sleep, sleep deprivation resistance and barrier
integrity with Rab11 expression in surface glia.
(A) Day sleep time of female flies expressing Rab11 CA in all glia (Repo-Gal4), perineurial glia
(NP6293-GAL4), and subperineurial glia (Rab9-GAL4) as compared to GAL4 and UAS controls
(n =15-30). One-way ANOVA with Holm-Sidak post-hoc test with * P < 0.05, **P < 0.01, *** P <
0.001. Error bars represent standard error of the mean (SEM).
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(B) Sleep during deprivation for Repo-Gal4 and driving UAS-Rab11 CA for female flies (n=16,
each genotype). Statistics as above.
(C) Intact hemolymph-brain barrier visualized by injection and fixation of Alexa647-10kd Dextran
in Repo-GAL4>UAS-Rab11::YFP and UAS-CD8::GFP Control brains.
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Figure 5. Sleep promotes endocytosis at the surface glia
Brains (n = 20, per condition in experiment) from 9-137-GAL4, UAS-CD8::GFP flies were
dissected, dissociated, and the samples incubated with Alexa647-conjugated 10kd dextran in the
presence or absence of the dynamin inhibitor, dynasore hydrate. Endocytosis measured from
surface glial cells by AF647-Dextran signal, expressed as normalized median fluorescence
intensity (MFI) (left) and percentage of cells with high endocytosis signal (right). Dextran MFI is
normalized to the average MFI of the DH-treated samples. Paired Student’s T-test with * p <0.05
and ** p<0.01. Percentage of GFP+ cells displaying high signal with vehicle conditions was
normalized to inhibitor for each respective timepoint to compare between experiments. One-way
ANOVA with correlated measures with post-hoc Tukey’s test with * p <0.05 and ** p<0.01.
(A) Endocytosis at ZT2, ZT2 following sleep deprivation (12 hours, mechanical stimulation) and
ZT14 (n = 4 per time point, pooled from 4 experiments)
(B) Endocytosis at night time points ZT14, ZT18, and ZT22 along with ZT2 (n = 4, pooled from 4
experiments)
(C) Endocytosis at ZT2 after feeding of 0.1 mg/mL Gaboxadol or vehicle (n = 3, pooled from 2
experiments)
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Figure 5 – figure supplement 1. Analysis of endocytosis using flow cytometry
(A) Gating strategy for FACS analysis. Events were gated on cell size, live cells, and
forward-scatter (FSC) and side-scatter (SSC) singlets. GFP+ gates were determined with
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a GFP- sample. (B) Endocytosis of Drosophila BBB cells. Total dissociated brain cells
from 9-137-Gal4>UAS-CD8GFP flies were treated with vehicle or dynasore hydrate and
analyzed by flow cytometry. Gates for dextran-high cells were determined using the
+

bimodal distribution of dextran in live singlets (right panels) and applied to GFP BBB
cells (left panels). Mean Fluorescent Intensity (MFI) and percentages used for the
analysis of endocytosis were derived from outlined panels. All primary data analysis was
performed using FlowJo software.
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Figure 5 – figure supplement 2. Endocytosis at the BBB across circadian timepoints and
upon Gaboxadol feeding at night (ZT14)
(A) Endocytosis measured from surface glial cells by AF647-Dextran signal at ZT14 after feeding
of 0.1 mg/mL Gaboxadol or control (n = 3, pooled from 2 experiments). Expressed as normalized
median fluorescence intensity (MFI) (left) and percentage of cells with high endocytosis signal
(right). Dextran MFI is normalized to the average MFI of the DH-treated samples. Paired
Student’s T-test with * p <0.05 and ** p<0.01. Percentage of GFP+ cells displaying high signal
with vehicle conditions normalized to inhibitor for each respective timepoint to compare between
experiments. One-way ANOVA with correlated measures with post-hoc Tukey’s test with * p
<0.05 and ** p<0.01.
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(B) Mean endocytosis amount represented by normalized median fluorescence intensity
(normalized to average MFI per experiment, as inhibitor was not used in these experiments) for
ZT2, ZT8, ZT14 and ZT20 (n=5 experiments). Not significant by JTK_CYCLE (p=0.13).
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Figure 5 – figure supplement 3. Blood-brain barrier restricts passage of 3kD dextran into
the brain.
Live dissected brains were incubated with 3kD FITC-conjugated dextran for up to 10 mins (A) or
(B) washed off after 5 minutes of incubation. (A) shows representative images of brains 3, 5, and
10 minutes following start of incubation. (B) After wash off, no fluorescence of dextran above
background was seen. (C) Live dissected brains were incubated with Rhodamine B. Brains were
imaged continuously by confocal microscopy. Representative images are shown of 3, 5, and/or
10 minutes following start of incubation.
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Figure 5 – figure supplement 4. Whole-brain biogenic amines and amino acids are
unaltered in Repo>Shi flies
A.) Dopamine, Octopamine, Histamine and Serotonin measured by LC-MS. n=20 brains per
sample, 7 replicates. B.) Amino acids measured by HPLC. n=20 brains per sample, 6 replicates.
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CHAPTER 3: AANAT1 functions in astrocytes to modulate sleep
homeostasis
Sejal Davla, Gregory Artiushin, Daryan Chitsaz, Sally Li, Amita Sehgal, Donald J. van
Meyel

Abstract
Sleep is subject to circadian regulation and the homeostatic response to sleep need, the
neural mechanisms for which remain incompletely understood. However, regulation of sleep
behavior from humans to insects includes a conserved role for monoamines. In Drosophila the
monoamines serotonin, dopamine and octopamine function within overlapping brain regions to
regulate the quantity and timing of sleep. These monoamines have been shown to be acetylated
in vitro by an enzyme, arylalkylamine N-acetyltransferase 1 (AANAT1), resulting in their
inactivation. Here we show AANAT1 expression in astrocytes and subsets of neurons in the adult
brain of Drosophila. AANAT1 mutant flies had heightened rebound sleep in response to overnight
sleep deprivation, and we found this was accompanied by increased serotonin and dopamine
levels in the brain. Selective loss of AANAT1 from neurons promoted the amount and
consolidation of night-time sleep under baseline conditions, but did not affect homeostatic sleep
rebound. In contrast, astrocyte-specific knockdown of AANAT1 increased rebound sleep in sleepdeprived animals but had no effect on baseline sleep. These findings distinguish sleep-control
functions of AANAT1 in neurons and astrocytes, and support a critical role for astrocytes in
mechanisms that calibrate the response to sleep need.
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Introduction
Sleep is an essential state shown to be important for immune system function
(Besedovsky et al., 2012), metabolic homeostasis (Benington and Heller, 1995, Petit et al., 2015),
brain repair (Xie et al., 2013, Mackiewicz et al., 2007), learning, and memory consolidation
(Tononi and Cirelli, 2014, Frank and Cantera, 2014). Characteristic features of sleep are
conserved among species, including consolidated periods of quiescence, reduced
responsiveness to sensory stimulation, and homeostatic regulation of the need for sleep, as when
sleep pressure builds after prolonged waking (Zheng et al., 2008). Sleep regulation is complex as
it involves many distributed neural circuits, which are influenced by hormones, cytokines (Krueger
et al., 2011), and most of the major neurotransmitter systems, including neuromodulators such as
monoamines (Brown et al., 2012, Lorincz and Adamantidis, 2016). Drosophila has an advanced
toolkit to investigate mechanisms that regulate sleep, where genetic perturbations affecting the
diurnal patterns of sleep/wake activity in flies have been used to identify both conserved and
novel regulators of sleep and wakefulness (Hendricks et al., 2000, Shaw et al., 2000, Artiushin
and Sehgal, 2017). Of the conserved regulators, the monoamines serotonin, dopamine and
octopamine are known to act in the fly brain to regulate the quantity and timing of sleep (Nall and
Sehgal, 2014). Thermogenetic approaches in flies have demonstrated that serotonergic neurons
can promote sleep, whereas dopaminergic and octopaminergic neurons are wake-promoting (Nall
and Sehgal, 2014, Artiushin and Sehgal, 2017).
As in mammals, neural circuits within the fly brain that control sleep are subject to
circadian clock regulation that influences the timing and consolidation of baseline sleep patterns
(Borbely et al., 2016). In Drosophila, multiple clock-containing neuron populations influence
baseline sleep (Artiushin and Sehgal, 2017, Dubowy and Sehgal, 2017) but it remains unclear
how they connect to the diverse non-clock sleep regulation circuits of the mushroom body,
ellipsoid body (EB) and elsewhere. Populations within these regions, and others, have divergent
roles in controlling baseline and homeostatic sleep (Dubowy and Sehgal, 2017). Growing
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evidence suggests that circuits within sub-areas of the central complex of the fly brain specifically
regulate sleep homeostasis. R2 neurons in the EB increase their activity with prolonged wake and
are thought to integrate sleep pressure or measure wake time (Liu et al, 2016). They indirectly
activate a subpopulation of sleep-inducing neurons within the dorsal fan-shaped body (FSB)
(Donlea et al., 2014, Liu et al., 2012, Ueno et al., 2012) that switch their activation state during
wake versus sleep by engaging two distinct potassium channels. Interestingly, the serotonin
receptor 5HT2b and the dopamine receptor Dop1R2 function in distinct neural circuits within the
FSB, affecting both baseline and homeostatic sleep (Pimentel et al., 2016, Qian et al., 2017).
Furthermore, wakefulness induced by activating dopaminergic or octopaminergic neurons limits
need for rebound sleep, suggesting a role for monoamines in regulating sleep homeostasis
(Seidner et al., 2015).
One of the first Drosophila sleep mutations to be discovered was an allele of the gene
encoding arylalkylamine N-acetyltransferase 1 (AANAT1), known previously as Dopamine
lo

acetyltransferase (Dat). Although these mutants (AANAT1 ) had normal baseline amounts of
sleep and motor activity, they showed increased rebound sleep following deprivation (Shaw et al.,
2000). AANAT1 belongs to a conserved family of enzymes (Maranda and Hodgetts, 1977) whose
acetylation of monoamines leads to their catabolism and, in mammals at least, produces Nacetylserotonin, an intermediate in the synthesis of melatonin (Hintermann et al., 1996). AANAT1
is expressed in neuropil regions throughout the Drosophila brain, with enriched expression in EB
and FSB (Brodbeck et al., 1998). However, understanding of the mechanism of action of AANAT1
remains incomplete, in part because the identity of AANAT1-positive cells has not been
characterized.
Glial cells have profound influence on neurotransmission and brain physiology, and
astrocytes are particularly well-suited for this because they have ramified processes that infiltrate
neuropil regions to lie in close proximity to synapses, and because they typically express
transporters and enzymes for the uptake and metabolism of neurotransmitters (Murai and van
Meyel, 2007, Frank, 2018). Astrocytes have been increasingly implicated in mechanisms of
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circadian and homeostatic sleep regulation in mammals and flies. For example, blocking
astrocytic vesicular release in mice prevents the homeostatic sleep response following sleep
deprivation (Halassa et al., 2009), while optogenetic activation of astrocytes in mice increases the
amount of sleep during stimulation (Pelluru et al., 2016). Astrocytes in mice are thought to
modulate homeostatic sleep drive by releasing adenosine, a sleep-promoting metabolite of ATP
that can act via A1 receptors to suppress the activity of neurons (Haydon, 2017). In flies, various
glial populations have been shown to influence baseline sleep (Chen et al., 2015, Farca Luna et
al., 2017, Stahl et al., 2018, Artiushin et al., 2018). In addition, homeostatic sleep has been
shown to be regulated through neuron-glial signaling via Notch (Seugnet et al., 2011) or a TNFα
ortholog eiger (Vanderheyden et al., 2018a). Despite these recent advances, it remains unknown
whether and how astrocytes might influence monoaminergic control of sleep.
Here we report that AANAT1 is expressed in astrocytes and specific subpopulations of
lo

neurons within the adult brain of Drosophila. AANAT1 mutants have elevated brain levels of
serotonin and dopamine upon sleep deprivation and AANAT1 acts in neurons to limits the
quantity and consolidation of nighttime sleep. Astrocyte expression of AANAT1 strongly
constrains the amount of rebound sleep that flies take in response to sleep deprivation. Our
findings illustrate a newly-discovered role for astrocytes in the control of monoamine
bioavailability and homeostatic sleep drive.

Materials and Methods
Fly stocks
Drosophila melanogaster stocks were obtained from the Bloomington Stock Center (BSC): TrhGal4 (BSC-52249), TH-Gal4 (BSC-8848), Tdc2-Gal4 (BSC-9313), Ddc1-Gal4 (BSC-7010), UASmCD8-GFP (BSC-32186), UAS-RFP.nls (BSC-30558), Mi MIC}VGlut

MI04979

(BSC-38078), Gad1lo

Gal4 (BSC-51630), Cha-Gal4 (BSC-6793), R56F03-Gal4 (BSC-39157), AANAT1 (BSC-3193),
Df(2R)BSC356 (BSC-24380), deficiency In(2LR)Px4 (BSC-1473), AANAT1 RNAi lines UAS-
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HMS01617 (BSC-36726), UAS-JF02142 (BSC-26243) and multi-color Flp-out (MCFO) stock hsFlpG5.Pest; 10xUAS(FRT-stop)myr::smGdP-HA, 10xUAS(FRT-stop)myr::smGdP-V5-THS10xUAS(FRT-stop)myr::smGdP-FLAG (BSC-64085). Alrm-Gal4 was provided by Dr. Marc
Freeman, and nSyb-Gal4 by Dr. Stefan Thor.
For RNA interference (RNAi) knockdown of gene expression, control animals carried only
a Gal4 driver, while experimental groups also carried a single copy of the transgene to elicit
RNAi. The chromosome carrying Alrm-Gal4 also bore a transgene encoding the nuclear reporter
UAS-nuRFP. To mitigate the effects of genetic background for sleep experiments, control Gal4
and UAS flies were crossed to the iso31 stock.
The morphology of single astrocytes was determined by the Multi-Color Flp-OUT (MCFO)
technique (Nern et al., 2015), where three differently tagged reporters under UAS control (HA,
FLAG and V5) are silenced by FRT-flanked transcriptional terminators. Heat shock-induced
FLPase expression removed terminators randomly in individual cells, driven by astrocyte-specific
Alrm-GAL4. This created a mosaic of differently-colored astrocytes. For this experiment, 3-5 day
old flies raised at 18C were heat-shocked at 37C for 5-8 minutes and dissected 2–3 days later.

Generation of AANAT1 antibody
A KLH-coupled peptide RRPSPDDVPEKAADSC (amino acids (aa) 94-109 of isoform
AANAT1-PA (FlyBase), or 129-144 of isoform AANAT1-PB (FlyBase) was synthesized and
injected into rabbits according to guidelines of the Canadian Council for Animal Care
(MEDIMABS, Montreal, QC).

Immunohistochemistry and imaging
Adult fly brains were dissected in cold phosphate-buffered saline (pH 7.4) and fixed in 4%
paraformaldehyde for 30 min. After three washes of 15 minutes (min.) each with PBS containing
0.3% Triton-X100 (PBTx-0.3%), the tissues were blocked in 5% normal goat serum (Jackson
Laboratories) in PBTx-0.5% for 45 min. Tissues were incubated in primary monoclonal antibodies
were rabbit anti-AANAT1 (1:2000; this study), rat anti-Elav (1:100; Developmental Studies
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Hybridoma Bank (DSHB) , mouse anti-nc82 (1:50; DSHB), mouse anti-GFP (1:200; Clonetech
#632381) overnight at 4⁰C. After three washes (15 min. each, PBTx-0.3%), tissues were
incubated with secondary antibodies overnight at 4⁰C: goat anti-mouse (Rhodamine Red-X,
Jackson ImmunoResearch #115-295-146), goat anti-rabbit (Alexa Fluor 488, Thermo Fisher
Scientific, #A11008), goat anti-mouse (Alexa Fluor 488, Thermo Fisher Scientific), goat anti-rat
(Alexa Fluor 568, Thermo Fisher Scientific, #A11077), goat anti-rabbit (Alexa Fluor 647, Thermo
Fisher Scientific, #A21245),. Tissues were again washed (3 × 15min, PBTx-0.3%), followed by a
final wash in PBS. Tissues were mounted in SlowFade™ Diamond Antifade Mountant (Thermo
Fisher Scientific, #S36964). Fluorescence images were acquired with an Olympus BX-63
Fluoview FV1000 confocal laser-scanning microscope and processed using Fiji.
For MCFO labeling, brains were dissected in ice-cold PBS, fixed with 4%
paraformaldehyde/PBS for 1 h at room temperature followed by three successive washes in 0.5%
PBTx for 20 min each. Simultaneous incubation (48 h at 4 °C) with rat anti-FLAG (1:100; Novus
Biologicals NBP1-06712,A-4) and rabbit anti-AANAT1, was followed by another (48 h at 4 °C)
with goat anti-rabbit (1:1000; Alexa Fluor 488, Thermo Fisher Scientific, #A11008), goat anti-rat
(1:1000; Alexa Fluor 568, #A11077) and V5-tag:AlexaFluor-647 (1:200; Bio-Rad MCA1360A647).
To quantify cells immuno-labelled for GFP and AANAT1, cells were manually counted from image
stacks of the central brain (excluding optic lobes).

Western blotting
Lysates for western blots were prepared from dissected adult brains in 50μl Laemmli
buffer as reported in (Parinejad et al., 2016). 10 brains were used per lysate and incubated at
90⁰C for 5 min. 15 μl of each sample was loaded per well, run on 15% SDS-PAGE gels, blotted
to nitrocellulose membrane, and probed with Rabbit anti-AANAT1 (1:2500) or anti-Ebony (1:3000;
Sean Carroll, University of Wisconsin-Madison), and mouse anti-actin (1:3000; Sigma #A4700).
HRP-congugated secondary antibodies anti-rabbit (1:3000; Bio-Rad) and anti-mouse (1:3000;
Promega #W4021) were used for detection with chemiluminescence (HyGLO Chemiluminescent
HRP Antibody Detection Reagent, Denville Scientific). Mean signal intensity for AANAT1 or
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Ebony was quantified using Fiji and normalized to actin. We used three separate lysates for each
genotype to analyze western blots. For sleep experiments, female brains were used for lysate
preparation.

High interaction liquid chromatography - Mass Spectrometry (HPLC-MS)
To prepare samples for HPLC-MS, the brains of twenty female flies (1-2 weeks old) for
each genotype were dissected into ice-cold (PBS) between ZT0.5-3.5. We dissected brain tissue
to avoid cuticle contamination because serotonin and dopamine are intermediates in the
sclerotization of Drosophila cuticle. Dissected brains were centrifuged, the PBS was removed,
and samples were quickly homogenized with a motorized pestle into an aqueous solution of
formic acid (0.1%). After centrifugation, the supernatant was collected and stored at -80ºC.
Preliminary analytical conditions were developed using reference standards in a solution
containing either serotonin, dopamine, or octopamine. The absolute values for each analyte were
measured in picograms (pg) per brain, through the addition of deuterated reference standards to
sample extracts.

Monitoring and measurement of sleep in Drosophila
Prior to experimentation, flies were kept on standard food in constant conditions (a 12hour light/dark cycle, and 25°C). At least 5 days after eclosion, mated adult females of were
loaded into glass tubes with 5% sucrose/2% agar food for behavioral recordings. The Drosophila
Activity Monitoring (DAM) system (Trikenetics, Waltham, MA) was used to quantify infrared beam
breaks representing locomotor activity. Files were processed with PySolo (Gilestro and Cirelli,
2009) in 1-minute bins, with sleep defined as 5 consecutive minutes without activity, as done
previously (Hendricks et al., 2000). As a measure of gross locomotor activity, activity index is
defined as the mean number of beam breaks within bins which are active (>1 break). In sleep
deprivation experiments, flies were placed in DAM monitors on a vortexer that was mechanically
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shaken a random 2 of every 20 seconds over the course of the 12 hours of the dark period (ZT12
– 24).

Results and Discussion
We generated antiserum to AANAT1 and confirmed its specificity with
immunohistochemistry (IHC) in the embryonic CNS. AANAT1 immunoreactivity was observed in
the cytoplasm of many cells (Fig. 1A) but was absent in age-matched embryos that were
homozygous for a deletion of the entire AANAT1 gene (Fig. 1B). In adult brains, IHC was done
with co-labeling for AANAT1 and Bruchpilot (nc82, Fig. 1C), a presynaptic marker that labels
neuropil regions. We found that AANAT1 was expressed in the cell bodies of neurons (Elav+

+

positive (Elav ), Fig. 1D,D') and glia (Repo , Fig. 1E,E') throughout the brain. The glial cells sat at
the interface between neuropil and the brain cortex where cell bodies of neurons and glia reside,
a position suggesting they were astrocytes or ensheathing glia. With Gal4 drivers specific for
+

astrocytes or ensheathing glia, we confirmed that AANAT1 glial cells are astrocytes. All
astrocytes labeled by a Red Fluorescent Protein (RFP) reporter driven by Alrm-Gal4
+

(Alrm>nuRFP) were AANAT1 in the central brain (Fig. 1F-F''), but there were some in the optic
lobes residing between the medulla and lobula layers that did not express AANAT1 (Fig. S1).
AANAT1 expression was absent in ensheathing glia marked by R56F03-Gal4 (Fig. S1). The
labeling of astrocytes in the central brain was confirmed to be specific for AANAT1 because it
was lost upon knockdown of AANAT1 from astrocytes with Alrm-Gal4 (Fig. S1), or from all glia
with Repo-Gal4 (Fig. S1).
With pan-neuronal RNAi-mediated knockdown of AANAT1 using the driver nSyb-Gal4,
the AANAT1-positive glial cells that remained could be identified more clearly as astrocytes by
their ramified morphology and the presence of AANAT1 in their thin processes that infiltrate
neuropil. RNAi knockdown of AANAT1 from all astrocytes using Alrm-Gal4 abolished AANAT1
labeling from astrocytes, revealing AANAT1-positive neurons in several clusters, and their axon
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tracts (Fig. S1). Based on this differential knockdown approach, we estimated that astrocytes
contributed far more to the AANAT1 labeling of neuropil than did neurons. AANAT1-labeled
neurons were marked with Elav in control flies (Fig. 1D), and this was lost upon RNAi-induced
knockdown with nSyb-Gal4, revealing astrocyte-derived AANAT1 in the IHC-positive neuropil that
remained (Fig. S1).
Previous studies have speculated AANAT1 expression in dopaminergic neurons
(Ganguly-Fitzgerald et al., 2006, Shao et al., 2011), but this has not been tested directly. With
IHC, we examined AANAT1 co-labeling of serotonergic, dopaminergic and octopaminergic
neurons using a mCD8-GFP reporter driven by either Trh-Gal4 (Alekseyenko et al., 2010), THGal4 (Friggi-Grelin et al., 2003), or Tdc2-Gal4 (Monastirioti et al., 1995), respectively. AANAT1
was expressed in 30% of serotonergic cells labeled with Trh>mCD8-GFP (Fig. 1H, I-I'',N).
+

AANAT1 serotonergic neurons belonged to a medial subeosophageal ganglion cluster. However,
AANAT1 did not co-label cells expressing TH>mCD8-GFP or Tdc2>mCD8-GFP (Fig. 1J, KK'',L,M-M'',N), indicating AANAT1 is not expressed in dopaminergic or octopaminergic neurons.
To identify the other types of neurons expressing AANAT1, we used a mCD8-GFP reporter driven
by either MiMIC-vGlut, Gad1-Gal4, or Cha-Gal4 and found AANAT1 in subpopulations of neurons
that release glutamate, gamma-aminobutyric acid (GABA), or acetylcholine, respectively (Fig.
S1). This is somewhat surprising since monoamines are mainly synthesized in the neurons that
release them, and it is generally understood that their re-uptake into these same neurons occurs
via specific transport proteins to prevent their accumulation at synapses. Why subsets of
glutamatergic, GABAergic and cholinergic neurons might express AANAT1 remains unknown
although it is possible that some might co-release monoamines. In mice, this occurs ventral
tegmental area and nucleus accumbens, where dopamine and glutamate are co-released from
medium spiny neurons and mesolimbic neurons, respectively (Broussard, 2012, Yamaguchi et
al., 2011, Tecuapetla et al., 2010). Alternatively, AANAT1 expressing neurons and astrocytes
could participate in monoamine uptake and catabolism, and thereby contribute to regulation of
monoamine bioavailability in the brain.
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The AANAT1 gene produces two isoforms, the shorter of which (FlyBase AANAT1-PA,
240aa in length) is the predominant one and known previously as aaNAT1b (Brodbeck et al.,
lo

1998). This shorter isoform was observed to be lost in AANAT1 mutants (Hintermann et al.,
lo

1996). AANAT1 is a spontaneous mutation that arose from insertion of a transposable element
into the AANAT1 gene, and extracts of these flies have reduced AANAT1 activity (Maranda and
Hodgetts, 1977, Hintermann et al., 1996). Using our new AANAT1 antiserum to perform Western
blotting of brain extracts, we observed only the short isoform in controls. In AANAT1

lo

lo

homozygotes and hemizygotes (AANAT1 /In(2LR)Px[4]), we observed dramatic reduction of
AANAT1 protein levels to 16% and 5% of iso31 controls, respectively (Fig. 2A,B). With IHC, we
+

found residual AANAT1 expression only in some Elav neurons, but it was completely lost from
lo

astrocytes in the brains of AANAT1 flies (Fig. 2C-C';D-D').
In vitro studies have shown that serotonin and dopamine are substrates for AANAT1 with
similar affinities (Hintermann et al., 1995). Whether the levels of these and/or other monoamines
are regulated by AANAT1 in vivo remains to be determined. We used HPLC-MS to measure
lo

levels of serotonin, dopamine, and octopamine in the brains of AANAT1 flies and controls
(iso31) (Fig. 2F). Under baseline sleep-cycle conditions, where brain tissues were collected in a
lo

3-hour window after lights-ON (ZT0), serotonin and dopamine levels in AANAT1 flies were
similar to controls. Octopamine was undetectable in controls, and found at low levels in brains of
lo

AANAT1 flies (Fig. S2). However, if this window was preceded by 12 hours (ZT12-ZT24) of
lo

sleep deprivation, AANAT1 brains had a robust increase in the levels of serotonin and dopamine
compared to controls (Fig. 2E,F), but this had no effect on octopamine levels (Fig. S2).
Importantly, in control animals the sleep deprivation protocol itself did not appear to affect the
levels of measured monoamines, or of AANAT1 itself (Fig. 2G). We conclude that catabolism of
serotonin and dopamine in the brains of flies lacking AANAT1 is severely compromised upon
sleep deprivation, leading to inappropriate accumulation of these monoamines.
lo

AANAT1 increases homeostatic sleep following deprivation (Shaw et al., 2000),
suggesting AANAT1 could be key to how the brain limits the response to sleep deprivation.
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lo

AANAT1 is also interesting because these flies have normal activity, and intact daily patterns of
sleep (Shaw et al., 2000), allowing genetic dissection of homeostatic sleep control from the
regulation of baseline sleep. We wondered whether the increased rebound sleep seen in
lo

AANAT1 animals could be explained by loss of AANAT1 function from neurons or astrocytes. To
test this, we selectively knocked down AANAT1 in distinct cell types with RNAi, and measured
both baseline and homeostatic sleep with the Drosophila Activity Monitoring System (DAMS). To
evaluate the contribution of neuronal AANAT1 in sleep, we tested nSyb-Gal4>UAS-AANAT1lo

RNAi flies for baseline and rebound sleep paradigms. As reported for AANAT1 allele (Shaw et
al., 2000), we found that when flies with neuronal knockdown of AANAT1 were awake, they were
as active as controls and displayed normal patterns of sleep (Fig. 3A-D). However, knockdown of
AANAT1 in neurons increased the amount of nighttime sleep compared to controls (Fig. 3E,F). In
addition, AANAT1 knockdown in neurons led to sleep bouts during the night that were increased
in duration and decreased in number, suggesting improved sleep consolidation at night (Fig. 3G,
H). This was observed for two independent RNAi lines that target the AANAT1 transcript at
distinct sites, though the effect was stronger for one (JF02142) than the other (HMS01617). We
then assessed whether AANAT1 knockdown in neurons (nSyb>AANAT1-RNAi) would impact
lo

sleep rebound after sleep deprivation, as was observed in AANAT1 flies. For this, flies were
subjected to overnight mechanical sleep deprivation and, somewhat surprisingly, we found that
these flies do not display an enhanced rebound sleep the next day (Fig. 3I-L). Flies lacking
AANAT1 in neurons were not totally deprived of sleep by the mechanical stimulation, but as this
was also the case in one of the controls, it is not indicative of a phenotype of AANAT1 loss.
Next, we used Alrm-Gal4 to selectively deplete AANAT1 expression from astrocytes with
RNAi (Alrm>AANAT1-RNAi). This had no effect on the numbers of astrocytes in the brains of
these flies (Fig. 4A), and they showed normal baseline patterns and amounts of daytime and
nighttime sleep compared to controls carrying either GAL4 or UAS transgenes alone (Fig. 4B-E),
lo

consistent with reported normal circadian sleep-cycle and motor activity of AANAT1 (Shaw et al.,
2000). However, upon overnight mechanical sleep deprivation, these flies had increased rebound
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lo

sleep the next day (Fig. 4F-I), mimicking AANAT1 flies and demonstrating that astrocytes
employ AANAT1 to restrict homeostatic rebound sleep.
Together with our finding that AANAT1 prevents accumulation of serotonin and dopamine
upon sleep deprivation, these data suggest that astrocytes are specifically engaged to handle the
particular demands on monoamine metabolism that are imposed by sleep deprivation.
Interestingly, neither gene expression studies nor RNA sequencing databases provide evidence
for monoamine-synthesizing enzymes in Drosophila astrocytes, so it appears likely that
monoamines inactivated by AANAT1 in astrocytes are brought into these cells by an as-yet
undefined transport mechanism. Nevertheless, astrocytes express molecules relevant for
processing of monoamines. For instance, Drosophila astrocytes express the enzyme Ebony,
which couples dopamine to N-β-alanine (Suh and Jackson, 2007). They also express a receptor
for octopamine and tyramine (Ma et al., 2016), with which they monitor and respond to
monoaminergic neuronal activity. Interestingly, astrocytes in rodents express the vesicular
monoamine transporter VMAT2 (Petrelli et al., 2018), passive monoamine transporters such as
OCT and PMAT, and receptors for dopamine and serotonin (Petrelli et al., 2018, Baganz et al.,
2008, Bacq et al., 2012, Huang et al., 2012, Vaarmann et al., 2010, Sanden et al., 2000).
Therefore, astrocytes in mammals are poised to participate in mechanisms that regulate
monoaminergic influences on sleep.
In Drosophila as in mammals, serotonergic signaling in the brain promotes sleep, while
dopaminergic signaling promotes waking. Levels of both serotonin and dopamine are upregulated
lo

in AANAT1 mutants where increased sleep prevails, and so understanding exactly how the
neural circuits determining sleep vs wake states are affected by these changes in monoamines
awaits further study. In this context, we note that loss of an AANAT1 ortholog in zebrafish larvae
decreases baseline sleep. This phenotype was attributed to a decrease in melatonin, but could
also involve changes in monoamines such that effects of wake-promoting monoamines (e.g.
dopamine) dominate. Clearly, the appropriate balance of monoamines is critical for the regulation
of sleep, and we show here that astrocytes are a major contributor to this balance. .
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Figure 1. AANAT1 expression in the adult Drosophila brain.
(A-B) AANAT1 IHC in age-matched embryos (stage 17) from controls (A; w

1118

) and AANAT1

nulls (B; homozygous Df(BSC)356). (C-M) AANAT1 IHC in the central brain of adults.
(C) Z-stack showing AANAT1 (green) and neuropil marker nc82 (magenta) in Alrm-Gal4/+ control
animals.
(D-D') Single optical slice showing AANAT1 (magenta) and the pan-neuronal marker Elav
(green), with examples of neurons in control animals that co-express both (D'; yellow
arrowheads).
(E-E'). Single slice of AANAT1 (magenta) and the pan-glial marker Repo (green) in control
animals where most glia (E'; yellow arrowheads) express AANAT1, but not all (E''; white
arrowheads). AL = antennal lobe.
(F-F'') Single slice of AANAT1 (green), Elav (blue), and astrocyte marker Alrm-Gal4>UAS-nuRFP
(Alrm>nuRFP, magenta) showing co-expression of AANAT1 and nuRFP in astrocytes (F''; yellow
arrowheads) and with Elav (F''; yellow asterisk).
(G) MCFO-labeled single cell astrocyte clones (magenta) co-labeled with AANAT1 (green), where
yellow arrowheads indicate AANAT1-positive astrocyte cell bodies.
(H-M'') Z-stack and single slice images of AANAT1 (magenta) and GFP (green) IHC in
monoaminergic neurons labeled with type-specific Gal4 drivers. Dotted boxes in H, J and L show
regions approximating those selected for imaging at higher power in animals of the same
genotypes shown in I, K and M, respectively. AANAT1 is expressed in some serotonergic
neurons (I''; yellow arrowhead), but not in dopaminergic or octopaminergic neurons (K'', M''; white
arrowheads).
(N) Quantification of the mean number of GFP-positive and GFP/AANAT1 double-positive cells in
the central brains of animals where Gal4 is used to express GFP in serotonergic (green),
dopaminergic (blue) or octopaminergic (red) neurons. Error bars represent standard deviation.
(O) Summary of AANAT1 expression in cell types of the adult Drosophila central brain. Scale
bars in A, B, D-G, I, K, M = 20 µm. Scale bars in C, H, J, L = 50μm.

105

106

lo

Figure 2 Characterization of AANAT1 .
lo

(A)Western blot of lysates prepared from dissected brains (ZT15-16) of iso31, AANAT1 and
lo

AANAT1 /Df(In(2LR)Px[4]) adult males.
(B) Quantification of AANAT1 expression, normalized to that of Actin (mean + standard deviation,
n=3 biological replicates).
(C, D) Single optical slices showing AANAT1 (gray or magenta) and Elav (green) in iso31(C, C')
lo

and AANAT1 (D, D'). Scale bars = 20 µm.
(E) Schematic of experiment for HPLC-MS analysis.
(F) HPLC-MS measurement of serotonin (One-way ANOVA with Tukey’s post-hoc test, *p<0.05,
**p<0.01,) and dopamine (Krusal-Wallis test, Dunn’s multiple comparisons, *p<0.05,) in iso31
lo

(black) and AANAT1 (red) fly brains under control and sleep deprivation (SD) conditions. Box
and whisker plots in this figure show 25-75% interquartile range (box), minimum and maximum
(whiskers), median (horizontal line in box), and mean (+). n=5 per genotype.
(G) Western blot of lysates prepared from dissected brains (ZT24-25) of iso31 females in control
and sleep deprivation (SD) conditions.
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Figure 3. Sleep with AANAT1 knockdown in neurons.
(A-D) Baseline sleep upon knockdown with UAS-HMS01617 (RNAi 1). 24-hr sleep profile
showing light/dark conditions on X-axis (A), and quantification during day (ZT 0-12) versus night
(ZT 12-24) of total sleep duration (B), sleep bout length (C) and bout number (D) for the nSybGal4 control (black), the UAS-HMS01617 control (blue), and knockdown animals
(nSyb>HMS01617, green). (n=16 per genotype, bar graphs show mean + standard deviation,
one-way ANOVA with Tukey’s post-hoc test, *p<0.05, ***p<0.001, ****p<0.0001).
(E-H) Baseline sleep upon knockdown with UAS-JF02142 (RNAi 2). (E) 24-hr sleep profile
showing light/dark conditions on X-axis. Quantification of total sleep duration (F), sleep bout
length (G) and bout number (H) for the nSyb-Gal4 control (black), the UAS- JF02142 control
(blue), and knockdown animals (nSyb>JF02142, green). The plotted nSyb-Gal4 control data is
the same as in A-D, as the experiments were done simultaneously. (n=16 per genotype, one-way
ANOVA with Tukey’s post-hoc test, ***p<0.001, ****p<0.0001).
(I, K) Rebound sleep upon knockdown with UAS-HMS01617 (RNAi 1). (I) 24-hr sleep profile of
baseline day (upper) and recovery day (lower), and the duration of sleep during ZT0-6 recovery
period (K) for the nSyb-Gal4 control (black), the UAS-HMS01617 control (blue), and knockdown
animals (nSyb>HMS01617, green). (n=16 per genotype, two-way ANOVA with Tukey’s post-hoc
test).
(J, L) Rebound sleep upon knockdown with UAS-JF02142 (RNAi 2). (J) 24-hr sleep profile of
baseline day (upper) and recovery day (lower), and the duration of sleep during ZT0-6 recovery
period (L) for the nSyb-Gal4 control (black), the UAS- JF02142 control (blue), and knockdown
animals (nSyb>HMS01617, green). (n=16 per genotype, two-way ANOVA with Tukey’s post-hoc
test).
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Figure 4. Sleep with AANAT1 knockdown in astrocytes.
(A) Compared with Alrm-Gal4 controls (Alrm>), the number of nuFRP labeled astrocytes in the
central brain is unaffected knockdown of AANAT1 with UAS-HMS01617 (RNAi 1) or UASJF02142 (RNAi 2). Box and whisker plot as in Figure 2F. One-way ANOVA with Tukey’s post-hoc
test, n=7-9 per genotype.
(B, C) Baseline sleep upon knockdown with UAS-HMS01617 (RNAi 1). 24-hr sleep profile (B),
and total sleep duration (C) for the Alrm-Gal4 control (black), the UAS-HMS01617 control (blue),
and knockdown animals (Alrm>HMS01617, green). (n=16 per genotype, one-way ANOVA with
Tukey’s post-hoc test).
(D, E) Baseline sleep upon knockdown with UAS-JF02142 (RNAi 2). 24-hr sleep profile (D), and
total sleep duration (E) for the Alrm-Gal4 control (black), the UAS-JF02142 control (blue), and
knockdown animals (Alrm>JF02142, green). The plotted Alrm-Gal4 control data is the same as in
B and C, as the experiments were done simultaneously. (n=16 per genotype, one-way ANOVA
with Tukey’s post-hoc test).
(F, H) Rebound sleep upon knockdown with UAS-HMS01617 (RNAi 1). 24-hr sleep profile of
baseline day and recovery day (F), and the duration of sleep during ZT0-6 recovery period (H) for
the Alrm-Gal4 control (black), the UAS-HMS01617 control (blue), and knockdown animals
(Alrm>HMS01617, green). (n=16 per genotype, two-way ANOVA with Tukey’s post-hoc test,
**p<0.01, ****p<0.0001).
(G, I) Rebound sleep upon knockdown with UAS-JF02142 (RNAi 2). 24-hr sleep profile of
baseline day and recovery day (G), and the duration of sleep during ZT0-6 recovery period (I) for
the Alrm-Gal4 control (black), the UAS-JF02142 control (blue), and knockdown animals
(Alrm>HMS01617, green). (n=16 per genotype, error bars are mean + standard deviation, Twoway ANOVA with Tukey’s post-hoc test, *p<0.05, ****p<0.0001)
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Supplementary Figure 1. AANAT1 expression in the adult Drosophila brain.
(A) Single optical slice showing AANAT1 (green), Elav (blue) and Alrm>nuRFP (magenta), with
AANAT1-negative astrocytes (white arrowheads) in the optic lobe.
(B) Single optical slice showing AANAT1 (magenta) and R56F03>mC8-GFP (green) showing
absence of AANAT1 in ensheathing glia (white arrowheads).
(C-F) AANAT1 IHC upon AANAT1 knockdown using UAS-HMS01617 RNAi expressed in all glia
(C; Repo-Gal4;UAS-Dcr-2), all neurons (D; nSyb-Gal4), astrocytes (E; Alrm-Gal4,UAS-nuRFP),
and in neurons and astrocytes (F; nSyb-Gal4;Alrm-Gal4). Cyan arrows in C and E depict axonal
bundles. Blue arrow in F shows background signal.
(G, H) Single slices showing AANAT1 (green) and Elav (magenta) showing loss of AANAT1
expression (white arrowheads) upon knockdown in neurons using nSyb-Gal4 to drive either UASHMS01617 (G; RNAi 1) or UAS-JF02142 (H; RNAi 2).
(I, J) Single slices showing AANAT1 (green) and Alrm>nuRFP (magenta) showing loss of
AANAT1 expression (white arrowheads) upon knockdown in astrocytes using Alrm-Gal4 to drive
RNAi 1 (I) or RNAi 2 (J). Yellow arrowheads indicate AANAT1 expression in neurons.
(K-P'') Z-stack and single-slice images of AANAT1 (magenta) and GFP (green) IHC in nonmonoaminergic neurons labeled with type-specific drivers. Dotted boxes in K,M and O show
regions approximating those selected for imaging at higher power in animals of the same
genotypes shown in L,N and P, respectively. AANAT1 is expressed in subsets of glutamatergic,
GABAergic and cholinergic neurons (L'', N'', P''; yellow arrowheads).
Scale bars in A, C-F, K, M, O = 50 µm. Scale bars in B, G-J, L, N, P = 20μm.
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Supplementary Figure 2. Octopamine and Ebony expression in AANAT1 mutants.
(A) Quantification of Ebony expression, normalized to that of Actin (mean + standard deviation,
n=3 biological replicates, One-way ANOVA with Tuckey’s post-hoc test).
lo

(B-D) Z-stack images showing AANAT1 (grey) iso31 (B), AANAT1 (C) and
lo

AANAT1 /Df(In(2LR)Px[4]) (D) animals. Blue arrowhead in D represents background signal.
Scale bar 50 µm.
lo

(E) HPLC-MS measurement of octopamine (Mann-Whitney test, p<0.533) in AANAT1 animals
(red) under control (n=2) and sleep deprivation (SD; n=5) conditions. Box and whisker plot as in
Figure 2F. n=5 per genotype.
(F, G) Quantification of AANAT1 (F; paired t-test, p=0.0831, n=3) and Ebony (G; paired t-test,
p=0.7036, n=3) expression, normalized to actin levels in iso31 animals under control and sleep
deprivation (SD) conditions.
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CHAPTER 4: Behavioral and metabolomic analysis of sleeprelevant trafficking through barrier glia
Gregory Artiushin, Amita Sehgal

Abstract:
The fly barrier glia control trafficking of solutes to and from the brain, and we have
previously shown endocytosis to be affected by sleep, and manipulations of trafficking to alter
sleep through these populations. We have conducted an RNAi knockdown screen of barrier glial
enriched genes and found multiple transporters to modulate sleep at the barrier. Metabolomics of
head tissue from flies which have increased sleep due to glial manipulation, revealed an
accumulation of acylcarnitines. Transporters within the barrier may be responsible for the
correlation between the sleep and metabolomic phenotypes.

Introduction:
Barriers that separate the solutes of blood/hemolymph of the periphery from the
interstitial fluid of the central nervous system display a rich profile of transporters, receptors, and
trafficking proteins, which often reflect their unique functions. The Drosophila barrier glia
populations share many conserved features with vertebrate barriers which employ endothelial
and astrocytic populations (DeSalvo et al., 2014, Weiler et al., 2017). For instance, both are
capable of moving lipids and carbohydrates, ions, amino acids and xenobiotics (Weiler et al.,
2017). Furthermore, the fly barrier populations may serve specialized roles in metabolism, as not
only the conduit of energy sources from the periphery, but also by containing the enzymatic
machinery necessary for processing energy sources (Volkenhoff et al., 2015), and secreting
signals in reference to nutritional state(Chell and Brand, 2010, Speder and Brand, 2014).
We have previously (Chapter 2) identified the barrier glia as a new cellular locus of sleep
regulation in the fly, and shown that interruption of endocytic and trafficking pathways is sufficient
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for altering sleep. Given that these genetic manipulations can directly impact endocytosisdependent carrier traffic as well as indirectly affect levels of membrane-associated
transporters/receptors by altered recycling, we chose to perform a knockdown screen to broadly
search for barrier genes involved in sleep regulation. As much of the traffic through the barrier
involves energetic substrates, we complemented this approach with metabolomic profiling to
identify candidate metabolites whose trafficking is disrupted in flies expressing Shibire in glia.

Results:
Pan-glial RNAi screen of genes enriched in surface glia
To select candidate genes for the screen, we referred to transcriptional profiling that
compared expression in both surface glial populations (SPG + PG), to all neurons, and all glia
(DeSalvo et al., 2014). Preference was given to previously studied genes, particularly
transporters, receptors and those involved in trafficking, although many genes among the top-50
highly expressed in the surface glia populations were also tested. Of the genes enriched in
surface glia, we focused on those that showed low variability in expression from sample to
sample. We considered that repoGeneSwitch and/or repo-Gal4 would be the strongest drivers to
affect both barrier glial populations, and would hence minimize the occurrence of false negatives
within the screen.
In this initial screen with pan-glial drivers, the majority of genes did not show a significant
change in total sleep as compared to controls . Of the potential hits, sleep was increased with
knockdown of the following genes: CG3036, CG6126, lsd-2, mnd, CG8036, nuf, VMAT, Vha16,
acon, MtnA, Rh50, CG6836, and CG4462. Knockdown of three genes, Cyp6a20, CG16700, and
Cln7 decreased total sleep (Figure 1).
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Candidate gene knockdown in barrier glia:
Since the candidate genes were selected based on enrichment within the barrier glia, we
chose to examine and secondarily validate promising phenotypes through knockdown with more
limited, barrier glia drivers. To date, we have thus screened a sub-set of the genes suggested by
results in Figure 1.
Knockdown of MtnA ( 105011 KK), CG6386 (108502 KK), CG4462 (105566 KK), or lsd-2
(102269 KK) did not significantly alter sleep when expressed in either of the barrier glial
populations alone. We found that the cytochrome P450 gene, cyp6a20, reproduced the pan-glial
sleep loss phenotype when expressed in the PG population, but this was not a reliable phenotype
(data not shown). An isoform of VMAT is thought to be specific to glia (Romero-Calderon et al.,
2008). Knockdown of VMAT (TRiP HMC02346) in the perineurial glia, but not the subperineurial
glia, increased total sleep (Figure 2A). This is consistent with protein expression, as VMAT-B
antibody can be used as a marker for the perineurial glia (DeSalvo et al., 2014). Cln7 has been
shown to be expressed in the perineurial glia (Mohammed et al., 2017). Pan-glial knockdown of
Cln7 decreased total sleep (Figure 1). Instead, when Cln7 RNAi was expressed in the PG, an
increase in total sleep time was observed, while no change was significant in the SPG (Figure
2B).

Metabolomic profiling:
To attain an unbiased, global assessment of metabolites that may be relevant to the
increased sleep seen in Repo>Shi flies, we chose to conduct LC-MS analysis. Heads of male and
female Repo-Gal4 > UAS-20xShi flies as well as Gal4 and UAS controls were collected on dry ice
with sieves and immediately frozen at -80 C. Each sample contained 200 fly heads (equal male
and female), for a total of 5 samples per genetic condition.
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As an initial analysis, raw signal was scaled per each metabolite in reference to other
samples within the dataset, and comparisons were made between Repo>Shi flies and each
control, as well as controls to each other by Welch’s t-test (Table 1).
Metabolites of interest are those for which signal from the experimental samples is
significantly different, in the same direction, when compared to both controls, while controls
compared to each are not significant. Of secondary interest are metabolites where a difference is
seen in controls, but is proportionally smaller to consistent differences of each control to the
experimental samples.
In surveying this dataset, the outstanding functional category, which contained multiple
metabolites whose signal was consistently different in experimental animals versus controls, were
the acyl-carnitines. Furthermore, the fold changes for given metabolites in this group were the
highest overall. Carnitinylation occurs on fatty acids of various chain lengths, but only a subset of
chain lengths in this dataset had sufficient quantity of signal, therefore we statistically compared
Repo>Shi flies to both parental controls for metabolites that had signal in at least three of five
biological replicates for each genotype. Expression of Shibire in glia increased abundance in fly
heads of the following acylcarnitine species: C2, C16, C16*1, C17, C18:1, C18:2* (Figure 3A).
The only metabolite of this group with less signal in experimental animals was the longer-chain,
C24* (Figure 3B). Carnitine and deoxycarnitine were not significantly altered as compared to
both controls.

Knockdown of candidate genes potentially related to metabolomics
results:
The results of metabolomic screening would indicate that lipid, and particularly carnitinelipid trafficking may be relevant for the Repo>Shibire phenotype. Therefore, we reassessed our
screen candidates to consider transporters and receptors which may function in these pathways.
Lrp1 and Megalin (Lrp2) are two LDL receptor-related protein members involved in transport of
lipid carrier proteins at the fly barrier (Brankatschk et al., 2014). Expression is likewise found in
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mammals at the endothelial barrier (Herz, 2003). The organic cation (Orct) transporters are multisubstrate transporters, which are known to transport carnitine (Lahjouji et al., 2001). In vitro
evidence suggests that carnitylated molecules can also be a substrate of Orct2 (Kou et al., 2017).
Knocking down these genes individually in the pan-glial screen did not significantly alter total
sleep time (Figure 1). Nevertheless, both Lrp1 and Megalin (Lrp2) as well as Orct and Orct2 have
been considered to be complementary (Brankatschk et al., 2014, Eraly and Nigam, 2002),
therefore it is possible that inhibition of a single gene is insufficient to appreciate an effect on
transport. Simultaneously knocking down Lrp1 and Megalin in all glia increased total sleep time
(Figure 4A), which was also the case when both Orct genes were knocked down (Figure 4C).
When both Lrp genes were knocked down with barrier glia drivers, a significant increase in total
sleep was seen in the PG, but not the SPG with either of two SPG drivers (Figure 4B). For the
Orct genes, knockdown in both PG and SPG replicated the increased total sleep phenotype,
although with only one line for the SPG (Figure 4D). It is worth noting that the phenotypes with
the barrier drivers are considerably more moderate than when knocked down in all glia.

Discussion:
We have conducted a pan-glial RNAi knockdown screen of candidate genes expressed in
the fly barrier. In follow-up experiments, we targeted knockdown to each barrier layer separately,
which is subject to the concern that behavioral phenotypes requiring simultaneous knockdown in
both barrier populations would be missed. Nevertheless, we consider this scenario to be less
probable, as permeability through the populations is quite different, with smaller solutes likely
passing through the PG but not the tight barrier of the SPG, lipophilic solutes or xenobiotics
potentially passing through each uninhibited, and larger solutes requiring endocytotic
mechanisms that likely have to work in each population in tandem. Therefore, in most cases of
knockdown, transport would either be inhibited by the one barrier population essential for it, or
would be interrupted by either population.
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An additional consideration of preliminarily screening with pan-glial drivers is that if
knockdown in multiple glial subtypes has opposing effects on sleep, we may have obscured a
role for the barrier cells. Again, we have attempted to minimize this risk by primarily selecting
genes whose expression is both highly abundant and specifically enriched in the barrier
populations, as opposed to the set of all glial cells in the transcriptome dataset (DeSalvo et al.,
2014). The assumption would be that multifold expression in the barrier populations is indicative
of prevailing importance in these cells, although this is a caveat.
The vesicular monoamine transporter (VMAT) has previously been identified as a target
of reserpine, which promotes sleep in the fly (Nall et al., 2014). VMAT mutants exhibit higher
baseline sleep, and are also lose less sleep than controls when subject to mechanical sleep
deprivation. VMAT can traffic multiple monoamines such as dopamine, serotonin, histamine and
octopamine, but no single neuronal population or neurotransmitter system was implicated as
responsible for the VMAT sleep phenotype (Nall et al., 2014). In flies, VMAT exists as two
isoforms, VMAT-A, which is expressed in monoaminergic neurons, and VMAT-B, which appears
to be specific to perineurial glia (DeSalvo et al., 2014), as it is found in fenestrated glia in the
visual system (Romero-Calderon et al., 2008), which are a specialized form of perineurial glia
(Kremer et al., 2017). It is unknown whether VMAT-B would functional similarly in glia as VMAT-A
does in neurons. VMAT-B contains an additional cytoplasmic domain, which has been suggested
to promote retention in the plasma membrane as opposed to trafficking to vesicles (Greer et al.,
2005).
VMAT knockdown increased sleep, as did disrupting endocytic trafficking at the barrier
(Chapter 2). Whole-brain levels of monoamines were not altered in flies that expressed Shibire in
glia, nevertheless it is possible that this gross analysis would not be sensitive to local changes at
the barrier. In the visual system glia, VMAT-B may be necessary for uptake of histamine
(Romero-Calderon et al., 2008). Histamine is known to alter permeability of the blood-brain
barrier in mammals (Lu et al., 2010). Minidiscs (mnd) is also an amino acid transporter,
particularly of leucine (Maniere et al., 2016, Martin et al., 2000), which was a hit of the pan-glial
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screen, although the effect was very weak. Whether or not knockdown of mnd in the barrier
changes sleep will need to be determined.
Cln7 is a major facilitator superfamily transporter implicated in neuronal ceroid
lipofuscinoses, and hence considered to impact lysosomal/autophagal function (Siintola et al.,
2007). Neither the function, nor what this transporter traffics, are known, but it is thought to be
vesicular as well, and is expressed in the perineurial glia in flies (Mohammed et al., 2017).
Knockdown of Cln7 in all glia affected sleep in the opposite direction from knockdown only in the
PG. One potential explanation would be that Cln7 acts on sleep in opposing ways in different glial
populations, although protein expression data suggest that Cln7 is quite limited in the brain, and it
is not clear whether it is in other glial populations.
Within the initial screen, several unnamed genes representing transporter classes also
appeared to be significant. While we did not recapitulate an effect in the barrier glia with some of
these genes (MtnA, CG6386, CG4462, lsd-2), others remain to be tested (CG3036, Rh50). SLC
transporters are a very broad family with many understudied constituents (Hediger et al., 2013). A
candidate gene within this class would be interesting, but not as readily accessible to further
mechanistic study, as the substrates trafficked are unknown and potentially permissive. Rh50 is a
putative ammonia transporter (Wu et al., 2010).
Our previous study showed that endocytic and endosomal recycling genes (Shibire and
Rab11) increased sleep through the barrier populations (Chapter 2). Due primarily to abundance
of expression in the transcription data, our screen also included genes involved in cytoskeletal
organization and intracellular trafficking. Given that manipulation of such genes would likely
impact many trafficking pathways simultaneously, we consider these of secondary interest to
discovering specific transporters or accessory proteins which would better indicate the nature of
the solute being trafficked. Nuf is a protein associated with Rab11 and it interacts with the
cytoskeleton (Cao et al., 2008). Multiple RNAi lines are available for this gene, which produced
mixed results, as some supported a sleep increase by knockdown, while others had no effect.
Vha16 is an H+V-ATPase that could be involved in multiple trafficking steps. The effects of both
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of these genes would need to be confirmed, and if so, tested as to whether the barrier
populations are sufficient.
Our metabolomic data indicated that acylcarnitines are elevated in the heads of the longsleeping Repo>Shibire flies. Acylcarnitines are used in fatty acid oxidation, but are also secreted
as they are found in plasma in mammals (Schooneman et al., 2013). Acylcarnitines are formed
from fatty acids and carnitine, which are transported into the cell. To this end we investigated
Lrp1/megalin and Orct/Orct2 knockdown to find that sleep is elevated when driven in all glia, as
well as with barrier specific drivers, although especially for the Lrps, this has so far been a weaker
phenotype. Lrp1 and megalin are lipoprotein carrier receptors known to function in the fly barrier
(Brankatschk et al., 2014). Orct and Orct2 are homologs of the human carnitine transporters
(Eraly and Nigam, 2002), which can transport carnitine but also acylcarnitines (Pochini et al.,
2004). Future experiments to strengthen the hypothesis that these transporters act through
acylcarnitines to impact sleep would be to measure acylcarnitines in heads/brains of flies that
have Lrps or Orcts knocked down in only the barrier glia, and also potentially stain for differences
in these transporters in Repo>Shibire flies. Determining whether accumulation is external or
internal to the brain, or possibly within the barrier populations themselves would further be
informative. It is also possible that the upregulation of acylcarnitines in Repo>Shibire flies is a
consequence, but not a cause of, elevated sleep.
Several other genes such as acon, a TCA cycle enzyme (Cheng et al., 2013) were found
to significantly increase sleep when disrupted in all glia. In Repo>Shibire heads, we did not see
an obvious alteration in TCA cycle metabolites, so it is unlikely that this gene is responsible in
those animals, but it could support an independent sleep-regulating role for other metabolic
pathways. If substantiated, this gene would require additional experiments to determine whether
the barrier is the essential locus.
In summary, these preliminary results suggest that barrier glia function might impact
sleep through multiple pathways. Many of what are deemed potential candidates are only the
result of a single RNAi line. To confirm these effects it will be important to employ multiple RNAi
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constructs and follow effects by multiple glial GAL4 drivers. Since RNAi lines differ in
effectiveness, it will also be prudent to validate knockdown, ideally at the level of protein, or
through some functional means. A promising direction will be to further examine the importance
of acylcarnitines, and barrier glia transporters that might contribute to their accumulation.

Methods:

Fly Stocks:
The initial screen was performed with lab stock drivers: ;;Repo-GAL4/TM6c, Sb and
UAS-Dicer; RepoGeneSwitch. The SPG driver moody-Gal4 was a gift of Roland Bainton, while
PG driver NP6293-GAL4 was a gift of Marc Freeman. UAS-20xShibire was a gift of Gerald Rubin.
RNAi lines were ordered from VDRC (KK and GD collection) and Bloomington (TRiP collection)
stock centers, with the stock number provided in Figure 1.

Behavior:
Flies were crossed and raised on standard food in bottles. Offspring were kept at 25 C, in
LD12:12 conditions until at least 6 days post-eclosion, before age-matched flies which were
group housed in bottles were used in sleep assays. Mated females were loaded into glass
locomotor tubes with 2% agar 5% sugar. Sleep was quantified by the Drosophila Activity Monitor
(DAM) system, by the established minimum definition of 5 minutes of inactivity. Data was
analyzed in PySolo (Gilestro et al., 2009).

Metabolomics:
Entire flies were quickly frozen in Falcon tubes chilled on dry ice, and placed at -80°C.
Each tube contained 50 flies. Heads were subsequently removed from the body by briefly
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vortexing the tube. Heads were separated from the rest of the body by an array of copper sieves,
whose housing was buried in dry ice to keep the preparation cool. Each sample contained 200 fly
heads, of equal parts from males and females, in 1.5 mL tubes which were quickly refrozen.
Samples were shipped on dry ice to Metabolon, Inc ., where they were assessed by LC-MS
(Evans et al., 2009).

Statistics:
For both behavioral and acylcarnitine metabolomics results, the experimental group was
compared to two parental controls by One-Way ANOVA with Holm-Sidak post-hoc tests. For the
initial comparisons of metabolomics data, Metabolon performed Welch’s t-tests on scaled signal
data for each metabolite, between all conditions. Raw signal was scaled so that the median would
be equal to 1, using all samples that had been concurrently run. Missing values were filled in with
the lowest value of run samples for that metabolite. Additional details of statistics tests are listed
in the figure legends.
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Table 1: Metabolomics of Repo>20xShibire fly heads
All measured metabolites and their respective categories are listed for samples from RepoGAL4>UAS-20xShibire, and both parental controls. Welch’s t-test was performed on scaled
signal for each metabolite, comparing each condition. Green highlighting marks a significant
difference (p≤0.05) between the groups, where metabolite ratio is < 1.00, while light green is not
significant, but close to the threshold (0.05<p<0.10). Red highlighting marks a significant
difference (p≤0.05) between groups where metabolite ratio is ≥ 1.00, and light red is not
significant, but close to the threshold (0.05<p<0.10).
Pathway

Biochemical Name

Platform

PubChem

Gal4>UAS Gal4>UAS
GAL4 Ctrl
UAS Ctrl

UAS Ctrl
GAL4 Ctrl

Amino Acids
glycine

LC/MS pos early

750

0.73

0.90

0.81

LC/MS polar

10972

0.77

0.96

0.80

sarcosine

LC/MS pos early

1088

0.36

1.12

0.33

betaine

LC/MS pos early

247

0.56

0.56

1.01

serine

LC/MS pos early

5951

1.09

1.01

1.08

N-acetylserine

LC/MS pos early

65249

0.87

1.02

0.85

2-methylserine

LC/MS pos early

94309

0.75

0.50

1.49

threonine

LC/MS pos early

6288

0.72

0.94

0.77

LC/MS polar

152204

0.56

0.90

0.63

homoserine

LC/MS pos early

12647

1.27

0.79

1.61

alanine

LC/MS pos early

5950

0.98

0.96

1.03

N-acetylalanine

LC/MS polar

88064

0.73

0.89

0.82

N-methylalanine

LC/MS pos early

5288725

0.59

0.63

0.93

LC/MS polar

65065

1.46

1.12

1.30

asparagine

LC/MS pos early

6267

1.11

0.81

1.37

N-acetylasparagine

LC/MS pos early

99715

0.81

0.89

0.91

glutamate

LC/MS pos early

611

1.41

1.06

1.33

glutamine

LC/MS pos early

5961

1.32

0.87

1.51

1.84

0.96

1.92

N-acetylglycine

Glycine, Serine and Threonine Metabolism

N-acetylthreonine

Alanine and Aspartate Metabolism

Glutamate Metabolism

N-acetylaspartate (NAA)

alpha-ketoglutaramate*

LC/MS polar

N-acetylglutamate

LC/MS polar

70914

1.27

0.61

2.08

N-acetylglutamine

LC/MS pos early

182230

0.68

0.92

0.74

glutamate, gamma-methyl ester

LC/MS pos early

68662

0.80

0.86

0.93

pyroglutamine*

LC/MS pos early

134508

0.34

0.95

0.36

gamma-aminobutyrate (GABA)

LC/MS pos early
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1.14

1.03

1.11

carboxyethyl-GABA

LC/MS pos early

2572

0.76

1.15

0.66

N-methyl-GABA

LC/MS pos early

70703

0.82

0.64

1.29

propionylglutamine

LC/MS pos early

0.65

1.05

0.62

LC/MS neg

6274

0.84

0.81

1.04

1-methylhistidine

LC/MS pos early

92105

1.11

0.73

1.51

3-methylhistidine

LC/MS pos early

64969

1.91

0.26

7.23

N-acetylhistidine

LC/MS pos early

75619

0.82

0.81

1.00

imidazole propionate

LC/MS pos early

70630

0.46

0.77

0.60

imidazole lactate

LC/MS pos early

440129

0.57

0.75

0.75

histamine

LC/MS pos early

774

1.05

0.93

1.13

4-imidazoleacetate

LC/MS pos early

96215

0.86

0.92

0.94

N-acetylhistamine

LC/MS pos early

69602

1.92

1.64

1.17

lysine

LC/MS pos early

5962

1.31

1.10

1.19

N6,N6,N6-trimethyllysine

LC/MS pos early

440120

0.96

1.96

0.49

5-(galactosylhydroxy)-L-lysine

LC/MS pos early

1.05

0.88

1.19

histidine

Histidine Metabolism

Lysine Metabolism

Phenylalanine Metabolism

Tyrosine Metabolism

saccharopine

LC/MS polar

160556

1.53

1.37

1.11

pipecolate

LC/MS pos early

849

0.74

1.22

0.61

N-trimethyl 5-aminovalerate

LC/MS pos early

3.87

1.87

2.07

phenylalanine

LC/MS pos early

6140

0.81

0.90

0.90

LC/MS neg

74839

0.58

1.37

0.42

tyrosine

LC/MS pos early

6057

2.61

1.29

2.03

dihydoxyphenylalanine (L-DOPA)

LC/MS pos early

6047

1.41

1.04

1.36

LC/MS neg

759256

1.50

1.31

1.15

tryptophan

LC/MS pos early

6305

1.17

1.02

1.15

kynurenine

LC/MS pos early

161166

2.29

1.44

1.59

kynurenate

LC/MS neg

3845

3.21

2.14

1.50

LC/MS pos early

89

4.59

1.17

3.94

xanthurenate

LC/MS neg

5699

2.05

1.07

1.91

N-acetylserotonin

LC/MS neg

903

0.81

0.99

0.82

N-acetylphenylalanine

N-formylphenylalanine

Tryptophan Metabolism

3-hydroxykynurenine
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Pathway

Biochemical Name

Platform

PubChem

Gal4>UAS Gal4>UAS
GAL4 Ctrl
UAS Ctrl

UAS Ctrl
GAL4 Ctrl

Amino Acids
leucine

LC/MS pos early

5246661

0.64

0.95

0.68

N-acetylleucine

LC/MS neg

70912

0.61

1.14

0.53

4-methyl-2-oxopentanoate

LC/MS neg

70

0.61

1.17

0.52

LC/MS polar

69362

0.81

1.05

0.78

LC/MS pos early

6306

0.71

0.94

0.76

LC/MS neg

47

0.75

1.16

0.65

alpha-hydroxyisovalerate

LC/MS polar

99823

0.81

0.96

0.84

ethylmalonate

LC/MS polar

11756

0.81

0.83

0.98

methylsuccinate

LC/MS polar

10349

0.96

0.82

1.18

LC/MS neg

6287

0.62

0.87

0.72

3-methyl-2-oxobutyrate

LC/MS polar

49

0.88

1.28

0.68

3-hydroxyisobutyrate

LC/MS polar

87

0.72

1.09

0.66

beta-hydroxyisovalerate
isoleucine
Leucine, Isoleucine and Valine Metabolism

3-methyl-2-oxovalerate

valine

methionine

LC/MS pos early

6137

0.75

1.08

0.70

N-acetylmethionine

LC/MS neg

448580

0.54

0.96

0.57

N-formylmethionine

LC/MS neg

439750

0.76

1.53

0.50

methionine sulfoxide

LC/MS pos early

158980

0.57

0.75

0.77

N-acetylmethionine sulfoxide

LC/MS pos early

193368

0.60

0.90

0.67

LC/MS neg

439155

1.14

1.22

0.93

cystathionine

LC/MS pos early

439258

0.97

1.14

0.85

cysteine

LC/MS pos early

5862

0.49

0.73

0.67

N-acetylcysteine

LC/MS pos early

12035

0.87

0.89

0.97

S-methylcysteine sulfoxide

LC/MS pos early

82142

1.12

0.71

1.58

LC/MS neg

67678

0.63

0.64

1.00

lanthionine

LC/MS pos early

98504

0.75

1.48

0.50

cysteine sulfinic acid

LC/MS pos early

109

1.84

0.87

2.12

taurine

LC/MS neg

1123

0.96

0.88

1.09

N-acetyltaurine

LC/MS neg

159864

1.02

0.85

1.20

cyano-alanine

LC/MS polar

13538

1.00

0.77

1.31

arginine

LC/MS pos early

232

0.99

0.96

1.03

argininosuccinate

LC/MS pos early

828

1.11

1.23

0.90

ornithine

LC/MS pos early

6262

1.38

1.38

1.00

2-oxoarginine*

LC/MS pos early

558

0.73

1.00

0.74

citrulline

LC/MS pos early

9750

0.73

0.97

0.75

proline

LC/MS pos early

145742

1.31

1.02

1.28

dimethylarginine (SDMA + ADMA)

LC/MS pos early

123831

1.38

1.09

1.27

N-acetylarginine

LC/MS pos early

67427

1.72

1.72

1.00

N-delta-acetylornithine

LC/MS pos early

9920500

1.35

1.09

1.24

N-alpha-acetylornithine

LC/MS pos early

439232

1.54

1.48

1.04

trans-4-hydroxyproline

LC/MS pos early

5810

0.77

0.62

1.23

argininate*

LC/MS pos early

160437

0.75

1.15

0.65

putrescine

LC/MS pos early

1045

5.09

0.83

6.14

N-acetyl-isoputreanine*

LC/MS pos early

1.00

1.00

1.00

spermidine

LC/MS pos early

1102

1.23

0.99

1.25

5-methylthioadenosine (MTA)

LC/MS pos early

439176

1.48

1.17

1.26

4-acetamidobutanoate

LC/MS pos early

18189

0.89

0.86

1.03

(N(1) + N(8))-acetylspermidine

LC/MS pos early

0.79

0.91

0.86

4-guanidinobutanoate

LC/MS pos early

500

1.00

1.14

0.87

glutathione, reduced (GSH)

LC/MS pos early

124886

4.09

0.83

4.94

cysteine-glutathione disulfide

LC/MS pos early

4247235

1.72

0.82

2.10

cysteinylglycine

LC/MS pos early

439498

0.36

0.49

0.73

cysteinylglycine disulfide*

LC/MS pos early

1.89

0.88

2.15

0.64

0.79

0.80

S-adenosylhomocysteine (SAH)
Methionine, Cysteine, SAM and Taurine
Metabolism

cystine

Urea cycle; Arginine and Proline Metabolism

Polyamine Metabolism

Guanidino and Acetamido Metabolism

Glutathione Metabolism

5-oxoproline

LC/MS neg
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7405

Pathway

Biochemical Name

Gal4>UAS Gal4>UAS
GAL4 Ctrl
UAS Ctrl

UAS Ctrl
GAL4 Ctrl

Platform

PubChem

gamma-glutamylalanine

LC/MS pos early

440103

0.88

0.91

0.97

gamma-glutamylcysteine

LC/MS pos early

842

0.25

0.58

0.43

gamma-glutamylglutamate

LC/MS pos early

92865

0.90

0.83

1.08

gamma-glutamylglutamine

LC/MS pos early

150914

1.66

1.13

1.47

gamma-glutamylglycine

LC/MS pos early

165527

0.37

0.63

0.59

gamma-glutamylhistidine

LC/MS pos early

7017195

0.55

0.75

0.73

gamma-glutamylisoleucine*

LC/MS neg

14253342

0.40

1.01

0.39

gamma-glutamylleucine

LC/MS neg

151023

0.45

0.87

0.52

gamma-glutamyl-alpha-lysine

LC/MS pos early

65254

1.29

1.32

0.98

gamma-glutamylmethionine

LC/MS pos early

7009567

0.43

1.40

0.31

gamma-glutamylthreonine

LC/MS pos early

76078708

0.61

0.94

0.65

gamma-glutamylvaline

LC/MS pos early

7015683

0.48

0.70

0.69

alanylalanine

LC/MS pos early

5484352

1.13

0.91

1.24

alanylglutamate

LC/MS pos early

656476

0.84

0.84

1.00

alanylproline

LC/MS pos early

418040

0.83

1.21

0.69

alanylthreonine

LC/MS pos early

426318

1.05

0.98

1.06

alpha-glutamylalanine

LC/MS pos early

100098

0.90

0.93

0.97

alpha-glutamylglutamate

LC/MS pos early

439500

0.87

1.07

0.81

asparaginylalanine

LC/MS pos early

1.12

0.98

1.14

glutaminylglutamate

LC/MS pos early

0.71

0.94

0.76

serylthreonine

LC/MS pos early

0.69

0.92

0.74

glycylglycine

LC/MS pos early

11163

0.86

1.05

0.82

glycylisoleucine

LC/MS pos early

88079

1.04

0.88

1.18

glycylleucine

LC/MS pos early

92843

0.89

0.83

1.07

LC/MS neg

92953

1.24

1.19

1.04

glycylproline

LC/MS pos early

3013625

0.69

0.75

0.92

glycylvaline

LC/MS pos early

97417

0.67

0.83

0.81

isoleucylalanine

LC/MS pos early

5246009

1.72

0.99

1.73

isoleucylglutamate

LC/MS pos early

0.96

1.23

0.79

isoleucylglutamine

LC/MS pos early

7020102

1.60

1.05

1.52

LC/MS neg

342532

1.15

1.09

1.05

isoleucylthreonine

LC/MS pos early

16122515

1.46

0.95

1.53

leucylalanine

LC/MS pos early

259321

4.22

1.01

4.19

leucylglycine

LC/MS pos early

79070

1.67

0.96

1.73

leucylleucine

LC/MS pos early

76807

5.53

0.92

6.02

leucylproline

LC/MS pos early

80817

0.52

0.94

0.56

leucylthreonine

LC/MS pos early

10353878

2.16

0.91

2.37

LC/MS neg

4422358

0.87

0.91

0.96

prolylalanine

LC/MS pos early

418041

0.87

0.96

0.90

prolylglutamine

LC/MS pos early

1.11

0.92

1.21

prolylglycine

LC/MS pos early

6426709

0.86

1.01

0.85

prolylleucine

LC/MS pos early

3527720

0.94

0.92

1.03

prolylproline

LC/MS pos early

11622593

0.71

0.89

0.80

prolylthreonine

LC/MS pos early

0.74

1.12

0.67

prolylvaline

LC/MS pos early

152307

0.72

0.81

0.89

serylalanine

LC/MS pos early

17958834

1.07

0.85

1.26

serylleucine

LC/MS pos early

7015695

1.15

1.11

1.04

serylproline

LC/MS pos early

4369021

1.04

0.90

1.16

serylserine

LC/MS pos early

138784

0.94

0.83

1.13

serylvaline

LC/MS pos early

7020159

1.45

0.95

1.54

valylaspartate

LC/MS pos early

9964657

0.91

0.92

0.99

valylglycine

LC/MS neg

136487

1.07

1.01

1.06

valylproline

LC/MS pos early

5003412

0.70

0.95

0.74

isoleucylleucine/leucylisoleucine

LC/MS pos early

2.09

0.79

2.65

alpha-glutamylproline*

LC/MS pos early

1.00

1.00

1.00

LC/MS neg

0.94

1.26

0.75

Peptides

Gamma-glutamyl Amino Acid

glycylphenylalanine

isoleucylglycine

Dipeptide

phenylalanylglutamate

Modified Peptides

pyroglutamylleucine*
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Pathway

Biochemical Name

Platform

PubChem

LC/MS polar

79025

Gal4>UAS Gal4>UAS
GAL4 Ctrl
UAS Ctrl

UAS Ctrl
GAL4 Ctrl

Carbohydrates
glucose

Glycolysis, Gluconeogenesis, and Pyruvate
Metabolism

Pentose Phosphate Pathway

Pentose Metabolism

Glycogen Metabolism

Fructose, Mannose and Galactose
Metabolism

Nucleotide Sugar

1.03

1.01

1.01

1.62

0.84

1.93

668

1.48

1.68

0.88

LC/MS neg

724

0.86

0.81

1.06

LC/MS neg

1005

0.77

0.73

1.06

pyruvate

LC/MS polar

1060

1.01

0.86

1.17

lactate

LC/MS polar

612

0.63

0.85

0.74

glycerate

LC/MS polar

752

1.04

1.12

0.93

6-phosphogluconate

LC/MS neg

91493

0.60

0.71

0.86

sedoheptulose-7-phosphate

LC/MS neg

616

0.87

0.77

1.13

ribose

LC/MS polar

5779

0.94

1.01

0.94

ribitol

LC/MS polar

6912

0.01

0.87

0.02

ribonate

LC/MS polar

5460677

0.78

0.91

0.86

arabitol/xylitol

LC/MS polar

6912

1.10

0.96

1.15

ribulose/xylulose

LC/MS polar

5289590

0.74

0.94

0.79

arabonate/xylonate

LC/MS polar

0.93

0.93

1.00

sedoheptulose

LC/MS polar

0.84

0.75

1.13

ribulonate/xylulonate*

LC/MS polar

1.01

1.00

1.01

maltotetraose

LC/MS polar

446495

0.68

0.74

0.91

maltotriose

LC/MS polar

439586

1.04

0.83

1.25

maltose

LC/MS polar

10991489

1.26

0.90

1.40

isomaltose

LC/MS polar

439193

1.02

1.13

0.91

fructose

LC/MS polar

5984

0.85

0.90

0.94

mannitol/sorbitol

LC/MS polar

5780

0.66

0.93

0.71

mannose

LC/MS polar

18950

0.71

0.62

1.15

galactitol (dulcitol)

LC/MS polar

11850

0.81

0.64

1.27

galactonate

LC/MS polar

128869

0.66

0.64

1.03

0.81

0.81

1.00

fructose 1,6-diphosphate/glucose 1,6-diphosphate/myo-inositol
diphosphates

LC/MS neg

dihydroxyacetone phosphate (DHAP)

LC/MS neg

3-phosphoglycerate
phosphoenolpyruvate (PEP)

UDP-N-acetylglucosamine/galactosamine

Aminosugar Metabolism

LC/MS neg

glucuronate

LC/MS polar

444791

0.75

0.95

0.79

N-acetylglucosamine 6-phosphate

LC/MS polar

439219

2.39

0.90

2.67

LC/MS pos early

123826

1.26

0.93

1.36

LC/MS polar

2781043

0.90

0.98

0.91

N-acetylglucosamine/N-acetylgalactosamine

LC/MS pos early

24139

0.87

0.93

0.94

N6-carboxymethyllysine

LC/MS pos early

123800

1.06

0.97

1.09

citrate

LC/MS neg

311

0.85

1.18

0.72

aconitate [cis or trans]

LC/MS neg

0.95

0.92

1.03

N-acetylglucosaminylasparagine
erythronate*

Advanced Glycation End-product

5459879

Energy

TCA Cycle

isocitric lactone

LC/MS polar

98259

1.59

1.85

0.86

alpha-ketoglutarate

LC/MS polar

51

1.35

1.07

1.26

succinate

LC/MS polar

1110

1.24

0.87

1.41

fumarate

LC/MS polar

444972

0.71

1.04

0.69

LC/MS neg

525

0.76

0.97

0.78

itaconate

LC/MS polar

811

0.92

0.59

1.58

tricarballylate

LC/MS polar

14925

0.90

0.92

0.98

LC/MS neg

439681

1.09

1.03

1.06

mesaconate (methylfumarate)

LC/MS polar

638129

0.91

0.62

1.46

acetylphosphate

LC/MS polar

186

1.13

0.71

1.60

LC/MS pos early

1061

1.00

0.99

1.01

malate

2-methylcitrate

Oxidative Phosphorylation

phosphate

129

Pathway

Biochemical Name

Platform

PubChem

Gal4>UAS Gal4>UAS
GAL4 Ctrl
UAS Ctrl

UAS Ctrl
GAL4 Ctrl

Lipids
Fatty Acid Synthesis
Medium Chain Fatty Acid

Long Chain Fatty Acid

Polyunsaturated Fatty Acid (n3 and n6)

Fatty Acid, Branched

malonate

LC/MS polar

867

0.85

0.86

1.00

caprate (10:0)

LC/MS neg

2969

1.45

1.04

1.40

laurate (12:0)

LC/MS neg

3893

0.79

1.08

0.73

5-dodecenoate (12:1n7)

LC/MS neg

5312378

1.17

1.14

1.03

myristate (14:0)

LC/MS neg

11005

1.18

1.04

1.14

myristoleate (14:1n5)

LC/MS neg

5281119

0.99

1.38

0.72

pentadecanoate (15:0)

LC/MS neg

13849

1.40

0.98

1.43

palmitate (16:0)

LC/MS neg

985

1.21

0.99

1.22

palmitoleate (16:1n7)

LC/MS neg

445638

1.19

1.01

1.18

margarate (17:0)

LC/MS neg

10465

1.41

0.91

1.55

10-heptadecenoate (17:1n7)

LC/MS neg

5312435

1.54

0.89

1.72

stearate (18:0)

LC/MS neg

5281

1.10

0.95

1.16

oleate/vaccenate (18:1)

LC/MS neg

1.16

1.04

1.11

nonadecanoate (19:0)

LC/MS neg

12591

1.25

1.08

1.16

10-nonadecenoate (19:1n9)

LC/MS neg

5312513

1.16

0.72

1.62

arachidate (20:0)

LC/MS neg

10467

1.34

0.92

1.45

eicosenoate (20:1)

LC/MS neg

5282768

1.55

1.16

1.33

erucate (22:1n9)

LC/MS neg

5281116

1.16

0.82

1.41

hexadecatrienoate (16:3n3)

LC/MS neg

5312428

0.88

0.96

0.91

stearidonate (18:4n3)

LC/MS neg

5312508

0.89

0.66

1.34

eicosapentaenoate (EPA; 20:5n3)

LC/MS neg

446284

1.25

1.45

0.86

linoleate (18:2n6)

LC/MS neg

5280450

1.10

0.96

1.14

linolenate [alpha or gamma; (18:3n3 or 6)]

LC/MS neg

5280934

1.08

0.97

1.11

dihomo-linolenate (20:3n3 or n6)

LC/MS neg

5280581

0.80

0.87

0.92

arachidonate (20:4n6)

LC/MS neg

444899

1.30

1.19

1.10

dihomo-linoleate (20:2n6)

LC/MS neg

6439848

1.61

1.87

0.86

13-methylmyristate (i15:0)

LC/MS neg

151014

1.20

0.86

1.40

15-methylpalmitate (i17:0)

LC/MS neg

17903417

1.18

0.77

1.54

17-methylstearate (i19:0)

LC/MS neg

3083779

1.27

0.80

1.59

LC/MS polar

743

0.90

1.00

0.90

LC/MS pos early

43

1.10

1.04

1.06

adipate (C6-DC)

LC/MS polar

196

0.90

1.38

0.65

suberate (C8-DC)

LC/MS polar

10457

1.46

1.51

0.97

LC/MS neg

2266

2.01

2.14

0.94

LC/MS polar

5192

0.72

0.94

0.76

dodecanedioate (C12-DC)

LC/MS neg

12736

0.59

0.94

0.62

tetradecanedioate (C14-DC)

LC/MS neg

13185

0.92

1.04

0.89

hexadecanedioate (C16-DC)

LC/MS neg

10459

1.30

1.18

1.10

hexadecenedioate (C16:1-DC)*

LC/MS neg

1.09

1.32

0.82

octadecadienedioate (C18:2-DC)*

LC/MS neg

1.00

1.00

1.00

glutarate (C5-DC)
2-hydroxyglutarate

azelate (C9-DC)
Fatty Acid, Dicarboxylate

Fatty Acid, Amino

sebacate (C10-DC)

2-aminooctanoate
N-acetyl-2-aminooctanoate*

LC/MS pos late

69522

2.29

0.97

2.36

LC/MS neg

95555

1.15

0.90

1.28

Fatty Acid Metabolism (also BCAA
Metabolism)

propionylglycine

LC/MS polar

98681

0.65

1.12

0.58

methylmalonate (MMA)

LC/MS polar

487

0.70

0.96

0.73

Fatty Acid Metabolism(Acyl Glycine)

hexanoylglycine

LC/MS neg

99463

1.19

1.10

1.08
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Pathway

Biochemical Name

Platform

PubChem

Gal4>UAS Gal4>UAS
GAL4 Ctrl
UAS Ctrl

UAS Ctrl
GAL4 Ctrl

Lipids

Fatty Acid Metabolism(Acyl Carnitine)

Carnitine Metabolism

Fatty Acid, Monohydroxy

Fatty Acid, Dihydroxy

Endocannabinoid

Inositol Metabolism

Phospholipid Metabolism

Phosphatidylcholine (PC)

acetylcarnitine (C2)

LC/MS pos early

1

4.25

2.68

1.59

myristoylcarnitine (C14)

LC/MS pos late

6426854

28.81

26.39

1.09

palmitoylcarnitine (C16)

LC/MS pos late

461

4.52

1.74

2.60

palmitoleoylcarnitine (C16:1)*

LC/MS pos late

71464547

26.50

10.35

2.56

stearoylcarnitine (C18)

LC/MS pos late

6426855

1.43

1.06

1.34

linoleoylcarnitine (C18:2)*

LC/MS pos late

6450015

6.77

3.14

2.15

oleoylcarnitine (C18:1)

LC/MS pos late

6441392

4.00

1.92

2.08

arachidoylcarnitine (C20)*

LC/MS pos late

1.28

1.17

1.09

behenoylcarnitine (C22)*

LC/MS pos late

1.31

1.09

1.20

eicosenoylcarnitine (C20:1)*

LC/MS pos late

2.28

1.24

1.84

lignoceroylcarnitine (C24)*

LC/MS pos late

0.72

0.83

0.87

margaroylcarnitine (C17)*

LC/MS pos late

4.05

1.47

2.76

nervonoylcarnitine (C24:1)*

LC/MS pos late

2.36

1.26

1.87

cerotoylcarnitine (C26)*

LC/MS pos late

0.85

0.97

0.87

ximenoylcarnitine (C26:1)*

LC/MS pos late

0.75

0.88

0.85

deoxycarnitine

LC/MS pos early

134

1.77

1.17

1.52

carnitine

LC/MS pos early

10917

1.62

1.01

1.59

3-hydroxypropanoate

LC/MS polar

68152

0.96

1.20

0.80

3-hydroxydecanoate

LC/MS neg

26612

0.90

0.71

1.25

3-hydroxysebacate

LC/MS polar

3017884

0.62

0.57

1.09

3-hydroxylaurate

LC/MS neg

94216

1.07

1.30

0.82

3-hydroxymyristate

LC/MS neg

16064

1.63

1.02

1.59

3-hydroxyoleate*

LC/MS neg

1.51

0.88

1.72

13-HODE + 9-HODE

LC/MS neg

43013

1.19

1.05

1.13

12,13-DiHOME

LC/MS neg

10236635

0.63

0.99

0.63

9,10-DiHOME

LC/MS neg

9966640

0.83

1.37

0.61

N-myristoyltaurine*

LC/MS neg

3810823

1.24

0.63

1.97

N-oleoyltaurine

LC/MS neg

6437033

1.16

0.81

1.42

N-palmitoleoyltaurine*

LC/MS neg

0.97

0.82

1.18

linoleoyl ethanolamide

LC/MS neg

5283446

1.02

0.73

1.40

LC/MS polar

892

1.03

0.94

1.10

choline

LC/MS pos early

305

1.01

1.04

0.97

choline phosphate

LC/MS pos early

1014

1.08

1.14

0.95

cytidine 5'-diphosphocholine

LC/MS pos early

13804

1.13

0.92

1.23

glycerophosphorylcholine (GPC)

LC/MS pos early

71920

0.97

0.99

0.97

phosphoethanolamine

LC/MS pos early

1015

0.93

1.05

0.88

cytidine-5'-diphosphoethanolamine

LC/MS polar

123727

0.97

0.85

1.14

glycerophosphoethanolamine

LC/MS polar

123874

0.89

0.97

0.91

glycerophosphoserine*

LC/MS pos early

3081457

1.33

1.48

0.90

glycerophosphoinositol*

LC/MS pos early

167572

1.23

1.31

0.93

1-myristoyl-2-palmitoyl-GPC (14:0/16:0)

LC/MS pos late

129657

0.79

0.92

0.87

1,2-dipalmitoyl-GPC (16:0/16:0)

LC/MS pos late

452110

0.71

0.90

0.79

1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)*

LC/MS pos late

1.04

0.92

1.12

1-palmitoyl-2-stearoyl-GPC (16:0/18:0)

LC/MS pos late

0.71

0.92

0.77

1-palmitoyl-2-oleoyl-GPC (16:0/18:1)

LC/MS pos late

0.95

0.97

0.98

1,2-dipalmitoleoyl-GPC (16:1/16:1)*

LC/MS pos late

0.95

0.83

1.15

1-palmitoleoyl-2-linolenoyl-GPC (16:1/18:3)*

LC/MS pos late

0.92

1.03

0.90

1,2-distearoyl-GPC (18:0/18:0)

LC/MS pos late

0.72

0.93

0.78

1-stearoyl-2-oleoyl-GPC (18:0/18:1)

LC/MS pos late

0.85

1.01

0.84

1-oleoyl-2-linoleoyl-GPC (18:1/18:2)*

LC/MS pos late

0.90

0.88

1.02

1,2-dilinoleoyl-GPC (18:2/18:2)

LC/MS pos late

0.78

0.81

0.97

1-linoleoyl-2-linolenoyl-GPC (18:2/18:3)*

LC/MS pos late

0.79

0.88

0.90

1,2-dilinolenoyl-GPC (18:3/18:3)*

LC/MS pos late

0.77

0.89

0.87

myo-inositol
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6436017

94190

5288075

Pathway

Biochemical Name

Platform

PubChem

Gal4>UAS Gal4>UAS
GAL4 Ctrl
UAS Ctrl

UAS Ctrl
GAL4 Ctrl

Lipids

Phosphatidylethanolamine (PE)

Phosphatidylserine (PS)
Phosphatidylglycerol (PG)

Phosphatidylinositol (PI)

1,2-dipalmitoyl-GPE (16:0/16:0)*

LC/MS pos late

445468

0.84

0.97

0.87

1-palmitoyl-2-stearoyl-GPE (16:0/18:0)*

LC/MS pos late

5326793

0.64

0.78

0.82

1-palmitoyl-2-oleoyl-GPE (16:0/18:1)

LC/MS pos late

5283496

0.96

0.94

1.02

1,2-dipalmitoleoyl-GPE (16:1/16:1)*

LC/MS pos late

9546809

0.84

0.86

0.98

1-stearoyl-2-oleoyl-GPE (18:0/18:1)

LC/MS pos late

0.96

1.03

0.93

1-oleoyl-2-linoleoyl-GPE (18:1/18:2)*

LC/MS pos late

9546753

0.93

0.91

1.03

1,2-dilinoleoyl-GPE (18:2/18:2)*

LC/MS pos late

9546812

0.85

0.85

0.99

1,2-dioleoyl-GPS (18:1/18:1)

LC/MS pos late

6438639

1.29

0.95

1.35

1-palmitoyl-2-palmitoleoyl-GPG (16:0/16:1)*

LC/MS pos late

1.32

0.78

1.68

1-palmitoyl-2-oleoyl-GPG (16:0/18:1)

LC/MS pos late

0.91

0.81

1.11

1,2-dipalmitoleoyl-GPI (16:1/16:1)*

LC/MS pos late

1.06

0.90

1.18

1-palmitoyl-2-oleoyl-GPI (16:0/18:1)*

LC/MS polar

0.91

0.77

1.18

1-oleoyl-2-linoleoyl-GPI (18:1/18:2)*

LC/MS polar

0.89

0.90

0.99

1-linolenoyl-GPG (18:3)*

LC/MS neg

1.17

0.98

1.20

1-palmitoyl-GPC (16:0)

LC/MS pos late

86554

0.79

0.98

0.81

2-palmitoyl-GPC (16:0)*

LC/MS pos late

15061532

0.98

0.92

1.07

1-palmitoleoyl-GPC (16:1)*

LC/MS pos late

24779461

1.06

1.07

0.99

2-palmitoleoyl-GPC (16:1)*

LC/MS pos late

1.14

0.99

1.15

1-stearoyl-GPC (18:0)

LC/MS pos late

497299

0.75

1.01

0.75

1-oleoyl-GPC (18:1)

LC/MS pos late

16081932

1.06

1.07

0.99

LC/MS neg

11988421

1.15

0.95

1.20

0.74

0.98

0.75

1-linoleoyl-GPC (18:2)

Lysophospholipid

5283509

1-linolenoyl-GPC (18:3)*

LC/MS pos late

1-palmitoyl-GPE (16:0)

LC/MS pos late

9547069

0.85

0.93

0.92

1-stearoyl-GPE (18:0)

LC/MS pos late

9547068

0.76

0.91

0.84

2-stearoyl-GPE (18:0)*

LC/MS neg

0.90

1.05

0.86

1-oleoyl-GPE (18:1)

LC/MS pos late

9547071

0.98

0.94

1.04

1-linoleoyl-GPE (18:2)*

LC/MS pos late

52925130

0.95

1.00

0.95

1-palmitoyl-GPS (16:0)*

LC/MS neg

9547100

1.57

1.17

1.35

1-stearoyl-GPS (18:0)*

LC/MS neg

9547101

1.23

0.87

1.42

1-oleoyl-GPS (18:1)

LC/MS neg

9547099

1.49

1.00

1.49

1-linoleoyl-GPS (18:2)*

LC/MS neg

1.11

0.81

1.38

1-palmitoyl-GPG (16:0)*

LC/MS neg

1.03

0.77

1.34

1-stearoyl-GPG (18:0)

LC/MS neg

0.96

0.93

1.03

1-oleoyl-GPG (18:1)*

LC/MS neg

1.27

1.16

1.09

1-linoleoyl-GPG (18:2)*

LC/MS neg

1.11

0.91

1.22

1-palmitoyl-GPI (16:0)

LC/MS neg

1.11

0.95

1.17

1-stearoyl-GPI (18:0)

LC/MS neg

0.83

0.66

1.26

1-oleoyl-GPI (18:1)*

LC/MS neg

1.65

1.12

1.48

1-linoleoyl-GPI (18:2)*

LC/MS neg

1.20

0.99

1.21
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3300276

Pathway

Biochemical Name

Gal4>UAS Gal4>UAS
GAL4 Ctrl
UAS Ctrl

UAS Ctrl
GAL4 Ctrl

Platform

PubChem

1,2-dilinoleoyl-galactosylglycerol (18:2/18:2)*

LC/MS pos late

6535011

1.05

0.90

1.16

1-(1-enyl-palmitoyl)-2-oleoyl-GPE (P-16:0/18:1)*

LC/MS pos late

1.23

1.06

1.15

1-(1-enyl-stearoyl)-2-oleoyl-GPE (P-18:0/18:1)

LC/MS pos late

0.94

0.86

1.09

1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)*

LC/MS pos late

0.75

1.02

0.74

1-(1-enyl-stearoyl)-GPE (P-18:0)*

LC/MS pos late

0.67

1.01

0.67

Lipids
Glycolipid Metabolism
Plasmalogen
Lysoplasmalogen

glycerol
Glycerolipid Metabolism

Monoacylglycerol

Diacylglycerol

Sphingolipid Synthesis

Dihydroceramides

Ceramides

Hexosylceramides (HCER)
Lactosylceramides (LCER)
Sphingosines
Mevalonate Metabolism

Sterol

LC/MS neg

753

1.19

1.09

1.09

glycerol 3-phosphate

LC/MS polar

754

1.09

1.15

0.95

glycerophosphoglycerol

LC/MS polar

439964

1.02

1.26

0.81

1-myristoylglycerol (14:0)

LC/MS neg

79050

1.26

0.76

1.65

1-palmitoylglycerol (16:0)

LC/MS neg

14900

1.04

0.93

1.12

1-palmitoleoylglycerol (16:1)*

LC/MS neg

2.31

1.29

1.79

1-oleoylglycerol (18:1)

LC/MS neg

5283468

1.85

1.31

1.41

1-linoleoylglycerol (18:2)

LC/MS neg

5283469

1.95

1.40

1.40

2-myristoylglycerol (14:0)

LC/MS neg

137938

1.06

0.75

1.41

2-palmitoylglycerol (16:0)

LC/MS neg

123409

1.49

1.09

1.37

2-palmitoleoylglycerol (16:1)*

LC/MS neg

2.25

1.15

1.96

2-oleoylglycerol (18:1)

LC/MS neg

5319879

1.66

0.87

1.90

2-linoleoylglycerol (18:2)

LC/MS neg

5365676

1.61

1.64

0.98

diacylglycerol (12:0/18:1, 14:0/16:1, 16:0/14:1) [2]*

LC/MS pos late

1.23

1.19

1.03

diacylglycerol (14:0/18:1, 16:0/16:1) [2]*

LC/MS pos late

1.39

1.07

1.30

diacylglycerol (16:1/18:2 [2], 16:0/18:3 [1])*

LC/MS pos late

1.18

1.10

1.07

palmitoyl-oleoyl-glycerol (16:0/18:1) [2]*

LC/MS pos late

1.45

0.93

1.56

palmitoyl-linoleoyl-glycerol (16:0/18:2) [2]*

LC/MS pos late

1.55

0.93

1.67

palmitoleoyl-oleoyl-glycerol (16:1/18:1) [2]*

LC/MS pos late

1.12

1.07

1.04

palmitoleoyl-linoleoyl-glycerol (16:1/18:2) [1]*

LC/MS pos late

1.22

1.13

1.08

oleoyl-oleoyl-glycerol (18:1/18:1) [2]*

LC/MS pos late

1.08

1.04

1.03

oleoyl-linoleoyl-glycerol (18:1/18:2) [2]

LC/MS pos late

1.00

1.17

0.86

oleoyl-linolenoyl-glycerol (18:1/18:3) [2]*

LC/MS pos late

0.93

1.81

0.51

linoleoyl-linolenoyl-glycerol (18:2/18:3) [2]*

LC/MS pos late

0.70

1.22

0.57

sphinganine

LC/MS pos late

0.55

1.00

0.55

tetradecasphinganine (d14:0)*

LC/MS pos late

1.15

1.08

1.07

hexadecasphinganine (d16:0)*

LC/MS pos late

1.21

1.04

1.16

N-arachidoyl-tetradecanoylsphinganine (d14:0/20:0)*

LC/MS pos late

0.89

1.07

0.84

N-behenoyl-tetradecanoylsphinganine (d14:0/22:0)*

LC/MS pos late

0.81

0.94

0.86

N-stearoyl-tetradecanoylsphingosine (d14:1/18:0)*

LC/MS pos late

1.02

1.09

0.94

N-arachidoyl-tetradecanoylsphingosine (d14:1/20:0)*

LC/MS pos late

0.95

1.17

0.81

N-behenoyl-tetradecanoylsphingosine (d14:1/22:0)*

LC/MS pos late

0.94

0.97

0.97

glycosyl-N-arachidoyl-tetradecanoylsphingosine (d14:1/20:0)*

LC/MS pos late

1.33

1.04

1.28

glycosyl-N-behenoyl-tetradecasphingosine (d14:1/22:0)*

LC/MS pos late

2.56

0.90

2.84

glycosyl ceramide (d14:1/24:0, d16:1/22:0)*

LC/MS pos late

5.01

0.70

7.14

lactosyl-N-arachidoyl-tetradecanoylsphingosine (d14:1/20:0)*

LC/MS pos late

1.44

1.44

1.00

tetradecanoylsphingosine (d14:1)*

LC/MS pos late

1.15

0.98

1.17

hexadecasphingosine (d16:1)*

LC/MS pos late

1.04

1.03

1.01

3126
656816

3-hydroxy-3-methylglutarate

LC/MS polar

1662

1.07

1.08

1.00

mevalonate

LC/MS polar

439230

0.89

1.91

0.46

beta-sitosterol

LC/MS pos late

222284

1.08

1.14

0.94

campesterol

LC/MS pos late

173183

1.00

1.19

0.84

ergosterol

LC/MS pos late

444679

0.93

0.99

0.94
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Pathway

Biochemical Name

Gal4>UAS Gal4>UAS
GAL4 Ctrl
UAS Ctrl

UAS Ctrl
GAL4 Ctrl

Platform

PubChem

LC/MS pos early

8582

1.19

0.70

1.70

LC/MS neg

6021

0.95

1.02

0.93

hypoxanthine

LC/MS polar

790

0.54

1.17

0.46

xanthine

LC/MS polar

1188

0.98

1.55

0.63

xanthosine 5'-monophosphate (xmp)

LC/MS neg

73323

0.75

1.00

0.75

xanthosine

LC/MS neg

64959

1.69

2.14

0.79

LC/MS pos early

65095

2.71

1.36

2.00

2'-deoxyinosine

LC/MS neg

65058

2.82

2.51

1.12

urate

LC/MS neg

1175

0.73

0.98

0.74

uric acid ribonucleoside*

LC/MS neg

164933

1.08

1.56

0.70

LC/MS polar

204

2.88

0.93

3.09

LC/MS neg

6022

1.08

0.56

1.93

Nucleotides
inosine 5'-monophosphate (IMP)
inosine

Purine Metabolism, (Hypo)Xanthine/Inosine
containing

N1-methylinosine

allantoin
adenosine 5'-diphosphate (ADP)
adenosine 5'-monophosphate (AMP)

Purine Metabolism, Adenine containing

Purine Metabolism, Guanine containing

LC/MS pos early

6083

1.13

0.65

1.74

adenosine 3'-monophosphate (3'-AMP)

LC/MS neg

41211

0.76

0.75

1.00

adenosine-2',3'-cyclic monophosphate

LC/MS neg

2024

1.01

0.87

1.17

adenosine

LC/MS pos early

60961

1.00

0.98

1.02

adenine

LC/MS pos early

190

0.59

0.85

0.70

1-methyladenine

LC/MS pos early

78821

0.46

1.11

0.41

N1-methyladenosine

LC/MS pos early

27476

0.87

1.03

0.85

N6-succinyladenosine

LC/MS pos early

165243

0.96

0.72

1.32

guanosine 5'- diphosphate (GDP)

LC/MS neg

8977

0.80

0.69

1.16

guanosine 5'- monophosphate (5'-GMP)

LC/MS neg

6804

0.98

0.75

1.31

guanosine-2',3'-cyclic monophosphate

LC/MS neg

92823

1.01

0.75

1.35

guanosine

LC/MS neg

6802

1.26

1.18

1.07

guanine

LC/MS pos early

764

1.05

0.99

1.06

7-methylguanine

LC/MS pos early

11361

0.99

1.20

0.82

LC/MS neg

1.53

1.18

1.30

LC/MS pos early

1.15

0.91

1.26

2'-O-methylguanosine
7-methylguanosine

Pyrimidine Metabolism, Orotate containing

Pyrimidine Metabolism, Uracil containing

N2,N2-dimethylguanosine

LC/MS neg

92919

1.86

1.11

1.68

2'-deoxyguanosine

LC/MS neg

187790

1.36

1.22

1.12

dihydroorotate

LC/MS polar

648

4.52

0.68

6.61

orotate

LC/MS polar

967

1.34

0.92

1.45

uridine-2',3'-cyclic monophosphate

LC/MS neg

439715

0.78

0.79

0.98

uridine

LC/MS neg

6029

1.50

1.53

0.98

uracil

LC/MS polar

1174

0.90

0.91

1.00

pseudouridine

LC/MS neg

15047

1.49

1.74

0.85

2'-O-methyluridine

LC/MS neg

102212

1.69

2.76

0.61

3-ureidopropionate

LC/MS pos early

111

1.00

1.29

0.77

beta-alanine

LC/MS pos early

239

1.21

1.00

1.21

LC/MS polar

76406

1.07

1.20

0.90

cytidine 5'-monophosphate (5'-CMP)

LC/MS pos early

6131

1.55

1.00

1.55

cytidine 2' or 3'-monophosphate (2' or 3'-CMP)

LC/MS pos early

0.96

0.93

1.03

N-acetyl-beta-alanine

cytidine 2',3'-cyclic monophosphate

LC/MS neg

417654

0.76

0.82

0.92

cytidine

LC/MS neg

6175

1.82

1.47

1.24

cytosine

LC/MS pos early

597

1.05

1.39

0.76

3-methylcytidine

LC/MS pos early

159649

1.28

1.21

1.06

5-methylcytidine

LC/MS pos early

92918

2.98

1.09

2.72

2'-O-methylcytidine

LC/MS pos early

150971

2.78

1.94

1.43

Pyrimidine Metabolism, Thymine containing

3-aminoisobutyrate

LC/MS pos early

64956

0.56

0.96

0.59

Purine and Pyrimidine Metabolism

methylphosphate

LC/MS pos early

13130

1.17

0.94

1.24

Dinucleotide

(3'-5')-adenylyluridine

LC/MS neg

112074

1.00

1.00

1.00

Pyrimidine Metabolism, Cytidine containing
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Pathway

Biochemical Name

Platform

PubChem

Gal4>UAS Gal4>UAS
GAL4 Ctrl
UAS Ctrl

UAS Ctrl
GAL4 Ctrl

Cofactors and Vitamins

Nicotinate and Nicotinamide Metabolism

nicotinate

LC/MS pos early

938

0.93

1.21

0.77

nicotinamide ribonucleotide (NMN)

LC/MS pos early

14180

1.11

1.05

1.06

nicotinamide riboside

LC/MS pos early

439924

1.37

2.01

0.68

nicotinamide adenine dinucleotide (NAD+)

LC/MS pos early

5893

0.90

0.76

1.19

LC/MS neg

25246170

0.88

0.75

1.18

trigonelline (N'-methylnicotinate)

LC/MS pos early

5570

1.11

0.90

1.23

riboflavin (Vitamin B2)

LC/MS pos early

493570

2.72

0.71

3.84

flavin adenine dinucleotide (FAD)

LC/MS neg

643975

0.73

0.74

0.99

pantothenate

LC/MS neg

6613

0.75

0.91

0.82

pantetheine

LC/MS pos early

439322

0.52

0.75

0.70

ascorbate (Vitamin C)

LC/MS pos early

1.63

1.24

1.31

835

0.58

0.70

0.82

nicotinate adenine dinucleotide (NAAD+)

Riboflavin Metabolism
Pantothenate and CoA Metabolism

Ascorbate and Aldarate Metabolism

Tocopherol Metabolism
Biotin Metabolism
Tetrahydrobiopterin Metabolism

Pterin Metabolism

dehydroascorbate

LC/MS polar

threonate

LC/MS polar

151152

0.97

1.11

0.87

gulonate*

LC/MS polar

9794176

0.75

1.01

0.74

alpha-tocopherol

LC/MS pos late

14985

1.09

1.23

0.89

gamma-tocopherol/beta-tocopherol

LC/MS pos late

1.58

1.51

1.04

biotin

LC/MS pos early

171548

1.31

1.20

1.09

LC/MS neg

445040

0.67

0.85

0.79

dihydrobiopterin

LC/MS pos early

1879

0.52

0.78

0.66

isoxanthopterin

LC/MS pos early

10729

0.82

0.76

1.09

LC/MS neg

73000

1.23

1.12

1.09

LC/MS pos early

65253

0.54

0.83

0.65

LC/MS polar

8397

0.88

0.70

1.26

5-aminolevulinate

LC/MS pos early

137

0.72

1.67

0.43

thiamin (Vitamin B1)

LC/MS pos early

1130

0.61

0.56

1.09

thiamin monophosphate

LC/MS pos early

3382778

0.92

0.61

1.51

carotene diol (1)

LC/MS pos late

0.88

1.10

0.80

carotene diol (2)

LC/MS pos late

0.78

1.25

0.62

carotene diol (3)

LC/MS pos late

0.52

1.09

0.48

pyridoxal

LC/MS pos early

1050

1.10

0.94

1.16

pyridoxate

LC/MS neg

6723

1.48

0.96

1.55

4-hydroxyhippurate

LC/MS neg

151012

0.34

1.36

0.25

4-hydroxybenzoate

LC/MS neg

135

0.69

1.06

0.65

2,3-dihydroxyisovalerate

LC/MS polar

677

0.39

1.13

0.35

2-isopropylmalate

LC/MS polar

77

0.87

0.84

1.04

gluconate

LC/MS polar

10690

0.88

0.87

1.01

LC/MS pos early

3032311

1.10

1.17

0.94

erythritol

LC/MS polar

222285

0.76

1.03

0.74

kojibiose

LC/MS polar

164939

1.20

1.14

1.06

panose

LC/MS polar

5288421

1.23

0.87

1.42

quinate

LC/MS polar

6508

0.80

1.03

0.78

stachydrine

LC/MS pos early

115244

0.52

0.55

0.95

methyl glucopyranoside (alpha + beta)

LC/MS pos early

1.10

0.98

1.13

biopterin

pterin
sepiapterin
xanthopterin

Hemoglobin and Porphyrin Metabolism
Thiamine Metabolism

Vitamin A Metabolism

Vitamin B6 Metabolism

Xenobiotics
Benzoate Metabolism

ergothioneine
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Figure 1: Pan-glial RNAi knockdown screen of candidate genes enriched in the barrier glia
Total sleep in female flies with RNAi knockdown of listed genes (KK and GD are VDRC
collections, TRiP lines from Bloomington Stock Center) by either Repo-Gal4 (labeled R) or UASDicer;RepoGeneSwitch on RU+ food (labeled RGS). n = 9 – 16 flies per genotype, median = 16.
One-way ANOVA, with Holk-Sidak post-hoc comparisons. * = p < 0.05, ** = p < 0.001, *** = p <
0.0001. Significance values only marked for genes in which experimental flies were different from
both parental controls. Certain experiments were performed simultaneously and therefore share a
Gal4 control, re-plotted per each gene.
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Figure 2: Knockdown of potential hit genes with barrier glial drivers
Total sleep in female flies with knockdown of (A) VMAT, UAS- HMC02346 driven by (PG)
NP6293-Gal4. n=15-16 per genotype. (B) Cln7 (CG8896), UAS-109291 KK driven by (PG)
NP6293-Gal4 and (SPG) moody-Gal4. n = 15-16 per genotype. One-way ANOVA, with HolkSidak post-hoc comparisons. * = p < 0.05, ** = p < 0.001, *** = p < 0.0001
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Figure 3: Acylcarnitine levels are increased in Repo>20xShibire fly heads
(A) Short and medium chain length or (B) long chain length acylcarnitines from Repo-G4 >UAS20xShibire fly heads and parental controls. The raw signal from LC/MS is plotted, n=3 – 5
samples, of 200 fly heads each. One-way ANOVA, with Holk-Sidak post-hoc comparisons. * = p <
0.05, ** = p < 0.001, *** = p < 0.0001
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Figure 4: Knockdown of Lrp and Orct genes in all glia and barrier glia
Total sleep in female flies with knockdown of (A) Lrp1 (8397 GD) and Megalin (105071 KK)
driven by Repo-GAL4. n = 11-16 per genotype (C) Orct (6782 GD) and Orct2 (106681 KK) driven
by Repo-GAL4 (B) Lrp1 (8397 GD) and Megalin (105071 KK) driven by (PG) NP6293-GAL4, n =
13-16 per genotype, by (SPG) moody-GAL4, n=16 per genotype, by (SPG) Rab9-GAL4, n=13-16
per genotype. (S) Orct (6782 GD) and Orct2 (106681 KK) driven by (PG) NP6293-GAL4, n = 1316 per genotype, by (SPG) moody-GAL4, n=15-16 per genotype, by (SPG) Rab9-GAL4, n=15-16
per genotype. One-way ANOVA, with Holk-Sidak post-hoc comparisons. * = p < 0.05, ** = p <
0.001, *** = p < 0.0001
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CHAPTER 5: Discussion

Monoamines and glia in the regulation of sleep:
A plurality of studies that have manipulated astrocytes and examined sleep have found
an effect on homeostatic sleep (Halassa et al., 2009, Seugnet et al., 2011, Vanderheyden et al.,
2018a). These effects have occurred through two basic mechanisms: metabolic or cytokine
signaling, and recycling and metabolism of neurotransmitters. We have described a result that
likely falls in the latter category, whereby astrocytic loss of AANAT1, an enzyme capable of
metabolizing monoamines, increases homeostatic sleep.
Previous evidence suggests that glia can metabolize monoamines, such as through
ebony, which is expressed in glia in a rhythmic fashion and can affect circadian activity patterns
(Suh and Jackson, 2007). Likewise, the barrier glia may traffic monoamines, as they express a
specific isoform of VMAT, and our preliminary results indicate that knockdown of VMAT in the
perineurial glia increases sleep (Chapter 4). Aside from early fly work (Shaw et al., 2000),
aaNAT2 in zebrafish was found to reduce sleep, potentially through melatonin (Gandhi et al.,
2015), which is opposite to the effect in flies. Zebrafish also have multiple isoforms of AANAT,
which could reflect separate functions or localization, as the AANAT1 knockout had no effect on
sleep (Gandhi et al., 2015). Melatonin treatment has been linked to longevity in flies (Bonilla et
al., 2001), but largely, melatonin has not been reported to have a central role in sleep or circadian
rhythms in flies (Hardeland and Poeggeler, 2003).
It is unclear as to whether the effect of AANAT1 knockdown on fly sleep, to the extent
that it would be through dopamine or serotonin (elevated in mutants after sleep deprivation),
occurs by global or more localized influence. Elevated levels of dopamine in the fumin mutant,
which lacks the dopamine transporter, decrease total sleep time (Kume et al., 2005). Serotonin,
on the other hand, is sleep promoting, and serotonin receptor mutants have reduced rebound
sleep (Yuan et al., 2006). Sustained dopamine might induce a switch in excitatory state in sleep
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controlling populations (Pimentel et al., 2016), or serotonin might act directly to promote sleep –
in either case the dorsal fan-shaped body would be a strong candidate population (Pimentel et
al., 2016, Qian et al., 2017).
Future experiments could expand this finding by locating the astrocytic effect on
monoamines within specific sleep-wake circuitry in the fly (Chapter 1). A potential means would
be through genetic tools that allow the local expression of UAS driven transcripts in astrocytes
that are in contact with neuronal populations of interest (Huang et al., 2016).

Drosophila and mammalian barriers:
The main finding explored in Chapter 2 and Chapter 4 of this thesis, is the contribution
of fly hemolymph-brain barrier populations to sleep. We have described that manipulation of
endocytic traffic produces differences in sleep behavior, while measurements of endocytosis
revealed a state-dependence, which can be affected by prior time awake. For the purpose of
discussing implications of these results for flies and mammals, it is beneficial to briefly review
barriers in these representative models.
Separation and specialization of the central nervous system environment from
fluctuations of the periphery is a fundamental and broadly evolved adaptation of complex
organisms. Fly barriers can be seen as an evolutionarily ancient form of mammalian barriers
(Bundgaard and Abbott, 2008). While the solely glial barriers of flies differ in ways from those of
mammals, the functional similarities are substantial. One immediate difference between flies and
mammals is the factor of vasculature, since flies have an open circulatory system. Crucially, both
have a principle exclusionary layer, which in mammals is formed by endothelial cells bound by
tight junctions, and in flies by subperineurial glia containing septate junctions (Weiler et al., 2017).
Mammalian barriers are also made of pericytes, which communicate with endothelial cells
through gap junctions and participate in transcytosis and extracellular matrix formation (Winkler et
al., 2011). Subperineurial glia are only abutted by perineurial glia, which also form the
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extracellular matrix, and are connected to the subperineurial glia by gap junctions (Speder and
Brand, 2014, Zhang et al., 2018). Glia are also involved in mammalian barriers since astrocytes
project endfeet, which line the pericytes and endothelial cells, and control traffic and even
permeability of the barrier (Abbott et al., 2006).
Both fly and mammalian barriers display an abundance of transporters (DeSalvo et al.,
2014, Enerson and Drewes, 2006). Apart from both containing means of tight paracellular
exclusion, analysis of the trafficking functions of insect and mammalian glia reveals a deep
functional conservation. There are multiple categories of transport that occur at blood and
hemolymph barriers. These include small molecules and lipophilic compounds which pass
directly, solute carriers and transporters, active efflux transport, and receptor-mediated transport
and transcytosis, often depending on various endocytosis mechanisms (Barar et al., 2016),
Weiler et al., 2017). These processes regulate a plethora of xenobiotics, lipids, carbohydrates,
amino acids, and other compounds (Weiler et al., 2017). Therefore, the barrier populations have
a rich repertoire of trafficking functions, which may be modulated by sleep and are potentially
revelatory of substrates required for brain function.

Outgoing traffic – implications for a restorative function of sleep
One of the most exciting developments in the sleep field, and a foundational claim for
brain physiology at large is the description of the glymphatic system (Iliff et al., 2012, Jessen et
al., 2015, Xie et al., 2013). The claims relevant to state-dependence are that perivascular flow is
enhanced during sleep, as a function of increased interstitial space (Xie et al., 2013), and that
sleep loss in turn stymies clearance (Achariyar et al., 2016). This function is crucially dependent
on astrocytes as Aqp4 channels are involved in altering flow rates. Recently, the necessity of
Aqp4 was supported by a stringent analysis of multiple knock-out mouse models (Mestre et al.,
2018) as another study had not found an effect on clearance (Smith et al., 2017). Multiple
modeling studies have also questioned the glymphatic hypothesis on the grounds that diffusion,
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rather than a convective flow, is driving fluid movement in the brain (Asgari et al., 2016, Jin et al.,
2016). Nevertheless, all computational modeling approaches are only as valid as the extent of
knowledge that they are based upon, and it has been claimed that these attempts are insufficient
to capture the complexity of the interstitium (Mestre et al., 2018).
Aside from functional imaging in living organisms, the state-dependent phenomena of the
glymphatic hypothesis may be difficult to interrogate by other means, and even warrant care
depending on injection technique, in vivo (Mestre et al., 2018). One claim is that interstitial space
is increased in sleeping animals (Xie et al., 2013). Electron microscopy of mouse brain tissue
suggests that there are sleep-dependent differences in proximity and apposition of neurons by
astrocyte projections (Bellesi et al., 2015), but it is not clear whether changes in interstitial space
can be gleaned from such studies (de Vivo et al., 2017), as EM preparation itself can drastically
impact subsequent appearance of tissue, including astrocytic endfeet (Korogod et al., 2015).
Despite these challenges to the nature of interstitial fluid movement, no work to date has
challenged the sleep-dependent phenomena described above. It also remains a possibility that
movement of interstitial substrates is indeed altered across states, but by mechanisms apart from
perivascular flow.
Given that Drosophila and other invertebrates have open circulatory systems, the
putative mechanisms of driving glymphatic clearance (pulsatile pressure, etc.) would not be
directly translatable. It is unknown to what extent solutes of the interstitial fluid in flies are
trafficked into the periphery, and whether and how this fluid would be rejuvenated. While the
glymphatic hypothesis, and particularly its relationship to sleep, need to be confirmed in other
mammals and humans, if a mechanism substantiating enhanced clearance of central nervous
system waste via efflux to the periphery was shown to be sleep-dependent in invertebrates, this
would be make a strong evolutionary argument for clearance being a core function of sleep.
One principle means to investigate transport of brain interstitial solutes to the periphery has been
through the analysis of molecular correlates of neurodegenerative diseases, such as Alzheimer’s.
Both tau and Aβ accumulation are correlative with sleep disturbances, and Aβ levels rise acutely
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with sleep deprivation (Lucey et al., 2019, Shokri-Kojori et al., 2018, Vanderheyden et al., 2018b).
In the glymphatic studies, Aβ was shown to be removed through the perivascular pathway (Iliff et
al., 2012, Xie et al., 2013). Independently, substantial work has examined Aβ clearance
mechanisms by movement across the endothelial blood-brain barrier (Yamazaki and Kanekiyo,
2017). This transport is thought to at least partially employ Lrp1 (Storck et al., 2016), and Rab11
has been implicated in completing transcytosis of the Aβ cargo (Zhao et al., 2015). Homologs of
Lrp1 are functionally relevant at the fly barrier (Brankatschk et al., 2014) and our own results have
supported the importance of Shibire and Rab11 for sleep in these populations. Our preliminary
findings (Chapter 4) also suggest that Lrps could affect sleep at the barrier. Therefore, the
elements required for clearance, even if only by this mechanism, are possible in this model, and
could be influenced by sleep-wake state.
Likewise, in Drosophila models of neurodegenerative diseases, there is also evidence
that an interaction with sleep is present. Neuronal expression of Aβ disrupts sleep and its
accumulation is exaggerated by sleep deprivation (Tabuchi et al., 2015), while pharmacologically
inducing sleep can alleviate the memory impairments in neurodegenerative disease models
(Dissel et al., 2015a). Likewise, manipulating Appl in fly glia results in a reciprocal relationship
with sleep (Luna et al., 2017). In a Huntingtin disease model, impressive age-dependent
spreading of Huntingtin protein occurs beyond even limited neuronal populations in which the
protein is originally driven, which depends on endocytosis (Babcock and Ganetzky, 2015). Glia
are also capable of phagocytosing Huntingtin (Pearce et al., 2015).
Therefore, future experiments may take advantage of the Drosophila genetic toolkit to
interrogate whether barrier glial trafficking is important for the accumulation and consequential
progression of neurodegenerative disease-associated genes, and how this function is governed
by sleep and wake. While this strategy will not necessarily identify endogenous substrates that
are cleared, it can serve as a proof of principle of solute efflux, and establish a mechanism by
which it unfolds.
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Peripheral influence on sleep:
The often unspoken dogma of the sleep research field was encapsulated by Alan
Hobson, in that sleep is ‘of the brain, by the brain, and for the brain’ (Hobson, 2005). Given that
sleep’s most defining characteristic is a shift in consciousness and sensory perception,
accompanied by a profound richness of electrophysiological changes, while sleep loss is quickly
followed by cognitive impairment – this conjecture is understandable. At the same time, the
benefit of sleep for the body is recognized both popularly and scientifically, with examples being
the release of growth hormone during sleep (Sassin et al., 1969) and the interaction of sleep and
exercise (Driver and Taylor, 2000).
A broader potential implication of our findings that a barrier population affects sleep and
shows state-dependent trafficking, is that it may be governing signals or substrates which
originate in the periphery. Such an interpretation would hold equally readily for insect and
mammalian barriers, as at the most fundamental level, they are highly selective screens for
isolating the central nervous system, and thus must be navigated to impact behavior. The
mechanisms by which brain and periphery interact during sleep are largely not well established.
There is evidence of peripheral influences on sleep. Knockout of the core clock gene,
Bmal1, in mice increased total NREM sleep – but surprisingly this phenotype can be rescued by
expression in skeletal muscle (Ehlen et al., 2017). Loss of Bmal1 in muscle alone was also
sufficient to increase NREM, and muscle expression of Bmal1 in either background also inhibited
markers of homeostatic sleep such as sleep gained and SWA following deprivation (Ehlen et al.,
2017). It is possible that this mechanism is through paracrine signaling, as muscle can secrete
various myokines and metabolites (Delezie and Handschin, 2018). Interestingly, although reports
vary (Nagy et al., 2014), a homeostatic sleep phenotype was also rescued through muscle in
C.elegans, by the expression of transcription factor Daf-16 in a mutant background (Driver et al.,
2013).
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A major potential intersection of barrier physiology and an established avenue of sleep
research is the influence of peripheral immune factors, such as cytokines. Cytokines can cross
the barrier by transcytosis, potentiate other signals from the barrier, and affect the function of
various native transporters (Pan et al., 2011). One example of such signaling affecting sleep may
be from peripheral IL-6 (Oyanedel et al., 2015). Another consideration is that sleep loss may have
detrimental and possibly pathological effects on barrier function, which could introduce any
number of substrates that might otherwise be held at bay (Hurtado-Alvarado et al., 2016). There
is evidence in rodents that sleep loss can impact tight junctions, and hence create a leakier
barrier (Gomez-Gonzalez et al., 2013, He et al., 2014). Whether or not barrier integrity is
compromised as a result of sleep loss in Drosophila has not been reported. At the same time,
there are other peripheral factors such as xenobiotics, which are actively pumped out upon
entering, and can affect behavior. These present a daily challenge, and their efflux follows a
circadian rhythm, controlled by a local clock within the fly perineurial glia (Zhang et al., 2017).
The provided examples are cases in which tissues signal the brain under specific
conditions, and this affects sleep. It is also possible that barriers impact sleep through less direct
means, simply through being a conduit for nutrients or metabolites. Such a function might be
difficult to measure in unperturbed conditions, but would be apparent if this traffic were disrupted.
Both mammalian and fly barriers contain specialized mechanism to transport carbohydrates (such
as the essential sugar trehalose in the fly), as well as lipids and other metabolites (Weiler et al.,
2017). The brain of flies is surrounded by the head fat body, which supplies lipoproteins that can
then be transferred across the barrier and delivered to appropriate neurons (Brankatschk et al.,
2014).
Our preliminary results suggest that flies with disrupted glial endocytosis have
accumulated acylcarnitines (Chapter 4). The barrier populations express transporters and
receptors capable of shuttling lipids and carnitines, which themselves might impact sleep if
knocked down in these cells. It is not at present clear where the accumulation is happening, but
one possibility is that it reflects a lapse at the barrier, and hence these substances might be
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coming from the periphery. In mammals, lipid transport at the blood-brain barrier can be
dynamically regulated, for example by signals from astrocytes within the brain (Dehouck et al.,
1994). Thereby, the barrier can serve as an interface to metabolic supply, and respond according
to need. Several hypotheses for neuronal energetic supply have been proposed, and the
implications of these continue to be assessed in the context of sleep and wake (Bennington and
Heller, 1995, Petit and Magistretti 2015), so it is quite feasible that a change in energetic
substrate supply, limited at the barrier, would modulate neuronal activity and be consequential to
sleep-wake amounts.

The internal roles of barriers – metabolism and signaling:
While the endothelial and glial barriers are intermediaries between the central nervous
system and periphery, it is also worth considering that these populations might impact behavior
by their own internal functions, either metabolic or through paracrine signaling, which may
depend on conditions in the periphery, but nevertheless originate within the barrier cells.
In flies, the barrier glia may have particularly important function not only in absorbing
trehalose from peripheral hemolymph, but also in its subsequent metabolism. Glycolysis was
found to be expendable for survival in neurons, but was essential in glia, and particularly,
expression of enzymes such as aldolase and pyruvate kinase was strongly enriched in the
perineurial glia, which also have trehalose transporters (Volkenhoff et al., 2015). Fly glia could
also secrete lactate and alanine (Volkenhoff et al., 2015), but whether this is specific to the barrier
cells is unknown. Therefore, it is also possible that our acylcarnitine accumulation results are
indicative of a metabolic block within the barrier population. Still other evidence finds that during
development, the barrier can secrete insulin-like peptides, which signal to neuroblasts, and that
this is a consequence of systemic nutrient availability that perineurial glia would be well
positioned to detect via hemolymph. Hence, there may be paracrine signals which act in adults to
influence behavior, such as sleep. In our preliminary screen we knocked-down sdr, a secreted
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decoy of insulin receptor, which by transcript data is expressed in the barrier glia, but did not
observe a sleep phenotype. Nevertheless, there are likely other means of signaling.
There is also evidence of paracrine signaling in mammals, which may originate in part
from barrier populations. Prostaglandin D2 is a lipid metabolite which promotes sleep (Ueno et al.,
1983) and whose levels correlate with sleep pressure (Ram et al., 1997). The choroid plexus,
which has classically been taken as the source of cerebrospinal fluid, forms yet another barrier,
the blood-CSF barrier which has some distinct trafficking functions from the blood-brain barrier
(Lun et al., 2015). Prostaglandin appears to also be synthesized in the choroid plexus (Urade et
al., 1993), although its major site of action is considered to be in the leptomeninges (Mizoguchi et
al., 2001).
Finally, another internal factor is the role of the circadian clock in the barrier. Our group
has identified a circadian clock in the perineurial glia of the fly, which permits ionic signaling via
gap junctions to control xenobiotic efflux in the subperineurial glia (Zhang et al., 2017). We have
found that endocytic traffic is potentiated with sleep (Chapter 2). Given that the barrier conducts
many forms of trafficking, and appears to also be important in metabolism, the clock may be a
useful means to temporally coordinate functions of the barrier, and hence could also contribute to
pathways which are involved in sleep.

Conclusion:
In conclusion, using the fly model, we have contributed two basic findings throughout the
work of this thesis. For one, we have added another dimension to how astrocytes regulate
homeostatic sleep, in this case through the modulation of neurotransmitters. This mechanism will
have to be incorporated in the growing number of ways by which these cells contribute to sleep
pressure. Second, and perhaps more foundationally, we have shown that the barrier cells can
influence sleep behavior and that this is a consequence of endocytic traffic, which itself appears
to be governed by sleep-wake state. With the addition of the barrier glial populations, all major
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glial classes in the brains of adult flies have now been implicated in sleep regulation (Figure 1).
Given the abundant functional consistencies between fly and vertebrate barriers, we trust that this
will be a fruitful area of further research, as many questions and possibilities arise. The roles that
glia play in sleep and wake are only beginning to be unraveled, and future works will hopefully be
a testament to the necessity of considering glia, in our efforts to understand not only sleep, but
the myriad properties of the brain.

Figure 1: Neuronal and Glial Populations Influencing Sleep
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